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SUMMARY 
The left heart (LH) is a key player of the cardiovascular system. Diseases of and associated 
with the left ventricle (LV)-valve complex account for a large share of cardiovascular 
disease (CVD)-related deaths. As accurate and detailed interrogation of cardiac function 
has been actively pursued clinically in recent years, computational modeling has emerged 
as a viable approach to study the LH dynamics in healthy and diseased states. Yet, most of 
the previous computational investigations have either solved the fluid or structural physics 
alone, have been limited to idealized or 2D geometries, have adopted linear elastic material 
models, have focused on a short time frame of the cardiac cycle, or have not incorporated 
all LH structures. Proper LV-valve dynamics require a balanced interplay between the LV, 
the left atrium (LA), the aortic valve (AV), the mitral valve (MV) and the blood flow. Thus, 
blood-leaflet interaction, leaflet coaptation, and flow dynamics into, within and outward of 
the LV are all critical parameters to investigate, an area where fluid-structure interaction 
(FSI) computational modeling is required.  
The main objective of this dissertation is to model the FSI between the blood flow, 
the heart valves and the cardiac wall during the entire cardiac cycle in order to improve our 
understanding of the biomechanics of the LH complex under baseline, diseased and 
repaired states. First, a novel FSI framework for modeling the 3D LV-valve dynamics will 
be developed and validated. Aim 1 will involve the creation of physiologic and 
pathological LH models that incorporate imaged-based cardiac wall motion, anatomically 
accurate valve geometries, anisotropic nonlinear hyperelastic constitutive models, and 
human cardiac tissue material properties. Next, these holistic LH models will be used to 
 xxv 
better understand the biomechanical challenges facing transcatheter valve technologies that 
cannot be fully evaluated by finite element (FE) or computational fluid dynamics (CFD) 
models, or by in vitro studies or medical imaging alone. Thus, Aim 2 will investigate the 
LH dynamics under various transcatheter MV repair (TMVR) and transcatheter AV 
replacement (TAVR) procedures. The findings from this study may unfold new 
perspectives for an improved understanding of cardiovascular pathophysiology, device-
host biomechanical interaction, inform treatment strategies, support better device design, 









CHAPTER 1. INTRODUCTION 
The LH is a key structure of the cardiovascular system and, when diseased, is associated 
with a large share of CVD-related deaths (1). After a few decades of research, the clear 
anatomic, functional and hemodynamic interdependency of the LV-valve complex and the 
use of various tools to analyze such interactions are well recognized and documented (2). 
While impressive advances in medical imaging techniques such as magnetic resonance 
imaging (MRI) and echocardiography now allow the extraction of anatomical details, valve 
and cardiac motion characteristics, and even time-resolved blood flow data, these imaging 
modalities on their own are not a predictive tool, only provide an incomplete picture of the 
LV-valve biomechanical environment, and do not yield detailed information on the loads 
applied to the valves that arise from the coupled fluid and structure interaction of the 
cardiac tissues and the blood flow (3). In order to better understand the biomechanics of 
the LH and significantly impact the diagnosis as well as the treatment of CVD, it is required 
to supplement clinical observations with computer technologies that allow for a detailed 
quantitative examination of the dynamics of the LH under physiologic, pathologic and 
repaired states.  
Investigation of cardiac function using computational models is an active research 
area that encompasses several numerical approaches, which can be broadly categorized 
into structural-only (FE), fluid-only (CFD), and FSI methods. LV-valve computational 
studies have provided insights into normal cardiac dynamics (2, 4), the biomechanics 
underlying LV and valvular diseases (5, 6), and treatment interventions (7, 8). However, 
previous studies have been limited to idealized geometries, have adopted linear elastic 
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material models, have been focused only on a short time frame of the cardiac cycle, have 
not included the complete LH apparatus, and particularly, have either solved the fluid or 
structural physics alone. FE models, mostly developed to study valve function, assume the 
hemodynamic pressure load is uniform over the surface of the valve, a factor which has 
been previously shown to affect full dynamic/transient valve dynamics (3). CFD models 
on the other hand, yield the non-uniform pressure field across the valve, yet do not account 
for its deformation, which in turn regulates the complex blood flow patterns into, within 
and outwards of the LV. FSI allows to accurately model the LH dynamics because the fluid 
and structural domains are coupled together, and the corresponding dynamics are solved 
simultaneously (changes in the structural domain affect the fluid domain and vice versa). 
The pressure load applied to the valve is calculated from the coupling applied to both 
domains, not from the boundary conditions applied to the model, and is non-uniform. Thus, 
FSI models can capture the 3D time-dependent intraventricular flow and the transient 
deformation of the valvular tissue. 
FSI modeling of LH dynamics, however, is made challenging by the complexity of 
the heart morphology,  the large deformation experienced by the valve leaflets and the 
cardiac wall, the nonlinear elastic behavior of the valvular tissue, and the pulsatile 
hemodynamic loads during the cardiac cycle. Significant progress is still required in the 
modeling procedures before patient-specific LH models can support professionals in 
clinical decision-making and device design. Thus, the overall objective of the present 
research was to develop and implement a LV-valve FSI framework that took into account 
the coupled interactions between blood flow, the heart valves and the cardiac wall during 
the entire cardiac cycle, such that LH dynamics in normal, diseased and repaired states can 
 3 
be accurately modeled. In this context, FSI simulations can provide highly controlled and 
quantitative analyses of the distinct effects of various working conditions and implantable 
devices on the coupled LH dynamics, and are thus advantageous over FE or CFD 
computational models, and complementary to imaging techniques and in vitro models 
alone. This proposed research will greatly advance the state of the art of cardiac modeling 
and will lead to more powerful large-scale simulation tools for future managing heart valve 
diseases of individuals, such as patient-specific modeling for valve design and placement.  
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CHAPTER 2. BACKGROUND 
2.1 Heart anatomy and physiology 
The human heart is a muscular organ that generates the force necessary to circulate blood 
through the entire body. The heart consists of four chambers: the left and right atria (LA 
and RA), and the left and right ventricles (LV and RV). The right side of the heart pumps 
blood to the pulmonary circuit, while the left side pumps blood to the systemic circuit. Two 
valves are located on each ventricle to guarantee the unidirectional blood flow through the 
heart. The inlet valves are the tricuspid and the mitral (TV and MV), while the outlet valves 
are the pulmonary and the aortic (PV and AV). This study will focus on the left heart (LH), 
which refers to the LV, LA, MV, AV and the LV outflow tract (LVOT).  
As seen in Figure 1, the events during a normal cardiac cycle can be divided into 
seven phases. During atrial systole (1), the atria contract ejecting blood into the ventricles 
resulting in a rise in ventricular pressure. At the onset of systole, which is typically 1/3 of 
the cardiac cycle, ventricular isovolumic contraction (2) occurs with the closing of the inlet 
or atrioventricular valves first followed by the outlet or semilunar valves. As the name 
suggests, the ventricular volume remains constant. In the rapid ejection phase (3), as soon 
as the pressure in the LV exceeds the pressure in the aorta, the AV opens and blood flows 
rapidly from the LV into the aorta. Following rapid ejection, the rate of outflow from the 
ventricle decreases, and the ventricular and aortic pressures start to decrease in the reduced 
ejection phase (4). At the end of systole, during the isovolumic relaxation phase (5), the 
ventricular ejection decreases to zero. The ventricular pressure falls below the pressures in 
the aorta and pulmonary artery, which causes the aortic and pulmonary valves to close 
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(beginning of diastolic phase). Once the ventricular pressure falls below the atrial pressure 
the atrioventricular valves open and rapid ventricular filling begins (6). During this period, 
the flow of blood from the aorta to the peripheral arteries continues, and the aortic pressure 
slowly decreases. This rapid ventricular filling phase is followed by the reduced ventricular 
filling phase (7) in which a large portion of filling occurs. The timing of the events can be 
seen in Figure 1. The diagram show the pressure variations in the LA, LV and the aorta, 
the LV volume change and the LVOT flow rate throughout one cardiac cycle. The opening 
and closing events of the valves are indicated with a star. 
The AV and MV are more susceptible to diseases and are subjected to a harsher 
environment than the valves in the right side of the heart, withstanding a pressure gradient 
of about 80 mmHg and 120 mmHg during closure, respectively. The amount of blood 
remaining in the LV when the AV closes is defined as the end-systolic volume (ESV), 
while the volume of blood inside the LV when the MV closes is called the end-diastolic 
volume (EDV). The total volume of blood ejected during systole is called the stroke volume 
(SV), and is defined as SV = EDV − ESV. In a normal resting adult heart at 75 bpm, systole 
lasts approximately 270 ms (1/3) and diastole lasts about 430 ms (2/3), having a SV ~ 70-
80 ml (9). 
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2.2 Left ventricular blood flow 
The LV is not a simple positive displacement pump. The efficiency of such a pumping 
function is dependent on the interactions between the blood flow, the motion of the cardiac 
wall, and the proper mechanical function of the heart valves. During diastole, the LV flow 
is primarily characterized by a strong compact jet that enters the chamber through the mitral 
orifice. The jet has two distinct pulses: the early-filling wave (E-wave) during ventricular 
relaxation, followed by the A-wave produced by the atrial contraction. The entering jet has 
an almost irrotational core surrounded by a shear layer that rolls up and immediately 
arranges into a compact ring-shaped vortex structure that enters the LV. Moreover, the MV 
acts as a flow-diverter, creating blood flow patterns characterized mainly by an asymmetric 
vortex. This asymmetric structure is considered to act as a reservoir that stores kinetic 
energy as it redirects blood towards the lateral LV wall and initiates MV closure and pre-
ejection filling of the LVOT in early systole (11, 12) (Figure 2). The loss of this vortical 
circulation has been associated with loss of energy, higher risk of thrombogenesis, and less 
efficient overall work (13, 14). 
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Figure 2. Blood flow patterns during a) diastole and b) systole (12). 
 
2.3 The mitral apparatus 
The MV, a key player in cardiac function, requires all of its components in order to work 
properly: the mitral annulus (MA), the two mitral leaflets, the papillary muscles (PM) and 
the chordae tendineae (abbreviated chordae); together they are called the mitral apparatus 
(Figure 3a). The MA is a ring of fibrous tissue which surrounds and supports the mitral 
orifice and anchors the two leaflets. The shape of the annulus approximates a hyperbolic 
paraboloid, often described as a 3D saddle shape. Studies indicate that the saddle shape of 
the annulus plays an important role in optimizing chordal force distribution (15) and 
reducing leaflet stresses (16). The MV and AV share a common fibrous boundary, as 
shown in Figure 3b. The anterior MA is flanked by the right and left fibrous trigones 
separated by a rigid span of fibrous tissue, the intertrigonal region. The anterior MA is 
anatomically coupled to the aortic annulus. This confluence is usually referred to as 
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the aortic-mitral curtain or intervalvular fibrosa (17). Normal physiological function of 
either of these two valves involves the complementary function of the other. 
The MV consists of two leaflets: the anterior (AML) and posterior (PML) mitral 
leaflets. They are indented at two points and these indentations are known as commissures. 
The AML is adjacent to the LVOT and occupies 1/3 of the annular circumference, whereas 
the PML occupies the rest. During valve closure, the leaflets will fold towards each other, 
forming a closed seal called the coaptation zone. Most commonly, surgeons adopt the 
suggestion of Carpentier (18), who labeled the functional components of the valve in 
alphanumeric fashion with the posterior scallops named P1 to P3, and opposing anterior 
segments named A1 to A3 (Figure 4). The anterior commissure is located where both 
leaflets free edges join in the A1 and P1 area, while the posterior commissure is located 
where both leaflet’s free edges join in the A3 and P3 area. 
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Figure 3. a) Mitral apparatus (adapted from (19)), b) the anterior MA is flanked by 
the left (A) and right (B) fibrous trigones. The confluence of the MA (C) and the 
aortic annulus (E) is called the aortic-mitral curtain (adapted from (20)). 
 
The subvalvular apparatus lies completely in the LV and is composed by the PM 
and the chordae (Figure 3a). The PM are cone-shaped muscles extending upward from the 
ventricular free wall and into the LV cavity. There are two PM: the anterolateral PM (APM) 
and the posteromedial PM (PPM). The chordae are string-like fibrous structures that extend 
from the tips of the PM and insert into the ventricular surface of the mitral leaflets. The 
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chordae divide into branches, with 15-32 major chordae trunks arising from the PM (21). 
The main function of the subvalvular apparatus is to prevent the valve leaflets from being 
everted into the LA when the ventricle contracts. During systole, the PM contract to tighten 
the chordae tendineae. The forces exerted by the leaflets on the chordae are transferred to 
the PM, hence they have an essential load-bearing role.  
 
Figure 4. Labeling convention for the various regions of the mitral leaflets (adapted 
from (22)). 
 
2.4 Mitral regurgitation 
MV disease is the most common valvular disease(23). Mitral regurgitation (MR) occurs 
when the MV does not close completely during systole. The current prevalence of moderate 
to severe MR in the U.S. is estimated to be 2 to 2.5 million(24). Additionally, a significant 
portion of the patient population that experiences MR is elderly: The AHA reports that of 
all patients aged 75 and above, 9% present with some form of MR (25). Causes of MR are 
divided into two different categories: primary (degenerative) and secondary (functional). 
Primary MR includes malformations or abnormal tissue properties of valve components. 
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Morphologic changes may include connective tissue deficiency or excess. Rupture or 
elongation of one or more chordae is usually observed (26). Consequently, primary MR 
almost always exhibits one or more locations of leaflet flail or prolapse into the LA (Figure 
5).  
 
Figure 5. Normal, prolapsed and leaking MV (adapted from (27)). 
 
Secondary MR, on the other hand, occurs when regurgitation is secondary to a 
disease of the LV. Secondary MR is typically caused either by ischemia or other disease-
related dilation of the LV, and is associated with a doubling in mortality among patients 
with mild or greater degrees of MR following a heart attack (28). In ischemic MR, LV 
remodeling after myocardial infarction results in PM displacement, causing systolic tenting 
of the MV (Figure 5). Global LV ejection fraction (LVEF) may or not be reduced; as 
regional wall motion abnormalities with remodeling may result in sufficient MV tethering 
to cause severe MR, despite preserved LVEF (29). Symmetric or asymmetric leaflet 
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tethering may occur. Symmetric tethering is usually associated with global systolic 
dysfunction with a central regurgitant jet. Asymmetric tethering most frequently results 
from tethering of the PML which is associated with an akinetic or hypokinetic 
posterolateral segment of the LV myocardium, resulting in a posteriorly directed 
asymmetric regurgitant jet into the LA (30). MA dilation typically occurs late in the 
pathophysiology of secondary MR, and is often asymmetric with greater involvement of 
the posterior MA (31). Significant MR eventually leads to volume overload and 
enlargement of the LV, in order to accommodate both the SV and the regurgitant volume 
with each heartbeat. There can also be an enlargement of the atrial chamber and an increase 
in the pressure. The increased atrial pressure can lead to pulmonary congestion and edema. 
Over time, further LV enlargement may not adequately address these demands, leading to 
reduced LVEF. If left untreated, moderate to severe MR can lead to heart failure (26).  
Table 1 shows the quantitative parameters recommended by the American College 
of Cardiology/American Heart Association (ACC/AHA) to evaluate MR and its severity 
(1). Echocardiography with Doppler is currently the method of choice for the detection and 
evaluation of the severity and etiology of valvular regurgitation (32). 2D echocardiography 
allows an evaluation of the valvular structure as well as the impact of the volume overload 
on the cardiac chambers. Structural parameters including LA and LV size, MV leaflet and 
support apparatus are examined through 2D echo and signs such as leaflet calcification, 
tethering, flail motion or vegetation, enlarged LA or LV and ruptured PM can give indirect 
clues as to the severity of regurgitation. Color flow Doppler provides three methods of 
quantifying MR severity including regurgitation jet area, vena contracta and flow 
convergence or proximal isovelocity surface area (PISA). Continous wave Doppler signal 
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provides information on the velocity profile and density which is a qualitative index of MR 
severity. Pulsed Doppler tracings at the mitral leaflet tips are commonly used to evaluate 
LV diastolic function while Pulsed Doppler evaluation of pulmonary venous flow is a 
useful adjunct to evaluating the hemodynamic consequences of MR (32). While the 
quantitative and qualitative information described above can be measured by both 
transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE), TEE 
has higher resolution, multiplane capabilities, and proximity to the MV which makes vena 
contracta imaging and PISA easier and more accurate. 
Table 1. Classification of MR severity in adults from ACC/AHA guidelines (1). 
Degree of MR Regurgitant fraction Regurgitant Orifice area 
Mild < 20% 
 Moderate 20 – 40% 
Moderate to severe 40 – 60% 
Severe > 60% > 0.4 cm2 
 
2.5 Corrections for mitral regurgitation 
Surgical MV repair or replacement is indicated in patients with severe MR and symptoms, 
or LV dysfunction (LVEF < 60% or LV end-systolic diameter > 40 mm) (26). There are 
different surgical repair options for the MV including, but not limited to: annuloplasty ring 
implantation, edge-to-edge repair, leaflet resection and neo-chordae implant. An 
annuloplasty ring is a prosthetic ring designed to restore normal MA shape and prevent 
future dilation (33). A ring is typically sutured in combination with another repair 
technique, as it reduces the tension on sutures used in leaflet and chordae repairs (33). 
There are many different ring designs that vary in shape (flat vs. saddle), stiffness (rigid 
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vs. semi-rigid vs. flexible), and length (closed vs. partial ring). Moreover, since the MA 
size varies between patients, the rings come in multiple sizes. The edge-to-edge repair 
technique, on the other hand, involves suturing the free margin of the prolapsing or flail 
leaflet with the corresponding edge of the normal opposing leaflet. As seen in Figure 6, 
there are two types of repairs: double-orifice stitch (central leaflet correction) and single 
orifice stitch (paracommissural leaflet correction) (34). The non-physiological dual-orifice 
geometry of the central leaflet correction remains a concern in regards to long-term 
durability, and is a topic of active investigation. 
 
Figure 6. Edge-to edge MV repair (adapted from (35)). 
 
There also exist several options for surgical MV replacement, although there is 
some debate as to which method of treatment is superior (36). Yet, cardiac surgeons are 
more likely to perform surgical MV replacement with the primary reason that many 
physicians do not have the experience and specialized skills to consistently repair the MV 
in complex MR cases (37, 38). Additionally, many patients – especially these elderly 
patients previously mentioned – present with significant comorbidities or LV dysfunction 
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that is severe enough such that they are not referred for conventional surgical treatment 
(39). It is therefore becoming increasingly relevant to develop minimally invasive repair 
and replacement devices to treat MR. The approaches for transcatheter MV repair (TMVR) 
are diverse and include indirect or direct annuloplasty, neochordae implantation and the 
MitraClip device (Abbott Vascular, Santa Clara, CA), which mimics the surgical edge-to-
edge technique. In current clinical practice, TMVR is mainly limited to the MitraClip 
device, as other techniques are currently at the experimental or first-in-human stages. In 
the U.S. and Europe, the MitraClip is approved for use in patients with primary and 
functional MR who have severe symptoms and are at high or prohibitive risk of surgery. 
2.6 Transcatheter aortic valve replacement and concomitant mitral regurgitation 
Aortic stenosis (AS) is the most prevalent valvular heart disease referred for treatment. 
First reserved for inoperable and patients at high surgical risk, transcatheter AV 
replacement (TAVR) has been expanded to patients with symptomatic intermediate- and 
low-risk (40), with the advantages of less trauma and shorter recovery time, and thus it is 
fundamentally changing the current paradigm of AV replacement. Since the first-in-human 
implantation in 2002, there has been explosive growth in its use throughout the world. 
Significant MR is common in patients with severe AS (41). In these cases, MV 
repair or replacement is generally performed at the time of surgical aortic valve 
replacement (SAVR) (42, 43). However, concomitant MR in TAVR patients is typically 
left untreated (44). The hallmark TAVR PARTNER trial reported incidences of moderate 
to severe MR of 19.8% and 22.2% in cohort A (comparison of TAVR to surgical 
replacement) and B (comparison of TAVR to standard therapy) patients, respectively. The 
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persistence of moderate-to-severe MR following TAVR is therefore a relatively new and 
important entity. The management of patients with severe AS and concomitant MR is 
challenging, mainly because the AV and MV share a common fibrous boundary and the 
two valves function in a reciprocal interdependent fashion. Thus, MV function could be 
altered after TAVR by displacing the aortic-mitral curtain (Figure 3b). Some studies have 
shown that MR severity improved in about 50% of patients who received TAVR (45, 46). 
On the other hand, MR severity remained unchanged or even worsened in a significant 
number of TAVR patients (47-52). Moreover, different degrees of MR improvement with 
the use of the self-expandable Medtronic CoreValve system compared to the balloon-
expandable Edwards SAPIEN valve have been suggested (49, 53). These confounding 
results indicate a pressing need to develop engineering methods to improve our 
understanding of the coupling TAVR-MR biomechanics and predict MR changes 
following TAVR. 
2.7 Bicuspid aortic valve disease 
Bicuspid AV disease (BAV), a malformation of the AV in which only two leaflets form 
instead of the normal three, is the most common congenital cardiac anomaly, occurring in 
0.5% to 2% of the general population (54). In the U.S. alone, approximately 4 million 
people are afflicted with BAV (55). BAV is characterized by a marked phenotypic 
heterogeneity of valve morphology. It is not simply the fusion of 2 leaflets, but a more 
complex process involving the leaflets, sinuses, commissures, and position of the coronary 
orifices(56). The fusion of two leaflets forms a ridge, called a raphe, the presence and 
position of which contributes to the variability of morphology. Several classifications of 
BAV morphology exist. As seen in Figure 7, Sievers and Schmidtke (56) proposed a 
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system based on 3 characteristics: the number of raphes, the spatial position of the leaflets 
or raphes, and the functional status of the valve. Briefly, type 0 was assigned to 
morphologies characterized by the presence of two symmetric leaflets and 1 commissure 
without evidence of a raphe. Type 1 was assigned to valve morphologies with one raphe, 
and type 2 when two raphes were present.  
BAV is recognized as a risk factor underlying many significant clinical 
consequences including: valvular calcification and stenosis, regurgitation, infective 
endocarditis, aortic dilation, and dissection (54). Most prominently, BAV patients account 
for nearly 50% of all AS cases (57). Despite the extensive experience with TAVR 
technology, BAV stenosis has been considered a relative contraindication for TAVR due 
to the numerous technical challenges related to bicuspid anatomy, including extreme and 
asymmetric calcification, heterogeneity of leaflet morphology, the presence of a densely 
calcified raphe, and aortopathy. The asymmetrical and heavy calcification of the BAV 
leaflets may prevent uniform or adequate expansion of the valve frame and affect valve 
hemodynamics and long-term durability, leading to higher transvalvular gradients and 
paravalvular leak (PVL). The risk of aortic dissection or rupture during TAVR is 
theoretically increased in the presence of aortic disease. BAV stenosis has therefore been 
an exclusion criterion in the randomized clinical trials of TAVR. Indeed, the Instructions 
for Use issued by the FDA for TAVR specify that the safety and effectiveness of TAVR in 
bicuspid AS is not yet established. Despite these concerns, BAV stenosis is increasingly 
being treated with TAVR under “off-label-use”, and there is a fundamental need for the 
understanding of the biomechanics involved in TAVR-in-BAV. 
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Figure 7. BAV classification. Dotted line shows the raphe position (adapted from 
(58)). 
 
2.8 Left ventricle-valve computational modelling 
Blood flow-leaflet interaction, leaflet coaptation, and flow dynamics into, within and 
outward of the LV are critical parameters to investigate in the study of LH dynamics. Yet, 
few modeling studies have integrated either the AV or the MV with the LV into a single 
model (59-61), particularly with FSI (62, 63). Reasons for this include: 1) the complex LV-
valve geometries, especially the connection between the mitral subvalvular apparatus and 
the LV, and the aortic-mitral curtain, 2) the strong coupling between the large deformation 
of the nonlinear elastic structure of the leaflets and the blood flow, 3) challenges when 
modeling complete valve closure, where the flow domain is separated into two 
unconnected regions, 4) difficult choices of boundary conditions, 5) limited human tissue 
material properties, and 6) large computational resources required by these simulations. 
From the few LV-valve FSI models that have been developed, the earliest is 
credited to Peskin and McQueen’s pioneering work in the 1970s (64-66) using the classical 
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immersed boundary (IB) approach (67). Using this same method, Yin et al. (68) 
investigated fluid vortices associated with the LV motion as a prescribed moving boundary. 
Chandran and Kim (8) also reported the MV dynamics in a simplified LV chamber model 
during diastolic filling using an immersed interface-like approach. Recently, Gao et al. (69) 
presented an integrated LV-MV model using an IB-FE approach with myocardial active 
contraction. Some of the key limitations of these coupled models were the idealized 
representation of the LV and the mitral apparatus, and the complete omission of the AV 
geometry, which can add uncertainties in the simulation results.  
2.8.1 Mitral valve computational modelling 
Computational models of the MV have been developed for several decades, starting from 
the simplified 2D approximation to 3D models, and to multi-physics/scale models (60, 70-
75). Most of the previous studies were based on structural-only and quasi-static analyses 
applicable to a closed valve (6). However, complete MV function during the cardiac cycle 
cannot be fully assessed without modeling the FSI between the valve, the proximal cardiac 
wall and the blood flow (6, 76). From the MV studies that have included the LV but not 
FSI, Wenk et al. (59) developed a FE model using MRI images from a sheep with moderate 
MR after myocardial infarction. This model was later extended to study MV stress 
distributions using a saddle shaped and asymmetric mitral annuloplasty ring (77). A more 
complete whole-heart model was later developed in the Dassault Systèmes’ Living Heart 
project (78) to simulate MR caused by infarction of the posterior PM. The model included 
four ventricular chambers, cardiac valves, electrophysiology, and detailed myofibre and 
collagen architecture. Using the same model, the effects of different annuloplasty rings 
were studied by Rausch et al. (79). However, these investigations did not account for FSI. 
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Because of the complex interactions between the MV leaflets, the sub-mitral 
apparatus, the cardiac wall, and the associated blood flow, most MV FSI studies to date 
have been carried out without the integration of the LV. Kunzelman, Einstein and co-
workers first simulated normal and pathological MV function by positioning the valve into 
a straight tube (80-82). Using a similar modeling approach, Lau et al. (3) compared MV 
dynamics with and without FSI, finding that valve closure configuration differed when 
using the FSI model. Over the last few years, a number of FSI models using the IB method 
have studied the flow across the MV (83-85). In a series of studies, Toma et al. (86-88) 
developed a SPH-based FSI MV model based on an in vitro experimental system to study 
the function of the chordae structure under normal and ruptured states. However, none of 
the aforementioned FSI models accounted for the MV interaction with the LV complex. 
Indeed, Lau et al. (3) found that even with a fixed U-shaped ventricle, the flow patterns are 
substantially different from those estimated using a tubular geometry. Despite the 
advancements in computational modeling techniques when modeling isolated MV (6, 75) 
or LV dynamics (89-91), it has remained a challenge to develop an integrated LV-valve 
FSI modeling framework that can handle the complex valve geometry, large leaflet 
deformation, and nonlinear and anisotropic material of the tissue. 
2.8.2 Mitral valve repair computational modelling 
In relation to computational modeling of MV repair procedures, to the best of our 
knowledge, the only LV-valve FSI model developed to study MV repair (edge-to-edge 
technique) had important simplifications regarding the geometry and the dynamics of the 
boundaries, including a rigid U-shaped LV geometry and the complete omission of the AV 
(92). On the other hand, several MV repair techniques have been simulated using FE 
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analysis in order to better understand the biomechanics of the valve in such states. The first 
FE analysis of the edge-to-edge intervention was by Votta et al. (93), where the effects of 
varying the suture length in MV models with different levels of annular dilation were 
studied. It was found that the principal stresses at systole did not differ significantly 
between the pre- and post-repaired models. However, during diastole the stresses in the 
repaired MV model were found to be similar in magnitude to the diseased model in systole. 
The combined effects of lateral suture positioning, length of the suture and severity of 
annular dilation have also been examined. Dal Pan et al. (94) created a MV model with the 
leaflets in a semi–closed configuration, with the free margin of the leaflet constrained 
simulating the effect of a suture. Suture position ranged from the center, forming two 
orifices, to adjacent to a commissure, forming one orifice. The different annulus sizes 
varied from larger than normal, as in a diseased state, to a contracted annulus, as if an 
annuloplasty ring had been implanted. The MV model by Avanzini et al. (95) used a similar 
initial configuration as the study by Dal Pan and colleagues, but suture positions included 
central, commissural and half-way. More recently, Mansi et al. (96) developed an 
integrated FE framework for edge-to-edge simulation on 25 patient-specific anatomical 
models. Comparisons between the simulated closed valve and 3D TEE images showed 
encouraging results. These studies provided useful analyses for technique improvement 
and optimization, and paved the way to quantitative and systematic evaluation of 
computational models of MV repair. 
As MV prolapse following rupture of the chordae is a major cause of MR, artificial 
chordae implantation by ePTFE sutures has become an established conservative surgical 
technique to treat this disease. Kunzelman  and colleagues (97, 98) were the first to study 
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the effect of chordae rupture and their replacement (variations in number, size, and length) 
on MV function. FE results showed that in the diseased state, the principal stresses in the 
mitral leaflets are comparable to the normal state. Although replacement of the chordae 
with stiffer neo-chordae restores the magnitude of the principal stress to the normal state, 
stress concentrations are induced at the location of the chordae due to a mismatch in 
stiffness. These localized peaks, however, can be minimized by increasing the number of 
artificial chordae.  
More recently, by developing a MV model using 3D TEE data in a patient with 
posterior chordae rupture, Kim and colleagues (99-101) studied the effect of chordae 
replacement on restoring MV function. Large stresses were found in the neighboring intact 
posterior leaflet tissue and chordae of the MV model with ruptured chordae, and these large 
stresses were markedly reduced when chordae replacement was performed. Similarly, 
Sturla et al. (102, 103) created a MV FE model to investigate the biomechanical effect of 
five different neo-chordae implantation techniques for the repair of isolated posterior mitral 
leaflet prolapse. Four patient-specific MV models were created based on cardiac MRI and 
integrated with intraoperative surgical details to assess the location and extent of the 
prolapsing region. Leaflet geometry, coaptation area, and stresses across native chordae, 
ePTFE sutures and regions of the posterior leaflet were compared between models. 
Simulation results demonstrated that all repair types corrected MR by restoring leaflet 
coaptation, and redistributed stress across the valve leaflets and prosthetic chordae, 
relieving excessive mechanical stress on the mitral leaflets. The models with more than one 
neo-chordae resulted in the greatest redistribution of stress across the repaired area of 
posterior leaflet. It was determined that suboptimal suture length can alter the chordae 
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forces and leaflet stresses, which may be key parameters in determining the long-term 
outcome of the MV repair. 
Although many different types of MV annuloplasty rings are commercially 
available, most clinical experts agree that proper ring selection and sizing present 
substantial challenges, and if performed incorrectly – can lead to a suboptimal clinical 
outcome. Early studies by Kunzelman et al. (104) developed FE models of the normal and 
dilated MV to simulate the effects of flexible and rigid annuloplasty rings. Although it was 
found that both rings improved leaflet coaptation, the flexible ring further reduced leaflet 
and chordal stresses. Subsequently, Maisano et al. (105) showed that the dog bone–shaped 
ring with selective reduction in the septolateral dimension is more effective than a standard 
D-shaped ring for treating leaflet tethering in functional MR. Votta et al. (106) also 
reported a comparative study between the commercial Physio and the Geoform 
annuloplasty rings. However, these studies were conducted on a generalized MV model 
and excluded or simplified the LV geometry. Recent advances were made, for example, by 
Wong et al. (77), who used a MRI-based ovine MV-LV model to investigate the effects of 
saddle-shaped vs. asymmetric annuloplasty rings. It found that all rings were capable of 
restoring normal valvular geometry and eliminating MR when properly implanted.  
By using 3D echo images, Xu et al. (107) reconstructed MV models to examine 
how leaflet coaptation area, noncoapted leaflet area, and interleaflet coefficient of friction 
affect leaflet and chordal stress distribution. The results indicated that MV repair 
techniques that increase or preserve noncoapted leaflet area might decrease stresses, and 
thereby enhance repair durability. Morrel et al. (108) also developed human MV models, 
and investigated on leaflet coaptation as well as on valvular, annular and suture stress 
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distributions for three different ring shapes. It was shown that all rings increased leaflet 
coaptation and reduced stress across the MV leaflets, however, saddle-shaped prostheses 
were the most effective, as were smaller sizes across all ring shapes. Stevanella et al. (74) 
created a patients-specific MV model using cardiac MRI, while Choi et al. 22 (109) used 
3D TEE. In both FE studies, restoration of leaflet coaptation was achieved. In general, the 
ring itself is not physically modeled, but approximated by fitting the mitral annulus to the 
shape of the ring. Measurements of the effectiveness of the ring implantation include: 
overall post-ring-implantation MV morphology, length of leaflet coaptation, regurgitant 
area, and stress distribution across the mitral leaflets. 
2.8.3 Transcatheter aortic valve replacement computational modelling 
In the last decade, computational models have been increasingly and extensively used for 
the simulation of TAVR. Capelli et al. (110) and Wang et al. (111) were among the first 
groups to perform patient-specific FE analyses of TAV deployment. These analyses 
showed that patient-specific geometries induce asymmetric stress distributions on the 
device and tissue, and impact a particular patient's risk of PVL, coronary occlusion, and 
rupture (112). Auricchio et al. (113), Gunning et al. (114), and Morganti et al. (113) have 
since shown that TAV leaflets may become distorted when the device is deployed within 
a realistic rather than an idealized and circular aortic root geometry. Thus, patient-specific 
analyses are important for predicting device function in addition to device-tissue 
interactions. Device positioning to align the TAV commissures with the native AV 
commissures may also be important for reducing TAV leaflet stresses and consequently 
achieving a durable result (114). More sophisticated FE models which included the 
calcification along with the aortic root and valve leaflets  have demonstrated that the extent 
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and location of calcium deposits significantly affect the stent expansion process and a 
patient's risk of aortic root rupture during deployment (112, 115-117). Sturla et al. (118) 
investigated the impact of different calcification patterns on TAVR outcome. High stresses 
acting on calcium deposits may be a risk factor for embolization of calcific material. 
More recent FE models have been applied to new-generation TAVR devices with 
improvements on the modeling accuracy, including precise 3D geometry of TAV through 
micro CT scanning (119, 120), crimping (121, 122), delivery apparatus (123), comparison 
against post-procedural clinical data (124, 125), and population-specific response (124-
126). Bosi et al. (124) studied TAVR with the SAPIEN XT in 14 patients. Implantation 
site material parameters were adjusted and optimized using an experimental approach. 
Bailey et al. (123) simulated SAPIEN XT deployment into a patient-specific aortic root 
model with different orientations. It was found that the preferred orientation of the TAV 
leaflets is the one aligned with the native AV leaflets. Hopf et al. (126) quantified the 
contact forces between the implanted Nitinol stent and the host for 46 patients with the 
Medtronic CoreValve. Comparison of systolic and diastolic data revealed slightly higher 
contact forces during diastole. By analyzing clinical outcomes, an increase in mean force 
was associated with higher incidents of PVL and the need for a permanent pacemaker. 
Bianchi et al. (127) evaluated the effect of various TAV deployment locations on 
procedural outcome by assessing the risk for valve migration. Proximal deployment led to 
lower contact area, which poses an increased risk for valve migration. It was also 
demonstrated by Bailey et al. (122) that including the TAV leaflets in the simulation has 
only a marginal impact on the results. Regarding TAVR CFD simulations, PVL was 
numerically evaluated under steady-state (128) and transient (129-132) conditions. Flow 
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patterns variations in the aortic root-induced by TAVR (133) and the relation between 
valve thrombosis and reduced leaflet motion has also been investigated (134).  
In the first TAVR FSI studies, only the coupling between blood and the aorta, or 
blood and the AV was considered. In the first study, TAV design was evaluated, neglecting 
the native valve leaflets and calcification (135). On the second study, a comparison 
between FE and FSI results on an idealized TAV was performed, confirming a more 
realistic representation of the valve when applying the FSI method (136). TAVR was also 
compared to the conventional surgical AV replacement in terms of leaflet stresses and 
thrombogenic profile (137). Up to now, only two FSI investigations have modeled the 
complete TAVR procedure (138, 139). In both studies, the deployment of the complete 
device, frame, leaflets, and skirt was performed. However, the patient-specific domain was 
simplified by considering the aorta as a rigid part or with a linear elastic material law. In 
both cases, the native AV and calcification were neglected, and the boundary conditions 
applied to the fluid domain were not patient-specific. Although a significant portion of AS 
patients referred for TAVR have concomitant MR, the biomechanical effects of TAVR on 
aortic-mitral coupling and MR severity are largely unknown. To the best of our knowledge, 
there is no computational (or experimental) study that has investigated the impact of TAVR 
on MR. Thus, development and application of the LV-valve FSI modeling framework to 
investigate the effect of TAVR deployment on MR severity as proposed in this study would 
represent a significant advancement in the field. 
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CHAPTER 3. OBJECTIVE AND SPECIFIC AIMS 
CVD are the leading global cause of death, accounting for >17.9 million or 31% of all 
deaths per year (1). As a key structure of the cardiovascular system, the LH constitutes one 
of the most important and challenging domains to study, due to its significance in the 
initiation and propagation of numerous CVD (1). In particular, the balanced interplay 
between the LV, LA, MV, AV and the blood flow plays a fundamental role in the structural 
and functional integrity of the heart. In the U.S. alone, the prevalence of moderate-to-severe 
AS in patients ≥75 years old is 2.8%, while the prevalence of at least moderate MR is 9.3% 
(140). When the functioning of a heart valve is sufficiently impaired, surgical or 
transcatheter valve repair/replacement is required. As valve diseases remain a major 
medical problem due to their close link to cardiac dysfunction leading to morbidity and 
premature mortality (140), an improved understanding of physiological and pathological 
LV-valve biomechanics is critical to unfold new perspectives on LH function, as well as 
for the evaluation, selection and optimization of next-generation transcatheter technologies 
aimed at restoring baseline LV-valve functioning. 
Investigation of patient-specific cardiac dynamics using computational models is 
an active research field that holds promise for the improved understanding of cardiac 
function in healthy and diseased states. A comprehensive computational assessment of LV-
valve dynamics, however, is challenging and requires a FSI modeling approach in order to 
capture the complex coupling between the large deformation experienced by the heart 
valves and the cardiac wall, the anisotropic nonlinear elastic behavior of the valvular tissue, 
the pulsatile hemodynamic loads throughout the cardiac cycle, and the large inter-subject 
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variability in the cardiac anatomy. A number of computational studies have seek to shed 
some light on the LV-valve biomechanics (2, 4, 8, 76), yet, most of these studies have 
either solved the fluid or structural physics alone, have been limited to idealized or 2D 
geometries, have adopted linear elastic material models, have focused on a short period of 
the cardiac cycle, or have not included the complete LH complex. With these challenges 
in mind, the main objective of this dissertation is to model the FSI between the heart valves, 
the blood flow, and the cardiac wall during the entire cardiac cycle in order to improve our 
understanding of the LH dynamics under healthy, diseased and repaired states. This will 
be achieved through the following specific aims: 
 
Specific Aim 1: Develop a novel FSI computational framework for modeling LV-valve 
dynamics. A FSI framework that combines smoothed particle hydrodynamics (SPH) and 
nonlinear FE method will be developed to describe the coupled bulk blood flow phenomena 
and the heart valves structural response of the LH complex throughout the cardiac cycle. 
This aim will involve the development of healthy and pathological LV-valve models that 
incorporate imaged-based cardiac wall motion, anatomically accurate valve geometries, 
nonlinear hyperelastic constitutive models, and human age- and gender-matched material 
properties. The LH models will be validated against in vivo phase contrast magnetic 
resonance (PCMR) imaging and echocardiography data, as well as to a traditional CFD 
numerical method. The validated LH FSI models will be used in Aim 2 to better understand 
the biomechanical challenges facing minimally-invasive AV replacement and MV repair 
procedures that cannot be fully evaluated by structural-only or fluid-only computational 
models, or by in vitro studies or medical imaging alone. 
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Specific Aim 2: Investigate the LV-valve dynamics under transcatheter MV repair 
(TMVR) and transcatheter AV replacement (TAVR) procedures. As TAVR is now the 
standard-of-care treatment for inoperable patients and the preferred treatment option for 
high-, intermediate- and low-risk patients with severe AS, there is a pressing need to 
improve our understanding of TAV-host interactions in more challenging scenarios, such 
as in patients with concomitant significant MR and BAV stenosis. Moreover, encouraged 
by the success of TAVR, cardiology is shifting focus toward the next major frontier in 
structural heart intervention: TMVR. This aim will: 1) Investigate the biomechanical effect 
of various TMVR technologies such as neochordae implantation, MitraClip edge-to-edge 
repair, and annuloplasty ring implantation on restoring baseline LH dynamics, and 2) 
Evaluate the biomechanical impact of TAVR on MR severity. More specifically, we will 
examine the effect of TAV type and implantation height on aortic-mitral coupling, and the 
potential to improve or worsen MR severity immediately after TAVR. Altogether, a 
quantitative mechanistic evaluation of LV-valve dynamics in the setting of MR and AV 
stenosis is not only expected to unfold new perspectives for the improved understanding 
of cardiac pathophysiology, but may eventually inform the therapeutic decision-making 
process and provide insight into patient-specific surgical planning and better device design, 
ultimately supporting improved clinical outcomes. 
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CHAPTER 4. SPECIFIC AIM 1A – PART 1, PHYSIOLOGIC LV 
BLOOD DYNAMICS 
4.1 Introduction 
Investigation of cardiac flow using CFD is an active research area that encompasses several 
numerical approaches, which can be broadly categorized into mesh-based methods and 
mesh-free methods. Most numerical LV studies to-date are based on mesh-based methods 
such as the arbitrary Lagrangian–Eulerian (ALE) approach (141) or the IB method (64). In 
general, complex geometries, boundaries with large deformations, and moving interfaces 
involved in the study of LV blood flow remain a major challenge for mesh-based methods 
(142). 
To overcome these limitations, a new generation of numerical methods called 
mesh-free methods have been developed and adapted in recent years. Mesh-free methods 
are based on a Lagrangian approach instead of the Eulerian approach, therefore the 
continuum medium, such as blood, is discretized as a set of particles distributed over the 
solution domain without the need of a spatial mesh (143). In particular, the SPH method, 
created originally to simulate compressible flows in astrophysics (144), is a versatile fully 
Lagrangian approach that has been applied extensively to study a variety of physical 
phenomena (145-149). 
While SPH or other mesh-free methods have been successfully used for blood flow 
simulations before, the majority of these studies have focused on vascular hemodynamics 
(150-152), which are far simpler than that of the heart. To date, a limited number of studies 
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have used SPH to study cardiac blood flow (86, 153-155). Shahriari et al. (156) presented 
the first work demonstrating the capability of SPH to simulate the intraventricular blood 
flow in a simplified LV model. In this study, the SPH code and methodology were validated 
against two benchmark cases, and then combined to simulate pulsatile flow in a rigid LV 
model. Although this study clearly demonstrated the ability of SPH to simulate the LV 
flow dynamics, the main limitations associated with this study were the assumption of a 
2D geometry and a rigid LV model. 
Although SPH is a relatively new tool in the study of cardiac flow, this method is 
attractive for simulating the FSI phenomenon involved in the LV blood flow.  Due to its 
capability to handle complex geometric motion, SPH is particularly useful to model the 
complex LV-valve dynamics that involves nonlinear large deformations during the entire 
cardiac cycle with flow fragmentation during valve closure. However, there are some 
inherent limitations associated with SPH. For example, modeling of wall boundary 
conditions is non-trivial for SPH, requiring some special treatments such as placement of 
fixed ghost particles outside the computational domain (157, 158). Additionally, 
turbulence modeling has not been well developed in SPH and is currently an area of great 
interest (159, 160). These limitations are likely to affect the flow solution in the boundary 
layers and limit the study of the small-scale flow features seen in the intraventricular blood 
flow. Recently, SPH has been implemented in Abaqus (SIMULIA, Providence, RI), a 
widely used commercial nonlinear FE solver. In our recent study (155) using Abaqus/SPH 
coupled with nonlinear hyperelastic FE valve models, we compared SPH-FSI and FE-only 
simulations of a bioprosthetic valve. It was found that SPH-FSI was able to generate more 
realistic leaflet spatial and temporal dynamics, as well as stress and strain fields.   
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The ultimate goal of this dissertation is to develop a comprehensive SPH-FE FSI 
framework to model subject- and patient-specific LH dynamics throughout the cardiac 
cycle. As a first towards this goal, Specific Aim 1a – Part 1 will investigate the capability 
of the SPH flow solver to model the large-scale blood flow dynamics in two realistic human 
LV models (LV-SPH), since the bulk flow ultimately drives the deformation of the heart 
valves. Part 1 will also involve the validation of the LV-SPH flow results with a traditional 
finite volume-based CFD method (LV-CFD), and to in vivo subject-specific hemodynamic 
data, specifically PCMR (LV-MRI) and echo data, in terms of clinically significant large-
scale blood flow measurements. Results will be analyzed to identify and discuss the key 
challenges, limitations, and practical implications when using SPH to study the 3D LV 
bulk flow.  
In Part 2 of Specific Aim 1a, we will test the SPH-FE FSI method’s capability to 
model the coupled valves structural response and the intraventricular hemodynamics in a 
subject-specific LV-valve model (LV-FSI). LV-FSI flow and structural results will be 
validated against subject-specific echo data and MSCT images, clinical observations, and 
in vivo and in vitro studies of healthy LV-valve dynamics. Successful completion of 
Specific Aim 1a will yield a novel FSI framework for the study of healthy LH dynamics, 
which will serve as a basis for the investigation of pathological and post-procedural LH 
dynamics in Specific Aim 1b and Specific Aim 2, respectively. 
4.2 Materials and Methods 
One healthy human volunteer with no underlying cardiac diseases and one pre-operative 
TAVR patient with normal LV function were selected for Specific Aim 1 – Part 1, herein 
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denoted as Subject 1 and Subject 2, respectively. Institutional Review Board (IRB) 
approval was obtained for this study. Figure 8 shows the schematic of our study design. 
3D LV geometries and wall motion were obtained from medical images. In silico LV-SPH 
and LV-CFD models were then developed for each subject, and simulation results were 
compared to clinical in vivo hemodynamic data in terms of bulk blood flow features.  
 
Figure 8. Schematic of Specific Aim1a – Part 1. 
 
4.2.1 Patient information 
4.2.1.1 Subject 1 
Cine magnetic resonance (Cine-MR) imaging was performed in a 31-year-old healthy male 
volunteer on a 3T scanner (Magnetom TRIO, Siemens Medical Systems, Erlangen, 
Germany) using a six-element body array coil. Retrospectively ECG-gated, short axis 
images covering the entire LV, proximal LA and aortic root were acquired using a balanced 
steady-state free precession (SSFP) cine sequence, as shown in Figure 9a. An acceleration 
factor of 2 was used using the GRAPPA technique. The SSFP cine images were acquired 
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with an in-plane resolution of 1.3 x 1.3 mm, a slice thickness of 4.8 mm, and 19 phases. 23 
short-axis slices were acquired to cover the entire volume of interest. Slices were acquired 
during and end-expiration breath-hold to minimize alignment errors caused by changes in 
breath-hold position. 
4.2.1.2 Subject 2 
From our full phase MSCT database from patients at Hartford Hospital (Hartford, CT), a 
72-year-old female pre-TAVR patient with normal LV function was selected for this thesis. 
The MSCT examination was performed on a GE LightSpeed 64-channel volume CT 
scanner. A total of 2540 slices of images with an in-plane resolution of 0.82 x 0.82 mm 
and a slice thickness of 0.625 mm were collected for the whole cardiac cycle (Figure 9c). 
A collimation of 25–30 x 0.625 mm and a rotation time of 375 ms were used, resulting in 
10 phases through the cardiac cycle.  
4.2.2 In vivo hemodynamic data 
Following acquisition of cine-MR images, LV flow was acquired for Subject 1 using a 4D 
phase-contrast MR sequence (4D PCMR) with the same orientation and anatomical 
position as the cine images. The 4D PCMR sequence provides time resolved 3D data, 
where each frame in time and space has 3D velocity components. The 4D PCMR sequence 
was an ECG-gated, gradient echo sequence with a slice thickness of 4 mm and in-plane 
resolution 1.8 x 1.8 mm. Other imaging parameters were as follows: repetition time (TR) 
51.2 ms, echo time (TE) 3.475 ms, flip angle 15°, velocity encoding 150 cm/s. The volume 
of interest was resolved into 28 slices, and 17 phases were acquired through the cardiac 
cycle. 4D PCMR imaging provided four sets of images per time-point, i.e., magnitude 
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image and flow-velocity encoded images at x-, y-, z-directions. Figure 9b shows a 
representative PCMR phase image with the velocity encoded along the vertical axis of the 
slice. PCMR data was processed using an in-house Matlab code (The Mathworks, Inc., 
Natick, MA) following the approach in Uribe et al. (161).  
4D PCMR magnitude images had relatively low spatial resolution and therefore 
were only used for manual registration and localization of imaging planes between the 
cine-MR and the PCMR anatomical data. Getting clear flow data during the entire cardiac 
cycle was challenging due to various factors, such as artifact generation due to respiratory 
motion, high temporal-spatial averaging, and limited signal-to-noise ratio (SNR) (162). 
Hence, the results obtained from PCMR are only used in this dissertation for a qualitative 
comparison. 
For Subject 2, pre-operative transthoracic echocardiogram Doppler examination 
with complete 2D, M-Mode, and Doppler data was obtained from Hartford Hospital 
(Hartford, CT). From this data, the pulsed-waved Doppler velocity recording at the LVOT 




Figure 9. a) Cine images of the LV for Subject 1, b) PCMR velocity image of the LV 
for Subject 1, c) MSCT images of the LV for Subject 2, and d) Doppler echo velocity 
recordings at LVOT plane for Subject 2. 
 
4.2.3 Model reconstruction 
Cine-MR and MSCT images were imported into Amira-Avizo (Thermo Fisher Scientific, 
MA) and 3D Slicer (www.slicer.org) software for image segmentation, while HyperMesh 
(Altair Engineering, Inc., MI) software was used for mesh generation. The reconstructed 
geometries captured the LV internal structure and motion in detail, including the MA and 
proximal LA dynamics during the entire cardiac cycle. Figure 10a,b shows the successfully 
reconstructed subject-specific LV models at end-diastole and end-systole for Subjects 1 
and 2, respectively. Although the AV and MV were not included in this first part of Specific 
Aim 1, we approximated valve function numerically by changing the boundary conditions 
for the corresponding systolic and diastolic phases (163), and geometrically by image-
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based anatomically-driven dynamic annular structures. The reference planes and lines 
where the velocity measurements will be analyzed are indicated in Figure 10c. 
 
Figure 10. LV models at end-diastole and end-systole for a) Subject 1, b) Subject 2, 
and c) reference planes and lines. A and P represent anterior and posterior 
directions. H and V represent the horizontal and vertical lines, with the black circles 
indicating the origin of the lines. 
 
4.2.4 Numerical methods 
4.2.4.1 SPH 
SPH is a fully Lagrangian particle solver where the particle connectivity evolves with time 
and needs to be determined by a particle search. As illustrated by a 2D example in Figure 
11, each SPH particle has its own physical properties, A, which are interpolated by a kernel 
function, W, using the properties of its neighboring particles. This concept is interpreted 







 𝑊(𝐫a − 𝐫b, ℎ) (1) 
where 𝐴b denotes any physical property at particle ‘b’ within the neighboring domain 
(limited by the influence length h of the kernel) of particle ‘a’ at position 𝐫a. Particle ‘b’ 
has mass 𝑚b, position 𝐫b, and density 𝜌b. In this work, a cubic spline kernel function W 
was adopted. Using this equation and its derivatives, the governing equations of fluid flow 
can be rewritten under the form of SPH formulation. The time derivative form of the 
conservation of mass gives 
 d𝜌a
d𝑡
= ∑ 𝑚b𝒗ab ∙ ∇a𝑊ab
b
. (2) 
Here ∇a𝑊ab is the gradient of the kernel function regarding the coordinates of given 
particle ‘a’ and 𝒗ab = 𝒗a − 𝒗b denotes the relative velocity vector between particles ‘a’ 




= −∑ 𝑚b (
𝑃a + 𝑃b
𝜌a𝜌b






where 𝑃 is pressure and 𝜇 is the dynamic viscosity of the fluid. The movement of the 
particles is governed by  
 d𝐫𝑎
d𝑡
= 𝒗a (4) 
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In Abaqus, the pressure is related to the density by the Mie-Grüneisen equation of state 









) + Γ0𝜌0𝐸𝑚 (5) 
where Γ0 is a material constant, 𝑐0 is the artificial speed of sound, 𝜂 = 1 − 𝜌0/𝜌 is the 
nominal volumetric compressive strain, 𝜌 is the current density, and 𝐸𝑚 is internal energy 
per unit mass. A detailed description of SPH fundamentals can be found in Monaghan et 
al. (144) and Morris et al. (146). 
In this thesis, blood was assumed as an incompressible, isothermal, Newtonian fluid 
with a reference density of 𝜌 = 1056 𝑘𝑔/𝑚3 and a dynamic viscosity of 𝜇 = 0.0035 Pa ∙
 s. For the blood flow in the heart and large arteries, the speed of sound is high compared 
to the bulk velocity of the blood, therefore an artificial sound speed of 𝑐0 = 145 m/s was 
employed to avoid very small computational time steps while keeping density fluctuations 
within a small range to maintain incompressible flow behavior. Other material parameters 
were chosen as s = 0 and Γ0 = 0. The stable time increment was between 10
-6 and 10-7 s. 
This small time-step size ensured numerical stability and temporal accuracy. 
SPH particles were initially uniformly distributed in the domain with a spatial 
resolution of 0.8 mm. This led to approximately 594,000 PC3D elements in the domain for 
the LV-SPH model of Subject 1, and 497,400 PC3D elements for Subject 2. The mesh 
sensitivity of SPH particles was checked previously (155), thus a similar particle density 
was adopted here. Two cardiac cycles were conducted and the results from the second cycle 
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were analyzed. It was found that the difference in the velocity results between the first and 
second cycle was within 5%.  
 
Figure 11. 2D illustration of the basic principle of SPH. Property A of particle ‘a’ is 
determined by properties of its neighboring particles (e.g., ‘b’), based on an 
interpolating kernel function (W) which is a function of the smoothing length, h, and 
the distance between particle ‘a’ and its neighboring particle ‘b’. 
 
4.2.4.2 CFD 
The Navier-Stokes equations for 3D unsteady flow with moving walls are solved using the 
finite volume-based CFD solver Star-CCM+ (CD-adapco, Melville, NY). For a control 
volume 𝑉 with surface 𝑆 moving with local surface velocity 𝒗𝑏, the integral form of the 





+ ∫ 𝜌(?⃗? − ?⃗? 𝑏) ∙ ?⃗⃗?  d𝑆 = 0
𝑆
 (6) 
where ?⃗⃗?  is the outward unit normal vector to the differential area d𝑆, 𝜌 is the density of 
the fluid, ?⃗? = (𝑢, 𝑣) is the velocity vector of the fluid in the fixed coordinate system, 
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and ?⃗? 𝑏 = (𝑢𝑏 , 𝑣𝑏) is the velocity vector of the moving boundary 𝑆 of control volume 𝑉. 





+ ∫ 𝜌?⃗? (?⃗? − ?⃗? 𝑏) ∙ ?⃗⃗?  d𝑆 = −∫ 𝑃?⃗⃗?  dS + ∫ ?̅? ∙ ?⃗⃗?  dS
𝑆𝑆𝑆
 (7) 
where 𝑃 is the pressure and ?̅? is the viscous stress tensor. In the above equation, the body 
forces are ignored. For an incompressible Newtonian fluid, ?̅? is expressed as 
 







For this type of problem where the mesh is moving, an additional equation called the space 





− ∫ ?⃗? 𝑏 ∙ ?⃗⃗?  d𝑆 = 0
𝑆
 (9) 
This relates the change in cell volume to the cell-face velocity. The simultaneous 
satisfaction of the space conservation law and all other equations of fluid motion facilitates 
the general moving mesh operations performed. The development and solution of the 
discretized forms of these equations is straightforward within the finite volume CFD 
framework, provided that appropriate measures are taken to ensure obedience to the space 
conservation law (165). The Navier-Stokes equations for 3D flow with moving walls are 
solved by a second order segregated iterative method (SIMPLE algorithm). A detailed 
description of the numerical method can be found in (165, 166). 
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The final volume mesh consisted of five prism layers near the wall and hexahedral 
cells at the core region. Convergence criteria for all the flow parameters were set to 10–6. 
To reach a periodic solution, the CFD simulations were run for four cardiac cycles using a 
time-step size of 1 ms. As shown in Figure 12, tests on mesh sensitivity were performed 
on the LV-CFD models by comparing results obtained with three different mesh densities: 
coarse (100,000 elements, 150,000 elements), medium (200,000 elements, 270,000 
elements), and fine (500,000 elements, 640,000 elements), for Subject 1 and Subject 2, 
respectively. The 𝐿1- relative error norm (𝐸𝐿1) of the instantaneous velocity profile along 
the LVOT plane center line at peak systole for Subject 1 was 8.6 % between the coarse and 
fine meshes, and 4.8 % between the medium and fine meshes.  For Subject 2, 𝐸𝐿1 was 5.2 
% between the coarse and fine meshes, and 3.9 % between the medium and fine meshes. 
Similarly, 𝐸𝐿1 of the instantaneous velocity profile along the MA plane centerline at the E-
wave for Subject 1 was 10.3 % between the coarse and fine meshes, and about 4.4 % 
between the medium and fine meshes. For Subject 2, 𝐸𝐿1 was 9.8 % between the coarse 
and fine meshes, and 4.9 % between the medium and fine meshes. A reasonable 
convergence was therefore achieved on the medium grid resolution in terms of the 
intraventricular flow field. Therefore, the CFD results presented in this study employed the 
medium mesh density. 
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Figure 12. Results of LV-CFD mesh sensitivity for Subject 1 (a,c), and Subject 2 
(b,d) models. 
 
4.2.5 Boundary conditions 
4.2.5.1 LV wall motion 
Cardiac wall motion was applied to the LV-SPH and LV-CFD models as a time-dependent 
nodal displacement boundary condition from the cine-MR and MSCT medical images. 
This approach keeps the correspondence of the surface nodes of the computational domain 
by creating a unique mesh for all time steps, thus the movement of each node can be tracked 
over time. For Subject 1, a total of 8 phases from the original cine-MR images were used 
to prescribe the LV wall motion for one cardiac cycle, while 10 MSCT phases were used 
for Subject 2. First, from the segmented mesh in end-systole, a high quality template mesh 
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was created in Hypermesh (Altair Engineering, Inc., MI), and divided in subdomains (LV, 
aortic root, MA, proximal LA). Second, a preprocessing inflation simulation in 
Abaqus/Explicit was implemented, in which the template mesh was inflated to match the 
mesh from the next cine-MR or MSCT phase. Third, for some complex regions such as the 
aortic-mitral curtain, the morphing toolkit available in Hypermesh software was used to 
deform and map the template mesh to the target mesh from the next MSCT frame. In this 
fashion, the LV wall mesh maintained the same number of nodes across all phases, thus 
ensuring one-to-one connectivity.  
As numerical simulations typically involve time steps smaller than the time interval 
between two cine-MR or MSCT phases, displacements were interpolated in time. Previous 
studies with linear interpolation of the LV wall showed high discontinuities in the flow and 
pressure solution due to the resulting discontinuities in mesh acceleration (167), thus, cubic 
spline was used to interpolate the displacement of each node in time. No-slip boundary 
condition was applied to the LV-CFD models. For the LV-SPH models, the interaction 
between SPH particles and the LV wall was based on node-to-surface contact. The node-
to-surface contact interaction in SPH is directly related to the no penetration boundary 
condition.  Thus, the combined effect of the smoothing kernel interpolation function near 
the wall and the node-to-surface contact interaction partially enforces the no-slip boundary 
condition. 
4.2.5.2 Inlet and outlet 
As blood was considered incompressible, reasoning based on mass conservation can be 
made to overcome the lack of detailed inflow and outflow information. The volume flow 
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rates into and out of the model are thus driven by the expansion and contraction of the LV 
and proximal LA. For the inlet boundary condition, the CFD and SPH models employed 
the diastolic flow rate waveform derived from the LV volume change (including the 
proximal LA), with its value set to zero during systole (61, 168-171) (Figure 13a). For the 
outlet boundary condition, a physiological aortic pressure waveform (172), as seen in 
Figure 13b, was applied. In order to avoid the boundary effects on the region of interest, 
the inlet and outlet boundaries of the models were moved away from the position of the 
mitral and aortic orifices by extending the proximal LA and LVOT with tubes (173, 174) 
(not shown in Figure 10). Since the SPH formulation in Abaqus lacks periodic boundary 
conditions, the tubes were extended long enough to accommodate the inflow and outflow 
of particles for two full cardiac cycles. Rigid plates at the extensions were used to apply 
the boundary conditions in the LV-SPH models  (155). Similarly to the LV-CFD models, 
the diastolic flow rate waveform was applied on the inlet plate, while the aortic pressure 
curve was applied on the outlet plate of the LV-SPH models.  
Note that differences in the diastolic flow rate between our results and physiological 
LV curves refer to 1) the fact that our flow curves included the volume change of not only 
the LV but also the volume change of the proximal LA, 2) imaging and segmentation 
uncertainties, as well as to the reduced number of imaging phases, since minor fluctuations 
in the volume curve lead to considerable changes in the flow rate waveform. Nonetheless, 
as explained in the following section, global flow parameters matched with in vivo clinical 
data and were within physiological range. The heart rate for both subjects was 
approximately 75 bpm, corresponding to a cardiac cycle of 0.8 s. 
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Figure 13. a) Inlet flow rate for Subject 1 (left) and Subject 2 (right), and b) Outlet 
pressure. 
 
4.2.6 Data analysis 
Blood flow velocity vector fields and contours at different long-axis and short-axis planes, 
and at different time instances of the cardiac cycle will be quantitatively compared between 
the LV-SPH, LV-CFD and LV-MRI models for Subject 1, and between the LV-SPH and 
LV-CFD models for Subject 2. An analysis and visualization of the 3D vortical structures 
of the intraventricular flow for the LV-CFD models was also performed. Another 
quantitative metric to be used for comparison between the in silico and in vivo flow data 
will be the velocity profile at different time instants and at different horizontal (H) and 
vertical (V) lines inside the LV models for Subject 1 (Figure 10c). Because of the 
Lagrangian nature of the SPH method, the velocity magnitude was calculated by averaging 
particle velocities enclosed from evenly space spheres of radius 1.5 mm along the lines. 
The error in the velocity measurements will be quantified by the 𝐿1- relative error norm 







For a more clinically relevant quantitative evaluation, we will also compare the 
maximum flow velocity at the LVOT plane during systole, and at the MA plane during 
diastole between the LV-SPH, LV-CFD and LV-MRI models for Subject 1, and between 
the LV-SPH model, the LV-CFD model, and the subject-specific Doppler velocity 
recordings for Subject 2. 
4.3 Results 
4.3.1 Global LV flow parameters 
Figure 14 shows the time-varying LV volume change waveform for both subjects, where 
the points indicate the cine-MR or MSCT phases and the lines represent the cubic spline 
interpolation. For Subject 1, the end-diastolic (EDV) and end-systolic (ESV) volumes were 
140 ml and 58 ml, respectively, which are within the physiological range typically 
measured in males (175). The stroke volume (SV) and the ejection fraction (EF) were 82 
ml and 58%, respectively. For Subject 2, the EDV and ESV were 112 ml and 47 ml, giving 
a SV of 65 ml and EF of 58%, values that closely match the patient-specific data obtained 
from Doppler Echo of 64 ml and 57%, respectively. 
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Figure 14. Time variation of LV volume for Subject 1 and Subject 2. 
 
4.3.2 Large-scale intraventricular flow patterns 
Figure 15 and Figure 16 show the velocity vectors in the anterior–posterior plane (Figure 
10c) for the LV-MRI (a), LV-SPH (b,d), and LV-CFD (c,e) models during peak systole 
(t=0.09 s) and early diastole (t=0.37 s), respectively. From the figures it can be seen that 
the intra-subject LV hemodynamics generated by the LV-SPH models had a similar overall 
topology as those measured in the LV-MRI and simulated in the LV-CFD models. At peak 
systole (Figure 15), a strong outward jet was developed at the LVOT, with an almost equal 
maximum velocity of 1.4 m/s. The LV-SPH models gave a good representation of the 
ejection phase, with the flow converging towards the outflow tract. As shown in Figure 
15a, the LV-MRI maximum velocity for Subject 1 was localized in the central outflow 
region, as compared to the CFD and SPH results. Since the MV is not included in the 
numerical models, some minor backflow of blood into the LA can be observed, especially 
in the LV-CFD for Subject 1 (Figure 15c). 
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Figure 15. Velocity vectors in the anterior-posterior plane for Subject 1 (a,b,c) and 
Subject 2 (d,e) during peak systole at t=0.09 s. 
 
Once diastole begins and the LV wall and MA start to expand, the blood enters 
from the LA to the LV, forming a jet through the mitral orifice. During early diastole 
(Figure 16), the intra-subject flow patterns of the LV-SPH models were similar to the CFD 
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results and PCMR measurements. For Subject 1, the LV-MRI maximum velocity 
magnitude at the level of the MA was approximately 0.68 m/s (Figure 16a), compared to 
the 0.45 m/s of the numerical models (Figure 16b,c). 
 
Figure 16. Velocity vectors in the anterior-posterior plane for Subject 1 (a,b,c) and 
Subject 2 (d,e) during early diastole at t=0.37 s. For clarity, for Subject 1, the scale 
of the velocity vectors is the same for the SPH and CFD models, while is different 




In mid-diastole, due to the high velocity differences of the inflow blood and the 
retaining blood inside the LV, a vortex ring is developed in the LVOT region, as shown in 
a representative image for Subject 1 (Figure 17). The vortex seen in the SPH and CFD 
models is generated from the jet shear layer that is rolled up by viscous forces exerted from 
the resting fluid onto the jet core (12). As shown in Figure 17a and further explained below, 
during this phase and late-diastole the velocities in the LV are low and the LV-MRI 
measurements do not show a clear distinction between the small-scale vortices and the 
background noise. 
 
Figure 17. Velocity vectors in the anterior-posterior plane for Subject 1 during E-
wave deceleration at t=0.42 s. For clarity, the scale of the velocity vectors is the same 
for the SPH and CFD models, while is different for the MRI model. 
 
4.3.3 Quantitative comparison of velocity profiles 
From Figure 18 it is clear that, in general, the SPH results were in good agreement with 
those extracted based on the CFD method. However, there was a discrepancy in the 
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velocity magnitudes, and this difference was mostly concentrated in the regions near the 
LV wall. For 𝐸𝐿1, shown in Figure 18, it is found that the velocity difference between the 
two models was around 11%. The highest discrepancy was 12.5%, and this occurred for 
line V at t = 0.32 s. 
 
Figure 18. Velocity profiles and errors at different time instants at mid-horizontal 
(H) and mid-vertical (V) lines for Subject 1. 
 
For a more clinically relevant quantitative evaluation, we compared the maximum 
flow velocity magnitude at the LVOT plane (Figure 10c) during the systolic phase between 
the LV-SPH (dotted line) and the LV-CFD (solid line) models for both Subjects. Figure 
19a shows that for both numerical models of Subject 1, the LVOT velocities reached a 
close agreement in regards to magnitude and velocity waveform with nearly identical value 
around t = 0.09 s. As discussed in the next section, inaccuracies, limited resolution, and 
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multiple-beat ensemble averaging of the 4D PCMR data prevented a direct comparison of 
the LV-MRI velocity waveform with the SPH and CFD models at the LVOT plane for 
Subject 1. 
 
Figure 19. Maximum LVOT velocity from different data sets during systole for a) 
Subject 1, and b) Subject 2. 
 
Similarly, for Subject 2, the maximum flow velocity magnitude at the LVOT during 
systole was compared between the LV-SPH model, the LV-CFD model, and the patient-
specific Doppler velocity recordings. Figure 19b shows that for both computational 
models, the LVOT velocity reached a nearly identical maximum value at 0.09 s, with a 
close agreement in the velocity waveforms. For the Doppler waveform, however, a 6.5% 
lower peak velocity was observed compared to the numerical models. Overall, the LV-SPH 
models quantitatively matched to a good degree with the LV-CFD models and to a 
reasonable degree with the patient-specific in vivo data. Despite the fact that the near wall 
flow features were not modeled accurately using Abaqus SPH formulation, we obtained 
similar bulk flow information as the traditional mesh-based CFD models.  
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4.3.4 Vortex dynamics 
Figure 20 illustrates the vortex structures of the LV-CFD models by plotting the λ2 vortex 
criterion at the indicated time instants. The λ2-method is an objective method that identifies 
3D vortex cores based on their physical fluid dynamics properties, and is considered one 
of the most accepted vortex detection techniques (176). Vortex structures are identified by 
extreme negative values of λ2, roughly corresponding to local pressure minima due to 
vortical motion. The isosurfaces of this criterion are color-coded by the longitudinal 
component of the velocity, and the corresponding time instants during the cardiac cycle are 
highlighted on the flow-rate curve. First, during the flow acceleration associated with the 
E-wave (Figure 20a,e), a weak vortex ring is observed to start to pinch off from the mitral 
orifice and propagates and impinges on the lateral wall. At the same time, the LA is filled 
with a vortex ring ejected from the inlet extension (Figure 20e). For Subject 1, the vortex-
induced boundary layer at the mitral inlet wall is a shear layer still not organized in a 
complete ring-like vortex (Figure 20a). Subsequently, due to the interaction with the wall 
the vortex ring becomes unstable and starts to breakdown. 
During the flow acceleration phase of the A-wave, there is formation of a second 
vortex ring just downstream of the mitral orifice for Subject 1 (Figure 20b), while for 
Subject 2 the incoming flow of the A-wave goes primarily to the wall due to the interaction 
with the clockwise circulation, and there is no clear distinction of a well-defined vortex 
ring (Figure 20f). However, for Subject 2, the primary weaker vortex ring continuously 
moves toward the apex (Figure 20f) and starts to dissipate. The stronger A-wave vortex 
ring found in Subject 1 compared to Subject 2 could be because the more pronounced 
deceleration and diastasis phases found in Subject 1 helped to dissipate the vortices formed 
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during the E-wave phase. At the end of diastole and as seen in Figure 20c,g, the asymmetric 
vortex ring impinges on the LV wall and begins to breakdown into small-scale structures. 
However, as evident in Figure 20c, the vortex structure for Subject 1 exhibited a larger 
spread across the ventricular cavity as well as a reduced penetration compared to Subject 
2. This is because two possible reasons: first, the end-diastolic vortical structure for Subject 
2 was closer to the apex of the ventricle, and second, the LV model for Subject 2 had a 
more dynamic MA motion, which caused a larger reduction of the effective orifice area 
and thus a stronger inflow jet.  
During systole (Figure 20d,h), blood gets ejected into the aorta and the small 
vortical structures that remain at the end of the diastole get stretched and aligned with this 
outwardly directed flow. These elongated structures are circulated within the LV by the 
clockwise rotational flow during early systole and subsequently pushed rapidly toward the 
LVOT. The overall intraventricular vortex configuration in this study is consistent with 
results of previous computational and experimental studies (169, 177-179). It should be 
noted, however, that the orientation and penetration depth of these vortex rings could be 
different from some studies, and this might be due to the differences in the boundary 
conditions, geometry, and the movement of the ventricle wall. 
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Figure 20. 3D vortical structures visualized by isosurfaces of λ2 (-2000) and colored 
by longitudinal component of the velocity (along the centerline of the mitral inlet). 
Negative velocity (colored blue) indicates towards apex. 
 
4.4 Discussion 
Specific Aim 1 – Part 1 investigated the capability of the SPH framework to simulate the 
bulk blood flow dynamics in two realistic 3D LV models. Quantitative and qualitative 
comparisons of SPH simulation results with those of in vivo clinical flow measurements 
and a CFD approach have been presented. The comparison between the three data sets is 
encouraging, showing that the SPH method can capture the large-scale flow dynamics with 
a similar level of accuracy as a traditional mesh-based CFD method. The study by Shahriari 
and colleagues (156) was essential to validate the SPH approach when applied to the study 
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of 2D cardiovascular flows. The main limitation of this study was, however, the assumption 
of a 2D rigid LV geometry. Cardiac flow with moving LV wall has also been investigated 
by Kulp et al (154). Nevertheless, the model analyzed in this study lacked verification of 
simulation results. 
The SPH results of this study indicate the capability of SPH as a promising tool for 
predicting clinically relevant large-scale LV flow information. First, there was generally a 
good match between the simulated and measured velocity fields at different time points of 
the cardiac cycle. During systole, the intra-subject flow patterns were qualitatively similar 
for the three data sets of Subject 1 (Figure 15a-c), and for the two data sets of Subject 2 
(Figure 15d-e). However, as shown in Figure 15a, the highly localized velocity vectors at 
the LVOT for the LV-MRI measurements probably originate from the level of uncertainty 
in the acquisition and interpolation of the PCMR data, as well as from the stronger jet flow 
due to the AV dynamics, which was not incorporated in this study. 
During early diastole, the intra-subject flow patterns were also similar but the 
velocity magnitude of the LV-MRI measurement for Subject 1 (Figure 16a) was higher 
than that from the in silico models (Figure 16b,c). The absence of MV leaflets in the 
computational models affected the accuracy of the velocity calculations, as a bigger orifice 
area, and thus a smaller flow jet, was obtained for the in silico models. In PCMR 
measurements of the velocity through the MV during diastole, Kim et al. (180) and 
Fujimoto et al. (181) noted velocity magnitudes at the leaflet tips between 15%–20% 
greater than that at the MA. During mid- to late-diastole, the LV-MRI results did not show 
a clear presence of the vortices as the simulation results did (Figure 17). A possible reason 
of this phenomenon is that the velocity encoding factor used in the PCMR imaging was 
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constant over the entire cardiac cycle, and was selected to exceed the expected peak systolic 
velocities in the LVOT to avoid velocity aliasing. As a consequence, small-scale vortical 
features and regions with low flow suffered from low signal in the PCMR data and thus 
lead to impaired depiction. 
When the intra-subject systolic velocity waveforms at the LVOT were 
quantitatively compared between the different models (Figure 19), a good agreement in 
regards to magnitude and velocity waveform was obtained. Moreover, the level of 
discrepancy between the computational and Doppler velocity measurements for Subject 2 
(Figure 19b) were in-line with the inherent uncertainties in the pulsed-waved Doppler flow 
recordings. Doppler velocity measurements are dependent on the ultrasound beam 
orientation, maximum velocity information should be obtained with the ultrasound beam 
aligned as parallel as possible to the flow, otherwise the maximum velocity will be 
underestimated (182). 
It is also noted that along the centerlines in Figure 18, the shape of the velocity 
profiles was similar, but there was a discrepancy in the velocity magnitudes near the LV 
wall. This may be because the no-slip condition was not fully constrained in the Abaqus 
SPH formulation. This situation caused differences between the LV-SPH and LV-CFD 
velocity profiles for Subject 1 of approximately 11%. However, the SPH method was able 
to capture the bulk LV flow with reasonably accuracy, and the large-scale intraventricular 
hemodynamic features obtained were similar to what have been reported in previous mesh-
based LV studies (61, 183, 184).  
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PCMR is currently considered the gold standard for non-invasive quantification of 
cardiac blood flow, as this technique has been validated extensively (185, 186). 
Nevertheless, there are some known limitations associated with PCMR flow measurements 
(187, 188). Blurring or ghosting artifacts are common due to breathing motion (189). 
Particularly for 4D PCMR data acquisition, large amounts of data require measurement 
durations that often exceed normal human breath-holding capabilities. To achieve a high 
SNR, the patient needs to be scanned for multiple cardiac cycles, and the velocity fields 
from different cardiac cycles are combined to form a single 4D velocity field (190). To 
achieve a high spatial resolution, a long imaging time is also required, which will lead to 
more artifacts induced by respiratory movement. Therefore, there is a trade-off among 
SNR, time-resolution and spatial-resolution. Our comparison of the in vivo measured and 
in silico simulated velocity results should be interpreted with the consideration of these 
PCMR recording limitations. 
4.5 Limitations 
In comparison with conventional CFD methods, implementation of boundary conditions, 
especially the no-slip condition, is not straightforward with SPH (157, 158). The default 
interaction between SPH particles and Lagrangian boundaries in Abaqus is based on node-
to-surface contact. The SPH discretization relies on a kernel interpolation that requires full 
support to obtain an accurate approximation of the field quantities and derivatives. When 
particles are close to the boundary, part of the supporting domain of the smoothing kernel 
will not be filled with SPH particles. Therefore, the integration accuracy for those SPH 
particles close to the boundary may be affected (191). To improve the SPH solution near 
the wall, it is possible to specify in Abaqus the so-called ghost particle method (192). Ghost 
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particles fill the boundary by mirroring real particles and their attributes are extrapolated 
such that the no-slip condition is satisfied. The two main drawbacks of this method are 1) 
the need of recreation of ghost particles at every time step, and 2) direct mirroring only 
works for simple geometries (193), thus, this boundary method could not be applied to our 
LV-SPH models.  
Another intrinsic modeling limitation of this study was ignoring the native heart 
valve structures. Past studies have shown that by choosing appropriate inlet information 
together with global geometric and flow parameters that are within physiological range, 
computational models with simplified valve structures can reproduce the flow features 
associated with LV function with reasonably accuracy (163, 169, 172, 194, 195). It is well 
known that for a computational heart model to become a clinically relevant simulation tool 
it must be able to capture the FSI between the blood flow and the heart valves (196).  
Conventionally, many of the FSI approaches used to study LV function have been based 
on conventional CFD mesh-based methods, however, complex LV dynamics can lead to 
computational challenges. A fully-coupled modeling approach that combines the 
transparent meshless character of SPH together with a nonlinear FE formulation can be 
implemented in a natural and simple way to simulate the intraventricular hemodynamics 
and valves structural response. This is the objective of Specific Aim 1a – Part 2.  
The final modeling simplification was the topology of the endocardium, by 
assuming a smooth-walled endocardium without PM and trabeculae. The influence of these 
structures on the LV flow field may be significant (177, 197), and should be explore in a 
future study. Given that the model simplifications were kept the same for the numerical 
models, it is expected that a comparison of these data sets provided useful insights into the 
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capability of SPH to model the large-scale LV blood flow dynamics. The LV-SPH 
framework presented here is an initial step towards a versatile and simple mesh-free 
methodology to study the global 3D LH flow phenomena.  
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CHAPTER 5. SPECIFIC AIM 1A – PART 2, PHYSIOLOGIC LV-
VALVE DYNAMICS 
5.1 Introduction 
The structure and kinematics of the hearts valves are expected to have a significant impact 
on the LV flow field (198). Seo et al. (199) found that the MV promote the formation of a 
circulatory flow pattern in the LV, increasing the strength of the apical flow and enhancing 
washout of ventricular blood. Results by Dahl et al. (60) also suggested that a physiological 
representation of the LA can influence the dynamics of the mitral leaflets and the 
intraventricular flow patterns. Additionally, recent studies have suggested that patient-
specific flow patterns in the LVOT are greatly affected by the dynamically deforming LV 
during diastole (200). These findings underscore the importance of comprehensive FSI 
models of the LV coupled with the mitral and aortic valves for reproducing many of the 
key features of cardiac function. 
Most of the LV FSI studies to date, however, have modeled either the AV (168, 201) 
or the MV only(60), have been limited to idealized geometries (63), or have focused only 
on a short time frame of the cardiac cycle - mainly the diastolic phase (60, 61). In general, 
previous LV FSI models have incorporated extensive simplifying assumptions regarding 
the geometry, tissue mechanical properties and boundary conditions, which can add 
uncertainties in the simulation results. Current FSI approaches employed to study LV 
dynamics are mainly based on conventional mesh-based methods such as the ALE 
formulation (141) or the IB method (64). The most significant challenge of mesh-based 
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FSI studies is dealing with the coaptation between the leaflets during valve closure, where 
the flow domain is separated into two unconnected regions, an issue that has been 
circumvented but not yet solved (202). Recently, there has been an increased interest in 
mesh-free methods, such as the SPH method (203). The fully Lagrangian nature of SPH 
offers several advantages, such as handling small material-to-void ratios, solving solid and 
fluid dynamic equations in the same algorithm (204), and modeling large deformations 
with domain fragmentation.  
SPH has been successfully applied in different fields of fluid and solid mechanics 
over the past two decades (203). More recently, some researches have used SPH in FSI 
problems and validated the SPH-FE coupling approach by benchmark cases such as beam 
impact and elastic gate (205, 206). To date, most of the mesh-free cardiovascular studies 
have mainly focused on the blood flow through vessels or idealized LV geometries (151, 
154, 155). Shahriari et al. (156) studied and validated the capability of SPH to simulate the 
blood flow in a rigid 2D LV model. The FSI capability of the SPH-FE approach has also 
been used to simulate blood flow in a transcatheter AV model (155). In Part 1 of Specific 
Aim1a, we extended the application of SPH to simulate the large-scale intraventricular 
hemodynamics in two realistic 3D LV models with simplified valve structures. The 
comparison between SPH results, a traditional CFD method, and in vivo PCMR and 
echocardiography data showed a good quantitative agreement. 
In Part 2 of Specific Aim 1a, we will test the SPH-FE FSI method’s capability to 
model the coupled complex AV and MV structural response and the intraventricular 
hemodynamics in one subject-specific LV-valve model (LV-FSI). In Specific Aim 1a, we 
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will focus on the LV-valve dynamics occurring under baseline healthy conditions. We 
therefore use the term “subject-specific” instead of “patient-specific”. 
Although some model simplifications are made, this work is considered the first 
attempt to simulate the coupled 3D AV and MV nonlinear soft tissue dynamics and the 
intraventricular hemodynamics in a realistic LH model throughout the entire cardiac cycle. 
The cardiac wall motion will be prescribed based on full phase MSCT scans, while leaflet 
dynamics will be simulated using a fully-coupled FSI method. The LV structure used in 
this study takes into account various degrees of sophistication, including detailed MA and 
proximal LA motion, imaged-based asymmetric leaflet geometries, anisotropic 
hyperelastic constitutive models, and human material properties. Leaflet kinematics, valves 
structural response, and large-scale intraventricular hemodynamics will be studied in 
detail, and compare to subject-specific echocardiography measurements. Finally, in order 
to investigate the coupling effects of the valves in the ventricular hemodynamics, the LV 
flow obtained from the FSI model will be compared with the one obtained with a LV model 
without valves (Specific Aim 1a – Part 1, Subject 2 model).  
5.2 Materials and Methods 
5.2.1 Subject-specific LH model 
Part 2 of Specific Aim 1a will build upon the validated Subject’s 2 LV-SPH model 
developed in Part 1 to increase the model complexity by adding the 3D native heart valve 
structures, creating a comprehensive subject-specific LH FSI model. The valve models 
include various degrees of sophistication, including imaged-based asymmetric leaflet 
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geometries, leaflet thickness and chordae tendineae with distinguishable chordal insertion 
points in the mitral leaflets. 
A semi-automated segmentation method previously developed was used to extract 
the main cardiac structures of interest (207, 208). Briefly, cardiac wall and valvular 
geometries were identified and manually segmented from the rest of the heart structures 
using Hounsfield intensity thresholding and region growing techniques for the cardiac wall, 
combined with the brush tool and manual pixel editing for the valve leaflets and 
subvalvular components, making sure to digitally dissect and clearly differentiate 
individual mitral chordae. Next, smoothing and wrapping operations such as islands 
editing, removing extrusions, filling small holes and specific automatic smoothing modules 
were used to fix inconsistencies in the model due to image noise and improve the mesh 
quality. Altogether, approximately 30 hours of work were required to segment the MSCT 
data, including segmentation of the 10 cardiac frames for the cardiac wall. 
The AV geometry was reconstructed at the mid-systolic phase (stress-free state) 
from this patient, however, valve calcification was not incorporated in order to mimic a 
healthy state. In addition, since the complete MV geometry was not clearly detected from 
the MSCT scans for this particular patient due to artifacts in the valve location, the MV 
was adapted from a previous study from our group that validated healthy MV dynamics by 
quantitatively comparing the closed valve shape from FE simulation with the MSCT 
images during systole (73). Special care was taken to ensure that the adapted MV 
resembled the same positioning of the subject-specific valve. The adapted MV geometry, 
reconstructed from the mid-diastolic phase (stress-free state), was scaled, translated and 
rotated until its boundary matched the MV boundary that was delineated from the subject-
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specific MSCT scans. Chordae were classified into five groups according to the respective 
insertion zone on the leaflets: anterior strut, anterior marginal, posterior marginal, posterior 
intermediate, and posterior basal (22). 
The reconstructed LH model with both valves can be seen in Figure 21a. The 
anterior-posterior long axis plane where the velocity measurements will be analyzed is 
indicated as a red line in Figure 21b. The red spheres denote the probe locations for velocity 
measurements through the valves. In Figure 21c, the blue rectangles represent the regions 
of interest for stress and strain calculations, while the red dots in the leaflets represent the 
location for leaflet kinematic measurements. In order to investigate the coupling effects of 
the valves in the flow dynamics, the LV-SPH model of that did not incorporated the AV 
and MV was used for comparison purposes. In the text, “LV-Valve” refers to the model 
with the valves, while “LV-NoValve” refers to the model without valves. 
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Figure 21. Schematic of LV-Valve model. (a) LV model at different phases, (b) The 
anterior-posterior long axis plane is shown by the red line. The red spheres denote 
the probe locations for velocity measurements, (c) Initial stress-free state for AV 
and MV. RCL: right coronary leaflet, LCL: left coronary leaflet, NCL: non-
coronary leaflet, AML: anterior mitral leaflet. Posterior mitral leaflet (PML) is 
divided into lateral P1 scallop, central P2 scallop and medial P3 scallop. 
 
5.2.2 FE modelling 
FE meshes were generated for the LH model using Hypermesh (Altair Engineering, MI). 
3D solid elements (eight-node hexahedral C3D8R elements) were used to capture the 
thickness of the AV and MV, 3D stress/displacement truss elements (two-node linear T3D2 
elements) were used to model the MV chordae, and shell elements (four-node reduced 
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quadrilateral S4R elements) were used to represent the cardiac wall (i.e. LV, LA and 
LVOT). A constant thickness of 0.5 mm was given to the AV leaflets, while the MV leaflets 
had locally varying thickness with average values of 1 mm and 1.2 mm for the leaflet belly 
and edge regions, respectively. Two layers of elements were used across the leaflet 
thickness. The leaflet-chordae transition zone was modeled by creating fork-shaped truss 
elements at the chordal insertion points to mimic the native geometry and avoid stress 
concentration in the mitral leaflets (73).  
Two different constitutive models were used to model the mechanical response of 
valve tissues. First, the modified anisotropic hyperelastic Holzapfel–Gasser–Ogden 
material (MHGO) model (209) was adopted to characterize the mechanical behavior of 
human AV and MV leaflets. The strain energy function was expressed as 












(𝐽 − 1)2 , 𝑖 = 1,2 
(11) 
where 𝐶10, 𝐶01, 𝑘1, 𝑘2, 𝜅 and 𝐷 are material constants, and 𝐼1̅ and 𝐼4̅𝑖 are the deviatoric 
strain invariants. 𝐶10 and 𝐶01 describe the matrix material, 𝐷 is a material constant to 
impose  incompressibility, and 𝐽 is the determinant of the deformation gradient. 𝑘1 is a 
positive constant with the dimension of stress to describe the fiber material and 𝑘2 is a 
dimensionless parameter. In addition, 𝜅 describes the distribution of fiber orientation. 
Local coordinate systems were defined for each leaflet to include local fiber orientation. 
The anisotropic MHGO material model was implemented into Abaqus/Explicit with a user 
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sub-routine VMAT. The second material model used was the isotropic hyperelastic Ogden 
model (210), which was implemented to characterize the mechanical properties of human 











𝑎𝑖 − 3) (12) 
where 𝜇𝑖 and 𝑎𝑖 are material constants, and ?̅?𝑖 are the modified principal stretches. Tissue 
material properties, obtained from in-house multiprotocol biaxial and uniaxial testing 
devices, were defined from a similar patient (age-, gender- and phenotype-matched) 
selected from an existing human cardiac tissue database established in our lab. Details of 
the determination of material parameters and FE implementation of these models have been 
described in our previous publications (211, 212). The material parameters used for valve 
tissues are listed in Table 2. 
Table 2. Valve tissue material parameters. 
MHGO 
model 
𝐶10 (kPa) 𝐶01 
𝑘1 
(kPa) 
𝑘2 𝜃 (°) 𝜅 𝐷 (kPa
−1) 
AV leaflets 1.738 11.368 2159.4 1158.9 4.59 0.2359 1.0e-5 
AML 0.1245 13.665 11.007 84.84 13.09 0.0800 1.0e-5 
PML 0.0502 15.004 3.021 144.48 25.51 0.0534 1.0e-5 
Ogden 
model 




10256.1 16.579 10653.8 16.554 10671.3 16.554  
Strut chordae 24341.7 11.338 10331.9 11.167 14913.6 11.188  
Marginal 
chordae 
12995.5 15.651 13082.9 15.683 12869.7 15.662  
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5.2.3 Boundary conditions 
Two plate pistons located at the extensions were used to apply the boundary conditions on 
the LH model. As seen in Figure 22a, the LV-Valve model employed a constant LA 
pressure of 20 mmHg at the inlet, while a physiological aortic pressure waveform was 
applied at the outlet. This realistic setting allows the transvalvular pressure gradients and 
the LV pressure to be computed from the coupling of the fluid and structural physics. The 
shape of the aortic pressure waveform was carefully adjusted to be in phase with the 
subject-specific LV volume change waveform. Note that the atrial pressure slightly 
exceeds the normal physiological value in order to compensate for the long inlet extension 
used in the LV model. The LV-NoValve model, on the other hand, employed at the inlet 
the diastolic flow rate waveform derived from the LV volume change, with its value set to 
zero during systole (Figure 13b). For the outlet, the same aortic pressure waveform as in 
the LV-Valve model was applied. The patient’s heart rate was approximately 75 bpm, 
corresponding to a cardiac cycle of 0.8 s. Note that in our models, the cardiac cycle begins 
at early systole, resembling the isovolumetric contraction phase. SPH particle sensitivity 
(155, 207) and valve mesh sensitivity (73) studies were previously performed. Simulations 
were run on an Intel Xeon E5-2670 cluster with 64 cores and required approximately 240 
hours to run two cardiac cycles. 
Cardiac wall motion was prescribed as previously explained in Part 1. The aortic 
and mitral leaflet boundaries were prescribed the same motion as the cardiac wall in the 
aortic and mitral annuli to move accordingly. Additionally, chordae origins were not 
directly attached to the PM tips in the LV-Valve model (see Figure 21b), but were tracked 
and displaced between two spatial locations representing PM tips location at mid-diastole 
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and mid-systole phases. The coupling between SPH and FE was handled by the node-to-
surface contact algorithm since both methods are based on the Lagrangian description. 
Briefly, the contact force at the interface was calculated by finding the best penalty force 
to prevent interface penetration and satisfy conservation of momentum. The combined 
effect of the smoothing kernel interpolation function near the boundary and the node-to-
surface contact interaction approximates the no-slip and no-penetration boundary 
conditions. 
 
Figure 22. a) Aortic and atrial pressure boundary conditions, b) LV volume change 
waveform. 
 
5.2.4 Data analysis 
5.2.4.1 Structural analysis 
Valve kinematics will be evaluated in terms of rapid valve opening (RVOT) and closure 
(RVCT) times, ejection time (ET), and MV leaflet opening and closing angles through the 
cardiac cycle. Subject-specific valve opening and closing times will be obtained from the 
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M-mode echo images, while MV leaflets angles will be measured from the Doppler 
recordings along the apical long-axis view. Maximum principal, radial and circumferential 
stress and strain distributions for the MV and AV will be quantified as well. 
5.2.4.2 Fluid analysis 
Global cardiac hemodynamics will be compared to subject-specific echo data in terms of 
mean and peak systolic pressure drops in the AV, mean and peak diastolic pressure drops 
in the MV, effective orifice area (EOA), E wave velocity, A wave velocity, E/A ratio, 
regurgitant volume (RV) and regurgitant fraction (RF). Hydrodynamic valve (drag) forces, 
that evaluate the contact forces exerted on the leaflets due to the blood flow. From the 





, where 𝑀𝑆𝐹 is the root mean square systolic flow rate (ml/s), and 
∆𝑃 is the mean systolic pressure gradient (mmHg). Likewise, the EOA for the MV (214) 




, where 𝑀𝐷𝐹 is the root mean square diastolic flow, 
and ∆𝑃 is the mean diastolic pressure gradient. The competency of the valves was 
quantified via the regurgitant volume (RV) and the regurgitation fraction, 𝑅𝐹 = 𝑅𝑉/𝑆𝑉, 
where RV is the sum of the closing volume and leakage volume. Similarly as in Part 1, 
velocity vectors and contours at different long-axis and short-axis planes and at different 
time instances of the cardiac cycle will be evaluated. Maximum velocity waveforms at the 
MV and AV planes during the cardiac cycle will also be compared between the LV-valve 
FSI model and the subject-specific Doppler measurements.  
5.3 Results 
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5.3.1 Valve kinematics 
Valve kinematics were analyzed in terms of opening and closure dynamics during the entire 
cardiac cycle, and monitored through the time-dependent radial velocity of the midpoint 
(belly) of each leaflet (see red dots in Figure 21c). Figure 23a shows the computed RVOT 
and RVCT, defined as the duration tracts of the radial velocity curve with a high positive 
and high negative slope (215). Additionally, ET was calculated as the time from the initial 
opening to complete closure of the valve. The results reported in Figure 23a are also 
summarized in Table 3.  
In Figure 23b, the opening and closing angles of the MV leaflets (dotted lines) are 
plotted against the angles measured from echo (solid lines) along the apical long axis view 
(Figure 23c). During early-diastole, the onset of rapid valve opening occurs after the LV 
pressure falls below the LA pressure. During this phase, the simulated leaflets followed a 
similar opening timing pattern as the echo measurements. During mid- to end-diastole, 
which represent some partial leaflet closing after the E-wave followed by a second opening 
due to atrial contraction (A-wave), the simulated leaflets followed a similar pattern as in 
the echo data, but with higher opening angles. Note that for both numerical and in vivo 




Figure 23. a) Time-dependent radial velocity of the belly (midpoint) of AV and MV 
leaflets. The measured RVOT and RVCT are highlighted in pale yellow and green, 
respectively, b) Opening angle of MV leaflets for LV-Valve model and echo data, c) 
schematic of angle measurements from echo video, d) M-mode echo recording at the 
MV. 
 
Additionally, Figure 23d shows the subject-specific M-mode echo recording at the 
MV position. Letters D, E, A and C represent end-systole before MV opening, peak of 
early opening, peak of late opening at atrial contraction, and MV closure, respectively. 
Therefore, RVOT can be calculated as the time interval between D and E, and RVCT as 
the time interval between A and C. As seen in Table 3, simulation results were consistent 
with measurements from in vivo and in vitro experiments (216-218), and with the subject-
specific M-mode echo data. The largest quantitative mismatch between the simulation and 
in vivo data was for the MV RVCT. 
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Table 3. Comparison of ET, RVOT, and RVCT between LV-Valve model, subject-
specific echo data and literature. 













ET 270 329 ± 63 470 N/A 473 
RVOT 30 57.5 ± 11.1 75 75-100 50 
RVCT 50 39.5 ± 5 55 100-150  94 
 
5.3.2 Stress and strain distributions 
Maximum principal logarithmic strain (LE) contours of the aortic and mitral leaflets at 
representative time points of the opening and closing phases are shown in Figure 24. For 
the AV, the peak strain during the ejection phase was observed along the leaflet attachment 
line, with a peak value around 16% (Figure 24a). During the valve closing phase, large 
strains were concentrated in the middle region of the leaflet attachment line, followed by 
the commissure regions. Some high strain areas were also observed in the ventricular layer 
near the central region, extending upwards towards the leaflet free edge during the closing 
and opening phases. 
For the MV, Figure 24b shows that during the closing phase a heterogeneous strain 
distribution was found in the mitral leaflets, with high values located in the belly to annular 
P2 region, in the AML close to the right and left fibrous trigone annular regions, and at the 
insertion points of the chordae tendineae. During the opening phase, much lower strain 
values were obtained, with the maximum strain occurring along the MA. In general, 
significant heterogeneity was observed in the strain distribution for both valves due to 
tissue anisotropy and geometric asymmetry. 
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Figure 24. Opening and closing of a) AV and b) MV leaflets colored by the 
maximum principal strain. Strain in chordae tendineae not plotted. 
 
In addition, Figure 25 shows the radial and circumferential averaged (over the 
measuring region) stresses and strains for AML and PML belly regions, as marked in the 
rectangles of Figure 21c. From Figure 25a and b it can be seen that, in general, higher radial 
and circumferential stresses were observed in the AML than in the PML. Note that the 
spike values enclosed by the red circles during MV closure are due to numerical artifacts, 
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which will be discussed later. In the diastolic phase, the stress values for both leaflets were 
negligible when the MV was open, with the PML circumferential stress being slightly 
higher at some time intervals. 
 
Figure 25. Averaged circumferential and radial stresses of (a) AML and (b) PML, 
and circumferential and radial strains of (c) AML and (d) PML, within the region of 
interest, as marked in Figure 21c. Note the spike values marked by the circles are 
due to numerical artifacts. 
 
5.3.3 LV hemodynamics 
Table 4 compares global hemodynamic parameters calculated from the LV-Valve model 
and obtained from the subject-specific echo data. In general, the comparison between the 
numerical results and the in vivo measurements showed a reasonable agreement. However, 
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it is noted that the difference between these values is significant during the diastolic phase. 
This is mainly due to the absence of calcifications at the MA in our adapted MV model 
compared to clinical observations. Additionally, Figure 26a shows the transvalvular 
pressure drop waveforms, measured one diameter upstream and three diameters 
downstream from the valve annuli. The shape and values of the pressure waveforms agree 
with well-known physiological measurements, except for the spike values enclosed by the 
circles during the early systolic phase, which will be discussed later.  
Table 4. Comparison of hemodynamic parameters calculated from the LV-Valve 
model and the subject-specific echo data. 
Parameters LV-Valve  Echo Doppler 
MSPD (mmHg) 11.1 10.1 
PSPD (mmHg) 23.3 18.2 
MDPD (mmHg) 2.0 3.6 
PDPD (mmHg) 5.2 8.2 
E/A 1.02 0.88 
EOAAV (cm
2) 1.6 1.3 
EOAMV (cm
2) 3.8 2.8 
RVAV (ml) 4.8 N/A 
RFAV (%) 7.4 N/A 
RVMV (ml) 9.8 N/A 
RFMV (%) 15 N/A 
 
5.3.4 Hydrodynamic forces 
Figure 26b shows the axial hydrodynamic forces acting on the AV and MV, calculated by 
vector addition of the axial contact forces exerted on the leaflets surface due to the blood 
flow. Positive values represent the opening force, while negative values correspond to the 
closing force. During systole, peak values were 2.17 N and -14.6 N for the AV and MV, 
respectively. In diastole, peak forces reached up to -8.28 N and 0.54 N for the AV and MV, 
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respectively. The MV opening force was found to be much lower than the value of the AV, 
which is due to the smaller mitral transvalvular pressure drop. During the closing phase, 
the hydrodynamic force on the MV was much higher than that on the AV. 
 
Figure 26. a) Transvalvular pressure drop, b) hydrodynamic forces acting on the 
valves, and c) flow rate through the valves. Note the spike values marked by the 
circles are due to numerical artifacts. 
 
Table 5 summarizes the average chordae tendineae tension at peak systolic 
pressure. These forces were found to be well within the range of in vitro experimental 
results (219). Additionally, PM forces for the LV-Valve model were determined as the sum 
of the reaction forces on the chordal origin nodes that represent the tips of the PMs. At the 
systolic peak, the forces for the anterolateral and posteromedial PMs were 5.18 N and 4.7 
N, respectively. These values agree with to the ones measured in vitro by Jensen et al. (15) 
and simulated by Wang et al. (73). 
Table 5. Chordae peak systolic tension. 
Chordae force (N) LV-Valve Jimenez et al. (219) 
Marginal 0.221 0.23 ± 0.06 
Strut 0.607 0.65 ± 0.13 
Basal 0.235 0.22 ± 0.07 
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5.3.5 Blood flow velocity 
Figure 26c shows the calculated flow rate through the valves during the entire cardiac 
cycle. The retrograde flow can clearly be seen during valve closing. By integrating the 
negative flow rate in time, the RV of the AV and MV was calculated as 4.8 ml and 9.8 ml, 
respectively, representing a healthy valvular state. Note that RV is an important clinical 
hydrodynamic metric that can only be calculated from a fully-coupled FSI approach, which 
several previously published models (220, 221) were not able to quantify. In Figure 27a, 
the maximum flow velocity downstream of the AV (Figure 21b) was monitored throughout 
systole and compared to the subject-specific Doppler recordings (Figure 27c). A 
quantitative comparison indicates that the AV velocity reached a similar peak value in both 
the LV-Valve model and the Doppler measurement. Furthermore, when compared to the 
LV-NoValve model, a much lower peak velocity of 1.16 m/s was observed. During the AV 
closing phase, a retrograde velocity is clearly seen for the LV-Valve model. In the LV-
NoValve model, however, the retrograde velocity cannot be calculated. It is also important 
to be aware of the considerable limitations associated with Doppler velocity measurements. 
Since CW Doppler examination cannot pinpoint where along the ultrasound beam the 
measured velocity comes from (222), retrograde flow measurements are challenging to 
obtain. 
Similarly, the comparison of the flow velocity through the MV is shown in Figure 
27b. The flow velocity was calculated at the midpoint between the tips of the opened MV 
leaflets (Figure 21b), which corresponds to the probe location usually used in PW Doppler 
measurements. It is noted that although the LV-Valve model had a similar MV waveform 
pattern as the echo data (Figure 27d), the peak value was not accurately predicted (0.74 
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m/s vs. 1.17 m/s). Moreover, it is observed that for the LV-NoValve model the velocity 
was much lower (0.28 m/s) than the echo data. 
 
Figure 27. Flow velocity through the (a) AV and (b) MV. Doppler echo velocity 
recordings at c) AV and d) MV. 
 
5.3.6 Large-scale intraventricular flow patterns 
Flow velocity vector fields in the anterior-posterior long axis plane (Figure 21b) for the 
LV-Valve and LV-NoValve models at two different time points are shown in Figure 28a. 
At peak systole (~80 ms), a constricted and symmetric central jet was observed 
immediately downstream of the AV in the LV-Valve model, whereas a relatively uniform 
velocity profile from the LVOT to the ascending aorta was observed in the LV-NoValve 
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model. As expected, without the constriction of the AV, the central jet velocity in the LV-
NoValve model is much lower. Similarly, during the E-wave (~490 ms), the flow jet 
through the MV cannot be observed in the LV-NoValve model. Additionally, a vortex 
adjacent to the AML that is developed in the LV-Valve model is not present in the LV-
NoValve model.  
Finally, flow velocity vector fields from the LV-Valve model at additional time 
points are shown in Figure 28b. During MV (~25 ms) and AV (~285 ms) closing, a large 
retrograde flow through the valve is observed, while the opposite valve remained fully 
closed. A large asymmetric vortex that has been shown to initiate MV closure and pre-
ejection filling of the LVOT (12) can be seen at late diastole (~740 ms). 
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Figure 28. a) Velocity vector fields in the anterior-posterior plane for the LV-Valve 
and LV-NoValve models at peak systole and E wave, and b) for the LV-Valve model 
during MV closing, AV closing and late diastole. 
 
5.4 Discussion 
5.4.1 Structural analysis 
Understanding the coupled interaction between the valves and the LV is important for the 
assessment of cardiac function in healthy and diseased states, as well as for the evaluation 
and design of clinical procedures and medical devices for valve repair and replacement. In 
Part 2 of Specific Aim 1a, we quantified the valves maximum principal strain, and the 
circumferential and radial stress and strain of the AML and PML throughout the entire 
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cardiac cycle. In particular, it was found that the leaflets experienced a highly anisotropic 
mechanical response. Note that during systole, Figure 258c,d shows that the radial strain 
was higher in the PML than in the AML. This feature was previously observed by Lee et 
al. (223) and Watton et al. (83). In the circumferential direction, however, the PML showed 
negative strain values during the entire aortic ejection phase. The PML compressive strain 
is likely caused by the strong mechanical coupling between the circumferential and radial 
directions at systole. Indeed, in vivo and in vitro studies (217, 224) have shown that the 
coupling of the stretches in two directions can generate compressive stretches in the 
circumferential direction of the PML at the beginning of MV closure, when there is a large 
stretch in the radial direction.  
Additionally, MV strains shown in Figure 25c,d were qualitatively similar to 
previous in vivo and in vitro studies (224-227), with a rapid strain increase to the point of 
full coaptation, followed by a stable plateau in both radial and circumferential directions 
during systolic ejection. In Table 6, the strains obtained numerically at the fully loaded 
state are quantitatively compared to those measured in vivo and in vitro in ovine and 






Table 6. Comparison of the MV strain values between the current study and the 
literature. 





Sacks et al. (225) In vivo 
Circumferential: 3.2 ± 0.4 
Radial: 16 ± 3 
Amini et al. (226) In vivo 
Circumferential: 8 
Radial: 21 
Sacks et al. (227) In vitro 
Circumferential: 11 ± 3 
Radial: 30 ± 8 
Jimenez et al. (228) In vitro 
Circumferential: 11 ± 5 





He et al. (217) In vitro 
Circumferential: 3 
Radial: 23 
Padala et al. (229) In vitro 
Circumferential: 10 ± 8 
Radial: 29 ± 8 
 
5.4.2 Fluid analysis 
A quantitative flow field comparison between the LV-Valve model and the LV-NoValve 
models is presented in Figure 28a. The presence of the AV resulted in a decreased orifice 
area of 2.24 𝑐𝑚2 at the tip of the leaflets during peak systole. Meanwhile, without the valve, 
the geometric orifice area at the annulus was about 4.55 𝑐𝑚2. The large-scale flow patterns 
were quite different as well. Figure 28a shows that for the LV-Valve model, the maximum 
velocity occurred just downstream of the AV, where the flow jet is highly concentrated but 
the flow velocity inside the sinus region is less than 0.1 m/s. However, in the LV-NoValve 
model, the maximum flow velocity occurred at the annulus with an unrealistically high 
flow velocity of 0.5 m/s in the sinus region. Similarly, the MV flow velocity was much 
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higher in the LV-Valve model than that in the LV-NoValve model. Due to the strong flow 
jet and the closure of the AV, a vortex adjacent to the AML was developed in the LV-
Valve model, which was not seen in the LV-NoValve model. This vortex is considered to 
act as a reservoir that stores kinetic energy as it redirects blood towards the lateral LV wall 
and initiates MV closure and pre-ejection filling of the LVOT in late-diastole (12). It is 
also noted that since complete closure of the MV and AV was achieved in the FSI 
simulation, several interesting characteristics such as regurgitant flow have been observed 
(Figure 28b) and quantified (Table 4).  
The spike values enclosed by the red circles in the leaflets stresses (Figure 25a,b), 
transvalvular pressures (Figure 26a) and hydrodynamic forces (Figure 26b) are thought to 
be caused by numerical artifacts in the FSI simulation. During early systole, there is a short 
time period when both valves are nearly closed, forming a nearly closed system. Due to 
the assumption of incompressible fluid, a small compression in volume for a closed system 
can cause a large change in pressure. In our FSI model, the motion of the cardiac wall was 
prescribed according to the MSCT data, thus, a small decrease in LV volume, which is 
very likely to occur during early systole, could lead to a large fluctuation in pressure. This 
fluctuation, however, damped out rapidly due to the viscous effect of the fluid. This 
numerical artifact could be resolved by modeling the interaction between the myocardium 
and the blood flow by considering the active contraction of the myocardium.  
Flow velocity passing through the MV from our models was compared to the Doppler 
echo data in Figure 27b. Even with the inclusion of the valves, our simulated flow velocity 
is lower than that of the subject-specific data. Two possible reasons may cause this 
discrepancy: 1) the MV geometry used in the LV-Valve model is not subject-specific but 
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was adapted from a previous study from our group (73). Specifically, MA calcification was 
detected in the subject-specific Doppler examination (see Figure 23c) but was not included 
in our model in order to mimic a healthy state. MA calcification could potentially restrict 
normal leaflet motion and cause a smaller opening area during diastole. Indeed, as shown 
in Figure 23b and Table 4, relatively larger mitral leaflets opening angle and EOA, as well 
as lower MDPD and PDPD values were obtained from the FSI simulation compared to the 
in vivo measurements; 2) only proximal LA wall motion was included in our model due to 
the limited imaging window of the MSCT images. The incomplete LA dynamics could 
affect the mitral flow during atrial passive filling and contraction (60, 230). Despite these 
limitations, our results are largely consistent with subject-specific in vivo measurements, 
clinical observations and in vivo and in vitro studies of healthy LV-MV-AV dynamics. 
5.5 Limitations 
As explained in Part 1, the no-slip boundary condition in Abaqus SPH is not fully 
constrained. This limited imposition is likely to affect the flow solution in the wall 
boundary layer and limit the study of the small-scale flow features seen in the LV blood 
flow (207). Second, cardiac wall motion was prescribed according to the subject-specific 
MSCT imaging data. With this approach, the mesh deformation is independent of the 
solution of the fluid equations because all the nodes of the cardiac wall have prescribed 
displacements at each time step. The use of this method is based on the assumption that the 
flow-induced load on the cardiac wall is minor in comparison to the structural-induced load 
on the fluid flow (231). It is important to remember that as long the prescribed wall motion 
closely resembles the subject-specific MSCT images, the blood flow dynamics will be 
similar whether the wall motion is prescribed or computed by a coupled solution.  
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CHAPTER 6. SPECIFIC AIM 1B – PART 1, LV-VALVE 
DYNAMICS UNDER PRIMARY MITRAL REGURGITATION 
6.1 Introduction 
MV prolapse following rupture of the chordae tendineae is a major cause of primary MR, 
and is associated with several causes such as bacterial endocarditis, local myxomatous 
degeneration, connective tissue abnormalities, hypertrophic cardiomyopathy, and blunt 
chest trauma (232). Mild varieties of mitral chordae rupture generally involve separation 
of a single chorda, which can lead to minimum hemodynamic effects and requires neither 
intervention nor treatment. Rupture of multiple chordae, however, may cause moderate to 
severe acute or chronic MR (232). Studies have shown that chordae rupture may be either 
immediate onset or a progressive process in which minimal rupture precedes more 
extensive or even complete rupture (233). To restore normal MV function and prevent 
further pathologic progression, MV repair or replacement can be performed (232). A 
variety of surgical and transcatheter repair treatments are currently available, however, in 
many cases there is a sub-optimal selection of the treatment attributed to the complicated 
repair techniques and the mitral apparatus complex geometry that require extensive 
surgical experience and specialized skills (38).  
Computational modeling of heart valve dynamics and function is an active research 
field that not only can allow an in–depth examination of the dynamics of the LV-valve 
complex under normal and diseased states, but can also offer potential to inform the 
therapeutic decision-making process (212). FE studies have been performed in the past 
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with the goal to investigate MV dynamics after chordae rupture. Kunzelman  and 
colleagues (97, 98) were among the first to study the effects of chordae rupture and their 
repair on MV function. More recently, Kim at al. (99-101) and Sturla et al. (102, 103) 
evaluated the biomechanical characteristics of MV models with PML prolapse, and 
compared different repair techniques such as neo-chordae and leaflet resection. In these FE 
studies, chordae structure was mainly determined from published clinical data and ex vivo 
findings due to the limited resolution of the medical image data. Moreover, FE or 
structural-only models assume the hemodynamic pressure load is uniformly distributed 
over the leaflet surface, a factor which has been previously shown to affect valve dynamics 
(3, 136). Structural valve models are appropriate for simulation of quasi-static events such 
as closed valves, but in order to accurately model full dynamic/transient valve dynamics, 
an FSI modeling approach that accounts for the strong coupling between the large 
deformation of the leaflets and the intraventricular blood flow is required (3).  
The first FSI model to investigate MV function with ruptured chordae was presented 
by Toma et al. (88). In this study, the importance of individual chordae on MV closure 
dynamics was assessed by simulating rupture in every of the 51 possible chordae branches. 
However, a rigid tube was used as an approximation of the LV domain, neglecting the 
cardiac wall motion and its direct effect on the blood flow. The severity of the resultant 
MR was also approximated by calculating the regurgitant orifice area, with no 
hemodynamic variables analyzed. In the study by Khodaei et al. (234), although the 
modeling approach included the LV geometry to account for a physiologic moving 
boundary, several critical simplifications such as an idealized MV geometry, the omission 
of the LA and AV geometries, and the modeling of only the valve closing phase limited 
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the findings of the study. Due to the complex mechanical coupling between the MV and 
the LV mediated through the PM, the chordae tendineae and the dynamic MA, rigorous 
modeling of MV dynamics under normal and diseased states should include the entire LH 
complex. Indeed, it has been determined that even with a rigid U-shaped LV model, the 
intraventricular mitral flow patterns are substantially different from that estimated using a 
tubular geometry (3).  
In Specific Aim 1b – Part 1, we will make use of the subject-specific LH model 
previously developed and validated in Specific Aim 1a – Part 2 to investigate the coupled 
LV-valve pathological dynamics under primary MR following mitral chordae rupture. The 
FSI framework used in this study takes into account the complexity of the LH morphology, 
the large deformation experienced by the aortic and mitral leaflets and the cardiac wall, the 
anisotropic nonlinear elastic behavior of the valvular tissue, and the pulsatile hemodynamic 
loads during the entire cardiac cycle. FSI simulations of LH dynamics under physiologic 
(control) and seven chordae rupture conditions will be performed and compared, and the 
effects on the force balance of the mitral apparatus, leaflets deformation state, MR severity, 
LH hemodynamics and overall cardiac efficiency will be investigated. 
6.2 Materials and Methods 
Figure 29 presents our computational modeling protocol for investigation of LH dynamics 
following mitral chordae rupture. This protocol was composed of FSI simulation of 
physiologic LH function (control), virtual modeling of multiple levels of chordae rupture, 
FSI simulation of LH function after chordae rupture, and evaluation of the functional and 
biomechanics characteristics of the coupled LV-valve pathological dynamics. 
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Figure 29. Computational modeling protocol for investigation of LH dynamics 
following mitral chordae rupture. 
 
6.2.1 Subject-specific LH model 
In this study, we employed the healthy LV-valve model developed in Specific Aim 1a – 
Part 2 (Subject 2). As seen in Figure 30A, this control LH model comprises all major 
cardiac structures, including the aortic root, AV, LV, MV and LA. As seen in Figure 30B, 
the detailed mitral chordae structure (number, position, length, branching, origins of the 
PM tips, and insertions into the leaflets) was clearly visible from the MSCT images, which 
had excellent clarity and crisp detail (73). Chordae were classified into five groups 
according to the respective insertion zone on the leaflets: anterior strut, anterior marginal, 
posterior marginal, posterior intermediate, and posterior basal (22). As shown in Figure 
30D, marginal chordae insert into the leaflet free edge, intermediate chordae insert on the 
leaflet rough zone, and basal chordae insert closer to the leaflet base. High-quality images 
also allowed us to identify and delineate the chordae that protruded from the PM heads. 
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Simple point insertions were then used to model the distribution of the chordae origins on 
the PM tips. Identifying and creating the chordae to leaflet transition zone, on the other 
hand, is a nontrivial problem, since chordae seamlessly fuse into the leaflets and limited 
image resolution can prevent the complete detection of this detailed structure.  
For the basal and strut chordae, the leaflet-chordae transition zone was easily 
identified from the MSCT images. Fork-shaped truss elements were used to follow the 
visible chordae splits and avoid local stress concentrations on the leaflets. For some of the 
intermediate and marginal chordae, however, the transition region was not clearly detected. 
Thus, the number of splits and their lengths were initially estimated and required further 
manual refinement. This optimization process aimed to quantitatively match the FE 
deformed MV systolic geometry with the subject-specific MSCT images (73). In summary, 
chordae originated from the APM and PPM tips, and distributed to the ventricular surface 
of the leaflets as presented in Table 7. A total of 17 chordae origins were modeled from the 
PM tips. Cross-sectional area values of 0.71 mm2, 2.05 mm2, and 0.38 mm2 were assigned 
to basal/intermediate, strut, and marginal chordae, respectively (73). Each chord was 
modeled with up to 10 elements, with an average element length of 1.5 mm. 
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Figure 30. A) Control LH model, B) MV model reconstructed from MSCT images, 
C) top view of MV with four sub-regions, D) PML chordae groups. AML chordae 
not shown for clarity. 
 
Table 7. Mitral chordae structure. 
  From APM From PPM 
Number of chordae origins 
AML 5 3 
PML 4 5 
Number of chordae leaflet insertions 
AML marginal 8 6 
AML strut 3 4 
PML marginal 7 6 
PML intermediate 7 1 





6.2.2 Chordae rupture modelling 
The control LH model was defined as having all mitral apparatus anatomical structures 
intact. PML prolapse is more prevalent than AML prolapse (235), usually involving 
ruptured chordae in the central scallop (P2), which then extends to the lateral P1 and P3 
scallops (102, 103, 236, 237) (Figure 30C). Thus, the chordae rupture LH models were 
virtually created by modifying the control model, initially removing marginal and 
intermediate chordae elements in the individual PML scallops, and then progressing 
towards rupture of the basal chordae; causing partial or total double scallop prolapse. A 
total of seven chordae rupture LH models were created.  
6.2.3 Boundary conditions 
Pressure boundary conditions were applied at the atrial inlet and aortic outlet of the LH 
models. For the control model, a constant LA pressure of 20 mmHg was prescribed at the 
inlet, while an aortic pressure waveform, as seen in Figure 31, was applied at the outlet 
(208). In acute MR due to ruptured chordae, 𝑅𝑉𝑀𝑉 in a normal-sized LA results in a marked 
increase in the atrial pressure (elevated V-wave) (238). Thus, the chordae rupture models 
employed a pathological atrial inlet pressure waveform (239), while the same aortic 
pressure waveform as in the control model was applied at the outlet. 
Cardiac wall motion was prescribed as previously explained in Specific Aim 1a. In 
this study, the cardiac wall motion was kept the same for all LH models. This approach 
aims to replicate the instantaneous changes in cardiac dynamics during acute MR due to 
chordae rupture, when the LV has not yet remodeled, but the afterload is decreased as the 
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result of partial systolic emptying into the LA. Thus, the compensatory and cardiac 
remodeling mechanisms under chronic MR were not considered. 
 
Figure 31. Aortic and LA pressure boundary conditions. 
 
6.2.4 Data analysis 
In addition to the structural and hemodynamics variables previously presented in Specific 
Aim 1a – Part 2, the following parameters were quantified in this study. The net force 
carried by the different chordae tendineae groups at peak systolic pressure. The force 
experienced by a particular chordae group was calculated as the sum of vectors 
representing the tension in each individual chorda attached to that chordae group. In order 
to facilitate visualization and analysis, LH models were grouped according to the PM from 
where the chordae ruptured. 
In order to quantitatively grade the severity of MR for the different LH models, the 
𝑅𝑉𝑀𝑉 was determined by the time integral of the negative transmitral systolic flow, where 
𝑅𝑉𝑀𝑉 is equal to the sum of the closing volume and the leakage volume. In this study, the 
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closing volume was defined as the volume of blood flowing retrograde through the valve 
during its closure, and was quantified for all models from the start of negative transmitral 
flow at early systole until the control model reached a positive mitral flow, as indicated by 
the dotted line in Figure 32B. Any fluid volume accumulation after valve closure resulted 
from leakage and it was referred to as leakage volume. We note that for MR cases, there is 
no widely-accepted definition to distinguish between the closing and leakage volumes. The 
combination of the forward stroke volume (𝑆𝑉𝐴𝑉) and the 𝑅𝑉𝑀𝑉 is known as the total SV 
of the LV (𝐿𝑉𝑆𝑉), which was used to calculate the regurgitant fraction, 𝑅𝐹𝑀𝑉 =
 𝑅𝑉𝑀𝑉 𝐿𝑉𝑆𝑉⁄  
LV efficiency, an important measure of ventricular pump performance, is defined as 
the efficiency of energy transfer from the LV to the arterial system (240). This variable 
represents the percentage of total energy expenditure by the myocardium that is converted 
into external stroke work (𝑆𝑊). LV efficiency was calculated as 𝑓𝑆𝑊 𝑃𝑉𝐴⁄ , where 𝑓𝑆𝑊 
is the forward 𝑆𝑊, and was defined as the time integral of the continuous product of flow 
across the AV and the aortic pressure during systole (241). From a pressure-volume loop, 
𝑃𝑉𝐴, known as the pressure volume area, represents the total mechanical energy generated 
by ventricular contraction, where 𝑃𝑉𝐴 = 𝑃𝐸 + 𝑆𝑊 (242). 𝑆𝑊 corresponds to the area of 
the pressure-volume loop, and characterizes the external mechanical work achieved by the 
heart to eject the 𝐿𝑉𝑆𝑉. 𝑃𝐸, or potential energy, on the other hand, is the mechanical energy 
that is available in the LV at end-systole that was not converted into external work and will 
be dissipated during relaxation (242). 
6.3 Results 
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6.3.1 Global hemodynamic parameters 
Figure 32 shows the computed volumetric flow rate through the AV and MV from systole 
to diastole for the LH models. The negative AV flow at early diastole in Figure 32A 
indicates backflow of blood into the LV during AV closure, while the negative systolic 
MV flow in Figure 32B indicates the backflow of blood into the LA due to MV closing 
and incompetence. During systole, the AV flow reached a peak value of 414 ml/s for the 
control model, while the minimum peak flow was obtained for the P2/P1 model, with a 
value of 169 ml/s. As seen in Figure 32B, this reduction in the aortic flow from the P2/P1 
model coincided with the highest mitral regurgitant flow. 
 
Figure 32. Flow rate across the AV and MV through the cardiac cycle. PML is 
divided into P1, P2 and P3 scallops. 
 
Table 8 summarizes the main hemodynamic parameters. By using the 𝑅𝐹𝑀𝑉 as a 
the parameter in the grading of MR severity (32), Table 8 shows that from the seven 
chordae rupture models, 3 can be classified as having mild MR, 2 moderate MR, and 2 
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severe MR. As per 2014 AHA/ACC guidelines (243), 2 chordae rupture models can be 
classified as having severe MR (𝑅𝐹𝑀𝑉 > 50%), while the other 4 models as having 
progressive MR (𝑅𝐹𝑀𝑉 < 50%). As expected, the 𝑅𝑉𝐴𝑉 was similar for all LH models, with 
the lowest value obtained for the control model. From these results it can be seen that the 
severity of MR not only has an impact on the 𝑅𝑉𝑀𝑉, but also on the onset of AV closing 
(especially in the severe MR models) and on the 𝑅𝑉𝐴𝑉 due to coupled valve dynamics. 













RVAV (ml) 4.27 4.34 4.63 4.73 4.61 5.05 4.62 4.72 
MV closing 
volume  (ml) 
8.65 8.54 10.21 11.26 11.86 13.19 16.25 17.08 
MV leakage 
volume (ml) 
0.62 3.36 4.54 6.47 12.46 13.33 31.04 34.45 
RVMV (ml) 9.27 11.90 14.75 17.73 24.32 26.52 47.19 51.53 
SVAV (ml) 58.22 55.18 51.55 48.43 41.94 39.72 20.46 16.16 
RFMV (%) 13.74 17.74 22.25 26.80 36.70 40.04 69.76 76.13 
MR severity 
(RFMV) 
Mild Mild Mild Mild Moderate Moderate Severe Severe 
 
6.3.2 Chordae tension 
Figure 33 shows the net force carried by the different chordae tendineae groups at peak 
systolic pressure. Table 9 presents the numerical values of Figure 33. In the control model, 
the highest PML chordae tension was found for the basal chordae, followed by the 
intermediate chordae, and lastly the marginal chordae. For the AML, the chordae tension 
was higher in the strut chordae than in the marginal chordae. When compared to the control 
model, Figure 33 shows that there was no evident change in the tension of AML marginal 
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chordae as the number of ruptured chordae increased. However, there was a noticeable 
increase in their tension (>20%) during total double scallop prolapse (i.e. P2/P3 and P2/P1 
models). On the other hand, the tension in the strut chordae appeared to decrease as the 
number of ruptured chordae increased. This reduction was more than 20% during total 
double scallop prolapse. 
In general, the tension in the PML basal chordae decreased as the as the number of 
ruptured chordae increased. Moreover, there was a clear reduction of more than 50% in 
their tension when partial or total double scallop prolapse occurred. In the isolated scallop 
prolapse models, as expected, the net PML marginal and intermediate chordae tensions 
decreased. However, in the partial double scallop prolapse models, marginal chordae 
tension increased more than 20% compared to the control model. When total double scallop 
prolapse occurred, while marginal chordae tension decreased and intermediate chordae 
tension increased in the P2/P1 model, the opposite trend occurred in the P2/P3 model, 
where marginal chordae tension increased and intermediate chordae tension decreased. 
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Figure 33. Chordae tension at peak systole. APM: anterolateral PM, PPM: 
posteromedial PM. 
 
Table 9. Summary of chordae and PM forces (N) at peak systole, and percentage 













 (N) (N) (%) (N) (%) (N) (%) (N) (%) (N) (%) (N) (%) (N) (%) 
AML marginal 1.61 1.63 1.22 1.92 19.04 1.71 6.28 1.36 -15.64 1.55 -4.05 1.95 20.65 1.99 23.62 
AML strut 3.49 3.11 
-
11.13 

































PML basal 4.97 4.28 
-
13.75 
4.64 -6.48 4.35 
-
12.33 















3.76 -38.77 5.99 -2.61 5.70 -7.32 2.45 
-
60.10 
PPM 5.73 5.02 
-
12.39 
5.32 -7.13 4.78 
-
16.59 






6.3.3 Leaflet stress 
Figure 34 shows the maximum principal stress distribution across the mitral leaflets at peak 
systole. A stress value threshold of 0.5 MPa was applied such that relatively large stress 
values were displayed in grey, facilitating the comparison between all models. 
6.3.3.1 Control model 
As shown in Figure 34, full leaflet coaptation was clearly observed in the control model, 
as this was confirmed by the computed MV leakage volume of 0.62 ml. In the PML, high 
stress regions were observed in the P2 belly to basal region, with a maximum value of 0.34 
MPa at the insertion of the basal chordae. Lower levels of tensile stress were found in the 
P1 and P3 scallops, even resulting in compressive stresses from the bucking or folding of 
the tissue. In all MV models, a similar pattern of stress distribution was observed in the 
AML, displaying large stresses in the belly region and close to the fibrous trigones along 
the MA, regardless of the presence of leaflet prolapse. For the control model, the maximum 
AML stress was 0.43 MPa, and was located close to the right fibrous trigone region and at 
the insertion of the strut chordae. 
6.3.3.2 Chordae rupture models 
PML stress distribution for the chordae rupture models differed from the control model. In 
the isolated scallop prolapse models, the free edge of the scallop was unrestricted and 
prolapsed towards the LA, whereas the belly region bent. However, an increase in the stress 
of the prolapsing scallop was not evident, and even seemed to become less tensile and more 
compressive. Between the three isolated scallop models, the maximum PML stress value 
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(0.46 MPa) occurred in the isolated P2 model, and was localized near the P2/P1 junction 
region where the remaining intact basal chordae were connected. 
 
Figure 34. Stress distribution in the mitral leaflets at peak systole. 
 
In the presence of partial or total double scallop prolapse, abnormal bulging of the 
PML was clearly found in all models. Overall, a broad band of large stresses (0.5-1.8 MPa) 
occurred in the belly region of the prolapsed segment. Additionally, high stress values (1.5-
2.8 MPa) occurred near the scallop junction free edge regions, where the adjacent 
remaining marginal chordae were connected. Between the four double scallop prolapse 
models, the maximum stress (2.8 MPa) occurred in the P2/P3 model, and was localized 
near the free edge of the P2 scallop where the remaining intact marginal chordae were 
attached. In order to quantitatively compare the stress in the leaflets, Figure 35 shows the 
maximum principal stress values averaged over the four sub-regions of the mitral leaflets. 
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Leaflet coaptation and mitral annular regions were not included for the averaged stress 
calculation. 
 
Figure 35. Averaged max. principal stress (MPa) in mitral leaflets at peak systole. 
 
6.3.4 LH hemodynamics 
Figure 36 shows the 3D velocity streamlines colored by velocity magnitude at peak systole. 
From the figure it is evident that chordae rupture causes a regurgitant jet into the LA, 
however, the structure and strength of this jet varies depending on the location and severity 
of the prolapse. Based on the jet direction, three types of MR jets were found: 1) an 
anterolaterally directed regurgitant jet was originated in the isolated P3 and P2/P3 models; 
2) an anteromedially directed MR jet was found in the isolated P1, isolated P2, and P2/P1 
models; and 3) an anteriorly directed central jet was developed in the partial P2/P1 and 
partial P2/P3 models. These 3D morphologies of the MV and flow structures obtained from 
the FSI simulations corresponded well to pathologic MR characteristics observed in 2D/3D 
echo and cardiac MRI data (99, 100, 103, 244). Additionally, Figure 36 shows that chordae 
rupture can produce eccentric and non-eccentric MR jets. An eccentric “wall-hugging” jet 
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that impinged the LA wall was visible in the 4 double scallop prolapse models. Conversely, 
a non-eccentric jet with more visible 3D flow features and flowing towards the central 
portion of the LA was found in the 3 isolated scallop prolapse models. Peak regurgitant 
velocity as well as peak aortic velocity for all models are presented in Table 10. Note that 
peak regurgitant velocity may not necessarily occur at peak systole. 















2.69 2.41 2.31 2.38 2.23 2.07 1.33 1.19 
Peak regurgitant 
velocity (m/s) 
N/A 5.05 5.01 5.47 4.71 5.71 5.17 5.47 
𝑓𝑆𝑊 (J) 0.89 0.84 0.78 0.74 0.63 0.60 0.31 0.24 
𝑆𝑊 (J) 1.02 1.01 1.01 1.00 0.98 0.98 0.93 0.91 
LV efficiency 
(%) 




Figure 36. Velocity streamlines showing regurgitant jet structures at peak systole. 
 
6.3.5 LV efficiency 
Figure 37 shows a representative pressure-volume loop for the isolated P2 model. LV 
efficiency results are summarized in Table 10. As expected, the highest LV efficiency was 
found for the control model, with a value of 75.64%. MR due to ruptured chordae caused 




Figure 37. Representative pressure-volume loop for isolated P2 model. 
 
6.4 Discussion 
6.4.1 Mitral apparatus force balance 
The results of this study showed that basal/strut chordae carried the majority of the systolic 
load acting on the leaflets (Figure 33). Further, basal/strut load decreased as the number of 
ruptured chordae increased. This reduction in the load was more than 50% for basal 
chordae when partial or total double scallop prolapse occurred, and more than 20% for strut 
chordae during total double scallop prolapse. This marked reduction in basal/strut chordae 
load, together with the corresponding increase in the marginal/intermediate chordae load 
could be caused by the reduction of the leaflet coaptation zone. A smaller coaptation area 
increases the tension of the remaining marginal/intermediate chordae, as they have to 
account for a higher pressure-bearing systolic load that otherwise would be absorbed by 
proper leaflet apposition. As it has been shown that the thinner marginal chordae are less 
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extensible (245, 246) and weaker than basal chordae (247), long-term results may lead to 
chordae elongation, further exacerbate chordae rupture, and eventually cause valve failure. 
Chordae tension has previously been measured in vivo and in vitro under 
physiological and pathological conditions (22). However, due to inherent procedural 
difficulty and in order to avoid interference with normal valve dynamics, these studies have 
been unable to simultaneously measure the forces across all chordae groups, and instead, 
have averaged the tension measured in few chordae. Overall, these studies have found that 
the average tension in a single AML strut chord is the highest among all chordae groups, 
and that individual marginal chorda force is lower than strut/intermediate chordae forces 
(15, 248). When the chordae tensions for each chordae group were averaged in our control 
model, our simulations results seem to agree with the experimental findings, showing that 
a single AML strut chord is subjected to the highest average load, with a value of 0.5 N. 
Furthermore, PML and AML marginal chordae carried the lowest average loads, with 
values of 0.05 N and 0.12 N, respectively. In MV FE models with isolated P2 prolapse 
developed by Sturla et al. (102, 103), the total tension in the chordae located in the 
proximity of the prolapsing region ranged between 2.56 N and 3.99 N. The present FSI 
study showed, however, that marginal and intermediate chordae tensions in the isolated P2 
prolapse model were 0.52 N and 0.43 N, respectively (Table 9). The discrepancy between 
our results and other computational studies could be due to differences in the numerical 
approaches, geometry, material properties, and boundary conditions. 
The measurement of the PM forces is critical for the understanding of the mitral 
apparatus force balance and redistribution under pathological conditions. As seen in Table 
9, the tension in the PM from where the chordae ruptured was reduced between 10%-17% 
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in the 3 isolated scallop prolapse models, more than 38% during partial double scallop 
prolapse, and around 60% during total double scallop prolapse. Contrary to our results, 
Sturla and colleagues (103) noticed a reduction in the PM force from a prolapsed MV to a 
repaired MV with neo-chordae, which should resemble a healthy MV. At peak systole, it 
is expected that the PM forces in a physiologic MV should be higher than of a prolapsed 
MV due to the larger leaflet area experiencing the transmitral pressure difference. Further, 
Sturla et al. (103) found that the combined PM tension under isolated P2 prolapse ranged 
between 13.58 N and 17.57 N, which is 30%-70% larger than the value found in our 
isolated P2 prolapse FSI model (10.17 N). For the control model, it can be seen that for 
both PM, the PML chordae carried between 54%-60% of the load. This distribution was 
not strongly affected in the isolated scallop prolapse models. Moreover, when partial or 
total double scallop prolapse occurred, the opposite PM did not show a significant increase 
or reduction in its tension, as the total load carried by the PML and AML chordae remained 
approximately the same as in the control model.  
 This capability to systematically quantify the force redistribution from the mitral 
leaflets to the PM from a healthy to a pathological state is a valuable tool that could lead 
to an improved understanding of how different pathologies and repair techniques influence 
LH dynamics and valve mechanics. For example, the use of neo-chordae has made a great 
number of complex MV pathologies amenable to repair rather than replacement (249). 
Nevertheless, determining the optimal number, location and proper length of neo-chordae 
remains a challenge (102). As shown by an elegant FE study by Sturla and colleagues (102, 
103), small differences in the neo-chordae technique used can significantly alter native 
chordae forces and leaflet stresses, despite comparable macroscopic successful clinical 
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outcomes. Neo-chordae placement should aim to bring the coaptation region back into the 
LV inflow region, prevent post-repair systolic AML motion, and overcome MR. Thus, FSI 
models are required in order to quantify the flow across the valve and accurately simulate 
full dynamic valve behavior (3), both of which are essential in the simulation of MV repair 
because valvular dynamics are affected by the reduction of the effective valvular orifice 
and restricted motion of the leaflets themselves.  
The FSI modeling framework developed in this study could overcome some of the 
weaknesses of the decoupled FE approach, and open the way to assess the coupled LV-
valve fluid and structural mechanics before and after MV repair. Combined with clinical 
data, FSI computational models can provide highly controlled and quantitative analyses of 
the distinct effects of various valve repair/replacement techniques, pathophysiologic 
conditions, and anatomical variations on the coupled LH dynamics, and are thus 
advantageous over FE- or fluid-only computational models, and complementary to in vivo 
and in vitro models. 
The development of these detailed cardiac computational models for functional 
evaluation and treatment planning is highly dependent on available clinical imaging 
modalities, since capturing anatomically accurate 3D images of the cardiac structures is a 
critical first step of any computational modeling endeavor. Currently, echo is the standard 
noninvasive clinical imaging modality to examine the cardiac function and valvular 
diseases. However, due to its limited spatial resolution, patient-specific detailed mitral 
chordae structure and distribution cannot be accurately captured or segmented (76). Other 
noninvasive 3D cardiac imaging modalities include cardiac MRI and MSCT. As shown in 
this study, high-quality MSCT images can enable accurate and detailed segmentation of 
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the valvular and sub-valvular structures of the LH. In case of low MSCT image quality, a 
complementary segmentation approach that uses optimization methods, parametric 
modeling using anatomic landmarks points of the valvular apparatus, or generalized 
anatomical models from literature-derived data, as commonly used in echo-derived 
computational models, would be required (8). Fortunately, recent developments in MSCT 
technology now allow rapid acquisition of volumetric datasets with high spatial and 
temporal resolution and unlimited 2D planar reconstruction post-processing capability. 
These new-generation MSCT scanners, together with a parallel rapid expansion of 
percutaneous valvular repair and replacement techniques have not only allowed that MSCT 
becomes the standard imaging modality in pre-procedural assessment, but that this imaging 
modality has the potential to play an important role in the diagnosis and evaluation of 
valvular pathologies (250). 
6.4.2 Leaflet stress distribution 
In the chordae rupture models where partial or total double scallop prolapse occurred, 
overall, a high-stress concentration was found in the prolapsed PML segment when 
compared to the control model. Our simulation results seem to agree with previous 
computational studies that have compared MV stresses under chordae rupture and 
normal/repaired states (100, 251, 252). For example, Kunzelman et al. (97) investigated 
MV dynamics under physiological and P2 chordae rupture states. Similar to our study, it 
was found that the leaflet stress increased during chordae rupture, and that stress 
concentrations were located close to the attachment point of the adjacent remaining native 
chordae. Similarly, Sturla et al. (103) found that the stress in the prolapsed P2 scallop 
increased during chordae rupture, indicating excessive loading of the remaining chordae 
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and adjacent leaflet tissue. Nevertheless, as seen in Figure 35, our study showed that 
chordae rupture in a specific scallop does not always involve an increase in the stress of 
the entire leaflet. For example, in the P1 and P3 isolated models, it was found that the 
average stress in the prolapsed scallop in fact decreased around 20%, while in the 
neighboring and opposite scallops decreased between 9%-18%. Moreover, in the isolated 
P2 model, the reduction in the stress of the P2 scallop was 50%, while in the neighboring 
scallops (i.e. P1 and P3) decreased between 8%-13%.  
On the contrary, in the four models where partial or total double scallop prolapse 
occurred, the stress in the lateral (P1 or P3) scallops  increased more than 65%, in the 
central (P2) scallop increased between 8%-80%, and in the healthy scallop decreased 
between 7%-25%. It is noteworthy that the average stress in the AML was also reduced as 
the number of ruptured chordae increased. This reduction was more than 20% when partial 
or total double scallop prolapse occurred. This indicates that PML chordae rupture also 
affects the stress distribution in the AML. It is reasonable to expect that these differences 
in tissue loading can cause the mitral leaflets to remodel and adapt to the geometric needs 
imposed by chordae elongation and rupture (253, 254), similar as chronic tension leads to 
permanent increases in size in bone, vessels, and skin (255-257). However, little is known 
about this phenomenon, in part due to the lack of a measuring technique that can accurately 
and parametrically quantify the MV mechanical state under different pathophysiological 
loads. The FSI modeling framework developed in this study can potentially allow for such 
measurements, which can provide invaluable data for exploring the basic mechanisms of 
tissue remodeling. 
6.4.3 Pathologic LH hemodynamics 
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Accurate grading of MR severity is crucial for clinical decision making, prognosis, and 
timing of treatment intervention. The most common method for noninvasive assessment of 
MR is echo, however, accurate and reproducible quantification of the 𝑅𝑉𝑀𝑉 is 
compromised by the presence of multiple jets, the dynamic regurgitant orifice, and 
geometrical assumptions of the mitral orifice and the LVOT (258). Moreover, given the 
possible eccentricity of the regurgitant jet into the LA with a marked Coanda effect, 
quantification of MR severity can be underestimated due to limitations of alignment, 
hydrodynamic principle assumptions using the PISA method, and Color Doppler jet size 
attenuation when the jet is wall hugging (259). Herein the importance of quantifying the 
𝑅𝑉𝑀𝑉 with a volumetric technique, that although is time consuming as it requires 
calculation of the 𝑆𝑉 and 𝑅𝑉 through the regurgitant and reference valves, has advantages 
in eccentric MR jets, multiple jets, and mid-to-late systolic MR.  
As shown in Table 8 and Table 9, the modeling approach implemented in this study 
was able to assess MR severity by directly quantifying the 𝑅𝑉𝑀𝑉, which is a strong indicator 
of MV function, as well as its effect on the aortic blood flow. Moreover, this is the first 
computational work that reported different MR jet structures in the LA using an FSI 
framework. As seen in Figure 36, while some regurgitant jets followed the direction of the 
flow determined by the prolapsed segment; with a more central location, other Coanda jets 
appeared to be attracted towards the atrial wall. The results of this work could be used to 
better understand how the regurgitant flow features can affect LA enlargement (260), as 
well as echo assessment of MR by performing a systematic comparison of the different 
semi-quantitative and quantitative techniques. Heart pumping efficiency is also an 
important hemodynamic metric that can be studied with an integrative computational 
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approach. When MR was present, there was a progressive reduction in the LV pump 
efficiency in performing 𝑓𝑆𝑊, since the total SW was divided into the 𝑓𝑆𝑊 and the 
ineffective work of the volume regurgitation into the LA. Impaired LV efficiency for the 
chordae rupture models was between 71.82% - 22.86%. Our model predictions seem to 
agree well with in vivo measurements under healthy and MR conditions (261). For example, 
Kameyama et al. (242) found that the human LV efficiency is 69% ± 10% under 
physiological conditions.  
It is also important to note that besides the expected increase in the MV leakage 
volume as the number of ruptured chordae increased (Table 8), a higher MV closing 
volume was also predicted; especially in the severe MR models. It was found that although 
the degree of MV opening and the timing of valve closure was similar for all LH models 
at end-diastole, the mitral leaflets coapt together faster in the control model. The reason 
behind this is that the basal chordae were the first to carry the pressure load early in systole, 
preventing the base of the PML to partially bulge upward into the LA due to the increased 
transmitral pressure, as it occurred in the LH models with partial or total double scallop 
prolapse. In the control model, this allowed that a larger leaflet area was perpendicular to 
the pressure gradient, therefore creating a larger closing force and causing the leaflets to 
coapt together faster. This finding underscores: a) the importance of basal chordae in 
optimizing MV closure, and b) the fact that blood flow dynamics and the structural 
mechanics of the valves should be modeled together using FSI in order to capture the full 
valve dynamics throughout the cardiac cycle. 
In this study, we make a first attempt in relating the ventricular fluid dynamics with 
the valve mechanics during MR by modeling flow-leaflet interaction, leaflet coaptation, 
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and flow dynamics into, outward and within the LV. Studies like this are significant 
because it is known that for complex systems such as the heart, the structural deformation 
of the valves is intricately associated with the blood flow dynamics, and a deeper 
understanding of the interaction between the different components may lead to useful tools 
to diagnose and treat any abnormality of one part based on available information about the 
other. Performing FSI simulations of the LH dynamics to a satisfactory level, however, is 
not a trivial task. The main challenges to overcome are: 1) the large nonlinear deformation 
of the valve leaflets, 2) flow domain discontinuity due to rapid valve closure, and 3) the 
computation of flow-induced loads on evolving complex fluid-solid interfaces. Regardless 
of significant advances in the field, existing FSI methods using either a boundary 
conforming formulation such as the ALE method, or a non-boundary conforming 
formulation such as the IB method experience several complications (137, 262), mainly 
because the fluid mechanics are most conveniently described using the Eulerian 
formulation, while the solid equations are normally described in the Lagrangian 
formulation.  
Using a Lagrangian description for both fluid and solid domains is a potential remedy 
to the simulation of FSI problems, and SPH is one of these methods. The meshless nature 
of SPH allows large deformations to be modeled more easily in cases where mesh-based 
methods would require dealing with expensive re-meshing and with a moving interface on 
a stationary mesh. Previous studies have concluded that the SPH method is a viable FSI 
technique to simulate the complex valve dynamics and the large-scale ventricular flow 
dynamics (86, 136, 156, 207, 208). Nevertheless, like any other numerical method, SPH 
has its own limitations and further developments are still required for SPH to compete with 
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established mesh-based methods. For example, in this study each cardiac cycle required 
approximately 5 days to run. As a result, the present FSI modeling framework cannot be 
used in a clinical setting and currently, is only suitable for a research environment. 
However, both FE and SPH solvers can use the GPU's extremely parallel architecture (88, 
263, 264), which will significantly reduce the running time in the near future and avoid the 
need for a large computer cluster. 
6.5 Limitations 
There are some limitations that should be taken into account when interpreting the results 
of this study. First, in this parametric FSI study we adapted one previously validated 
healthy LH model to create seven chordae rupture cases, employing the same baseline 
conditions for all diseased models, with variations of chordae rupture location and number. 
Such well-controlled, side-by-side comparisons are difficult to obtain in real patient 
conditions. However, we acknowledge that a large cohort of patient-specific LH models 
needs to be developed and simulated to replicate clinical conditions and draw statistical 
conclusions. Second, there is no direct validation of the chordae rupture LH models. We 
assume that LH and valve computational models that have been validated under 
physiological conditions (73, 207, 208) can also accurately simulate some pathological 
states, such as acute MR due to chordae rupture. To allow for validation of the chordae 
rupture LH models, a retrospective study of patients with mitral leaflet prolapse scheduled 
for MV repair would be needed, and clinical measurements should be compared to FSI 
results.  
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Third, the FSI modeling protocol adopted in this study required a considerable 
amount of human effort to create the LH models and of computational time to run the FSI 
simulations, which is not compatible with its use in a routine clinical setting. We are 
currently developing methods to streamline and automate the model generation and 
simulation process to facilitate analysis of larger patient cohorts (265). Fourth, although 
alterations in tissue properties have been found when MV prolapse is caused by chordae 
rupture (266), the same mitral tissue properties and geometry (e.g. tissue thickness) were 
used for all models in this study. Therefore, simulation results may differ if patient-specific 
pathological tissue and geometrical data are incorporated. Finally, due to the inherent 
limitation of Abaqus SPH formulation, small-scale flow and turbulence features may not 
be accurately solved close to the cardiac wall. When particles are close to the wall, part of 
the supporting domain of the smoothing kernel will not be filled with SPH particles, 
affecting their integration accuracy. However, the combined effect of the smoothing kernel 
interpolation function near the wall and the node-to-surface contact interaction partially 
enforces the no-slip boundary condition. 
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CHAPTER 7. SPECIFIC AIM 1B – PART 2, LV-VALVE 
DYNAMICS UNDER SECONDARY MITRAL REGURGITATION 
AND BICUSPID AORTIC VALVE STENOSIS 
7.1 Introduction 
In contrast to degenerative or primary MR that results from the pathologic abnormality of 
the valvular tissue, secondary or functional MR occurs on a structurally normal MV as a 
result of alterations in LV geometry and function. Functional MR represents a major 
clinical challenge, since severe MR has poor prognosis in patients with heart failure and 
reduced LVEF (267, 268). In ischemic MR, pathological LV remodeling contributes to the 
apical, posterior and lateral displacement of the PM, with reduced LV contractility and 
abnormal MA contraction. The displacement of the PM results in traction on the mitral 
leaflets and restriction on leaflet motion. Moreover, inadequate closure of the MV 
contributes to increased tethering forces and reduced leaflet closing force (269, 270).  
Using an undersized annuloplasty ring to improve leaflet coaptation is a common 
surgical treatment for functional MR. Significant recurrence of MR, however, has been 
reported following annuloplasty (271-273). Moreover, many patients with severe 
functional MR are not eligible for surgical MV repair due to multiple comorbidities and 
high surgical risk (274). Other treatments include leaflet resection, neochordae 
implantation, and edge-to-edge repair (272, 275-278). The highly complex structure and 
the interrelated function among the valve substructures and the continuous remodeling 
mechanisms of MR make MV treatment strategy difficult. Particularly for MV repair, the 
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success of a technique may be associated with the leaflet stress, MA force and chordae 
forces(279-281). Therefore, it is important to understand the LV-valve biomechanics under 
functional MR, in order to assess the effectiveness of repair strategies and determine the 
optimal strategy available for specific patients.  
Computational studies have been useful in assessing the MV mechanics under 
normal and diseased conditions, as well as evaluating surgical MV repair techniques. MV 
repair by annuloplasty and MitraClip intervention was studied using patient-specific FE 
MV models derived from echocardiography data (282-284). However, due to the limited 
resolution of echo data, the locations of chordal insertion points and single-point chordal 
origins on the PM in these models were assumed. PM and MA dynamic motion from 
diastole to systole is essential for accurate simulation of leaflet closing behaviors using 
healthy MV models (285). Realistic chordae and leaflet reconstruction has been achieved 
based on Micro-CT, but Micro-CT cannot be applied in a clinical setting (286).  
Hence, in Specific Aim 1b – Part 2, we aim to develop a patient-specific LH model 
with functional MR and concomitant BAV that includes detailed chordae tendineae 
structure and distribution, accurate leaflet geometry and thickness, dynamic MA and 
chordae origins, anisotropic hyperelastic material models, and human age- and gender-
matched material properties. Despite the presence of traction on the MV leaflets caused by 
displacement of the PM, the initial MV geometry constructed from clinical images has 
been assumed stress-free in previous studies. In this study, we will introduce the tethering 
pre-tension force, the tension existing in the chordae prior to systole, which plays an 
important role in accurately simulating MV dynamics under functional MR. The patient-
specific LH model will be validated first, by quantitatively comparing the closed MV 
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geometry obtained from the simulation with the in vivo MV geometry obtained from the 
clinical MSCT images at systole. MV model optimization, including chordae tethering 
adjustment and pretension will be performed until correct valve morphology and leaflet 
deformation are obtained. The second validation phase will consist of the comparison of 
the FSI hemodynamic results with the patient’s echo measurements.  
7.2 Materials and Methods 
7.2.1 Patient information 
A 71-year-old male patient with a mean aortic annulus diameter of 23 mm was referred for 
TAVR at Hartford Hospital (Hartford, CT). Pre-TAVR echo examination revealed 
classical low-flow, low-gradient severe AS, a BAV with eccentric coaptation between the 
non-coronary leaflet and fused left and right coronary leaflets, with no raphe between them 
(Sievers type 0 L/R) (56). Mild aortic insufficiency was detected. Moderate-to-severe 
functional MR was also found, with restricted PML motion and reduced leaflet coaptation, 
resulting in a posteriorly directed regurgitant jet. The LV wall thickness was normal, but 
the chamber was mildly dilated with severe global hypokinesis with regional variation. The 
LA was dilated despite a normal antero-posterior diameter.  
7.2.2 Patient-specific LH model 
The patient-specific LH model was created from the pre-TAVR cardiac MSCT images 
after obtaining approval from the Institutional Review Board. The MSCT images, acquired 
with a GE LightSpeed 64-channel volume CT scanner, had an in-plane resolution of 0.82 
x 0.82 mm and a slice thickness of 0.625 mm. Ten phases of the cardiac cycle were 
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collected using an ECG-gated sequence. DICOM images were imported into Amira-Avizo 
(Thermo Fisher Scientific, MA) and 3D Slicer (www.slicer.org) software to segment the 
cardiac structures, which included the ascending aorta, aortic root, BAV, calcification, MV, 
chordae, LV and LA endocardial walls. HyperMesh software (Altair Engineering, Inc., MI) 
was then used to create a high quality FE mesh. Figure 38A shows the patient-specific LH 
model. Two calcific deposits were found in the fused leaflet, as well as one in the coronary 
ostia close to the right coronary artery.  
The AV and MV geometries were segmented at mid-systole and mid-diastole, 
respectively, approximating their stress–free configuration (212). Similarly, the aortic root 
and ascending aorta were segmented at mid-systole. The patient-specific MV model used 
in this study was developed and validated in a previous work from our group that 
investigated MV dynamics under functional MR (287). Briefly, the detailed chordae 
structure (number, position, length, branching, origins of the PM tips, and insertions into 
the leaflets) was directly reconstructed from the MSCT images, as seen in Figure 38B. 
Chordae were classified into five groups: anterior strut (AS), anterior basal (AB), anterior 
marginal (AM), posterior basal (PB), and posterior marginal (PM). Cross-sectional area 
values of 0.38 mm2, 0.71 mm2 and 2.05 mm2 were assigned to marginal, basal and strut 
chordae, respectively (73). A total of 18 chordae origins were modeled from the PM tips.  
3D solid elements (eight-node hexahedral C3D8R/C3D8I elements, six-node 
wedge C3D6 elements, and four-node tetrahedral C3D4 elements) were used to discretize 
the ascending aorta, aortic root, BAV, calcification and MV. Stress/displacement truss 
elements (two-node linear T3D2 elements) were used for the mitral chordae, while shell 
elements (four-node quadrilateral S4 elements) were used to model the endocardial wall. 
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Two layers of elements were used across the mitral leaflet thickness. For the AML, the 
average thickness values for the leaflet belly and free edge were 1.26 mm and 2.09 mm, 
respectively. For the PML, the average thickness values of the leaflet belly and free edge 
were 1.31 mm and 1.57 mm, respectively (287). Four layers of elements were used across 
the ascending aorta/aortic root and BAV leaflet thickness, with a uniform total thickness 
of 2 mm and 0.7 mm, respectively.  
After a mesh convergence study, average mesh sizes for the BAV, MV, chordae, 
aorta/aortic root and calcification were 0.25 mm, 0.7 mm, 1.5 mm , 1 mm and 0.5 mm, 
respectively. Leaflet mesh size was refined until stress results were not affected by mesh 
size, with results showing a variation within 5%. The total number of elements used for the 
BAV was 48,567, 6550 for MV, 860 for chordae, 183,130 for aorta/aortic root, and 42,650 
for calcification. The BAV/aortic root and calcification shared the same nodes on the 
tissue-calcification interface, thus avoiding contact-related issues during the simulation. 
SPH particles were uniformly distributed in the domain with a spatial resolution of 0.8 mm, 
which led to approximately 1 million one-node (PC3D) elements. 
An anisotropic hyperelastic material model, based on Holzapfel et al. (209, 288), 
was adopted to characterize the mechanical response of most cardiac tissues, while the 
isotropic hyperelastic Ogden material model (289) was used to characterize the mechanical 
properties of mitral chordae and aortic-mitral curtain. Material parameters were determined 
by fitting in-house multiprotocol biaxial and uniaxial testing data of human cardiac tissues. 
Table 11 lists the fitted material parameters. Calcification was assumed to be a linear-
elastic material with a Young’s modulus of 12.6 MPa and a Poisson ratio of 0.3 (112). 
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𝑘2 𝜃 (°) 𝜅 𝐷 (kPa
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0 0.317 5.0e-4 
AML 0.285 61.303 9.295 99.684 0 0.333 5.0e-4 
PML 0.101 33.191 10.756 48.495 27.98 0.089 5.0e-4 
Sinuses 1.755 13.707 10.550 80.379 20.06 0 5.0e-4 










































Figure 38. A) Patient-specific LH model reconstructed from the MSCT images, B) 
MV model from MSCT segmentation, C) Aortic and LA pressure waveforms, D) LV 
volume waveform. 
 
7.2.3 Boundary conditions 
Time-dependent pressure boundary conditions were applied at the two atrial inlets 
(pulmonary veins) and at the aortic outlet of the pre- and post-TAVR LH models. As seen 
in Figure 38C, a pathological atrial pressure waveform was prescribed at the inlets, with 
an  elevated V-wave due to the regurgitant volume in the atrial cavity during systole (238). 
In order to match the patient’s clinical data, the mean diastolic atrial pressure value was 
adjusted to be 12 mmHg, while the peak systolic and diastolic aortic pressure values were 
set to 100 mmHg and 63 mmHg, respectively. 
Endocardial wall motion was imposed as a time-dependent nodal displacement 
boundary condition based on the ten cardiac phases from the MSCT images. A detailed 
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description of the cardiac wall motion modeling procedure can be found in Specific Aim 
1a. Figure 38D shows the time-varying LV volume change waveform obtained from the 
FSI model. The patient’s heart rate was approximately 60 bpm, corresponding to a cardiac 
cycle of 1 s. Note that FSI simulations begin at early systole. Two cardiac cycles were 
conducted and the results from the second cycle were analyzed herein.  
7.2.4 Data analysis 
7.2.4.1 Fluid parameters 
As introduced in Part 1, the 𝑅𝑉𝑀𝑉 and 𝑅𝑉𝐴𝑉 were obtained by integrating the negative MV 
systolic flow rate curve and negative AV diastolic flow rate curve over time, respectively. 
The 𝑅𝑉 was defined as the sum of the valve closing and the leakage volumes. Similarly, 
the 𝑆𝑉𝑀𝑉 and 𝑆𝑉𝐴𝑉 were obtained by integrating the positive MV diastolic flow rate curve 
and positive AV systolic flow rate curve over time, respectively. MR severity was graded 
using the regurgitant fraction criterion (32), 𝑅𝐹𝑀𝑉 = 𝑅𝑉𝑀𝑉 𝐿𝑉𝑆𝑉⁄ , where 𝐿𝑉𝑆𝑉 is the total 




where 𝑀𝑆𝐹 is the root mean square systolic flow rate, and ∆𝑃 is the mean systolic pressure 
gradient (213). 
7.2.4.2 Structural parameters 
For the validation of the MV model, the distance error between the deformed MV and the 
‘‘true’’ valve geometry obtained from the MSCT images during systole were computed in 
MATLAB as the point-to-node distance between the nodes of the deformed valve mesh 
and their corresponding projected points on the tissue surface segmented from the image 
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data (290). A point-to-node distance > 2 mm was considered unacceptable and required 
further model adjustment.   
For the FSI simulation, tissue mechanics were evaluated by the average maximum 
principal stress values calculated in the BAV leaflets and MV leaflets during peak diastolic 
and systolic pressure, respectively. Chordae forces at peak systole were also reported as 
presented in Part 1. Briefly, the force experienced by a particular chordae group was 
calculated as the sum of vectors representing the tension in each individual chorda attached 
to that chordae group. 
7.3 Results 
7.3.1 MV optimization and validation 
Due to the limitation of the MSCT image resolution, it was not possible to detect all of the 
chordae or the accurate chordae length. Therefore, the number of chordae and their lengths 
were estimated in the initial model and required optimization. The model was adjusted until 
the deformed MV model could closely match the true image model. If the surface of the 
valve leaflets were protruding towards the LA, the chordae in the vicinity were shortened. 
If a chorda was excessively tensioned and stretched the leaflet, it was then elongated. The 
chordae lengths were adjusted while keeping the insertion and origin points unchanged. 
After 20+ iterations, it was determined that adjusting the chordae length alone was 
insufficient to accurately simulate the systolic MV deformation. Therefore, an existing 
chordae tethering force at diastole due to LV dilatation in this functional MR patient, which 
could further restrict the leaflet motion, was needed. This pre-existing force was generated 
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by shortening the length of the tethered chordae by 1.99 mm on average in a total of 8 
chordae. The chordae origins were translated towards the annulus plane along the vector 
going from the chordae origin point to the insertion point by the magnitude of the chordae 
shortening. Hence, an additional step of pretension was added to the simulation process, 
where the translated origins were displaced from their adjusted locations to their original 
locations identified from MSCT to generate the pre-tension in the chordae. Approximately 
50 iterations were performed to optimize the chordae lengths and degree of pre-tension. 
Figure 39 shows the final optimized MV geometry after performing chordae 
optimization. The atrial, sagittal and isometric views of the valve demonstrated a good 
agreement between the deformed MV and the true image model at systole. During peak 
systole, a large regurgitant orifice was visible at the P1 and partial P2 regions. Figure 39d 
displays an overlay of the 2D projections of the regurgitant orifice in the deformed and true 
image models at systole. The 2D areas from the computational model and true image model 
were 60.55 and 51.86 mm2, respectively. 
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Figure 39. (a) Atrial, (b) sagittal and (c) isometric views of the deformed MV model 
overlapped with the true image model from MSCT at mid-systole, (d) the projected 
orifice areas of the deformed MV model and middle-systolic geometry from MSCT 
images; (e) atrial and (f) ventricular surface views of the calculated distance error 
maps at middle systole. 
 
7.3.2 Global hemodynamic parameters and validation 
Table 12 displays the computed hemodynamic parameters of the patient-specific LH model 
throughout the cardiac cycle. Numerical measurements are compared to the patient’s 
available echo data. Generally, there is good quantitative agreement between the simulation 
results and the clinical data, which demonstrates that the SPH-FE FSI modeling framework 
can accurately simulate the patient-specific LH pathological dynamics. FSI simulation of 
BAV function revealed the classical low-flow low-gradient AS found clinically, with an 
EOAAV < 1 cm
2, mean systolic pressure gradient < 40 mmHg, and decreased LVEF < 50%. 
Similarly, FSI simulation of MV function demonstrated moderate-to-severe MR, which 
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was consistent with the patient’s clinical echo examination. Additionally, Figure 40 shows 
the intraventricular velocity streamlines colored by velocity magnitude during peak 
systole. Due to the restricted PML motion, the pre-TAVR model displayed a posteriorly 
directed regurgitant jet, which qualitatively matched the Doppler color echo image shown 
in Figure 40. 
Table 12. LH hemodynamics and echo comparison. 
 FSI Echo 
SVAV (ml) 46.28 43 
RVAV (ml) 9.34 ̶ 
SVMV (ml) 74.64 ̶ 
RVMV (ml) 37.59 ̶ 
RFMV (%) 44.82 ̶ 
MR severity (RFMV) Moderate-to-severe Moderate-to-severe 
LVEF (%) 28.55 25 
AV peak gradient (mmHg) 34.82 34 
AV mean gradient (mmHg) 23.97 20 
AV peak velocity (m/s) 2.82 2.9 
EOAAV (cm
2) 0.77 0.67 
E wave (m/s) 0.79 0.9 
A wave (m/s) 0.54 0.6 
E/A 1.47 1.5 
MR peak gradient (mmHg) 118.59 ̶ 




Figure 40. Doppler color echo image and FSI velocity streamlines showing 
regurgitant jet structures at peak systole. 
 
7.3.3 Valve tissue mechanics 
Table 13 presents the average stress values calculated for the AV leaflets and MV leaflets 
during peak diastolic and systolic pressure, respectively. Due to the restricted motion of 
the PML observed clinically, the average stress in the AML was generally higher than in 
the PML. However, the peak mitral leaflet stresses were located at the tethered PML 
chordae insertion regions, near the leaflet free-edge and basal chordae locations. Since this 
patient had a postero-lateral regurgitant gap with PML tethering near the APM, the LH 
model experienced high PML chordae forces when compared to AML chordae tensions. 
There was an imbalanced force distribution between the two PM, with APM force being 
higher than PPM force.  
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Table 13. LH tissue parameters. 
 FSI 
Sɪ




Fchordae (N)  
AML marginal 1.14 
AML strut 2.04 
AML basal 3.84 
PML marginal 6.13 
PML basal 7.33 
 
7.4 Discussion 
7.4.1 MV deformation 
The MV model developed in this study was able to accurately captured PML tethering by 
accounting for the pre-tension tethering forces in the chordae and the mitral leaflets. We 
observed high chordae forces on the tethering PM at both diastole and systole. Early 
experiments have suggested that tension on chordae and mitral leaflets existed not only at 
systole but also diastole (291, 292). Due to functional MR, LV dilation and apical 
displacement of the PM could cause more traction on the leaflets and thus prevent proper 
coaptation. Systolic chordae forces as well as leaflet stress and strain values have been 
studied both experimentally and computationally by simulating an MR state of the MV 
(106, 293-295). However, few studies have looked into the tension that exists in diastole 
under functional MR due to PM traction, and MV models at diastole state have mostly been 
assumed stress free (106, 282, 293, 296). For this patient case, a lack of annulus and 
ventricular contraction, large tenting angle and area were observed from the MSCT images, 
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as well as restricted PML motion from diastole to systole. From our simulations, we found 
that ignoring the tension in the chordae and leaflets during diastole would overestimate the 
leaflet coaptation for this patient, with 84% larger in average point-to-mesh distance error 
compared to the model with pretension. The results indicated that the existing pre-tension 
force in chordae and leaflets at diastole is essential in accurately replicating the in vivo MV 
dynamics. 
7.4.2 Clinical validation 
To the best of our knowledge, this is the first validated patient-specific computational 
model that simulated the LH dynamics under functional MR during the entire cardiac cycle. 
Comparison between simulation results and available echo data demonstrated good 
quantitative agreement, with some computed variables agreeing better with the echo 
measurements than others. First, it is generally noted that differences in terms of the SVAV, 
RVMV, LVEF, E wave, A wave, E/A ratio, and MR peak gradient and velocity were mostly 
below 10% (Table 12). It is also noted that the errors in the estimation of the AV peak and 
mean gradients, AV peak velocity and EOAAV were below 20%. As with any image-based 
computational model, there exist sources of geometric and numerical uncertainties. 
Moreover, it is important to be aware of the inherent limitations and variability in the 
measurement of hemodynamic variables using echo (297). Echo examination is highly 
dependent on the experience of the operator, the technical quality of the study and on the 
patient’s acoustic window (298).  
7.5 Limitations 
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While, on one side, cardiac tissues were realistically described as nonlinear and anisotropic, 
on the other side, patient-specific cardiac tissue material properties were not available. 
Thus, tissues mechanical response was defined from an extensive human tissue database 
obtained from in-house multiprotocol biaxial and uniaxial tests. Second, since this study 
did not consider the zero stress–free configuration of the aortic wall, a rigid body constraint 
was assigned to the aortic root/ascending aorta wall elements during the FSI simulations. 
Third, the current SPH-FE FSI modeling framework involves a high computational cost. 
The FSI simulations required approximately 5 days to run one cardiac cycle in an Intel 
Xeon E5-2670 cluster. As a result, the present modeling methodology cannot be used in a 
clinical setting and currently, is only suitable for a research environment. Nevertheless, 
among other advantages, SPH is easy to parallelize. The ability to run both FE and SPH 
codes on GPUs will significantly reduce the running time in the near future and avoid the 
need for a computer cluster (299, 300). 
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CHAPTER 8. SPECIFIC AIM 2A – LV-VALVE DYNAMICS 
UNDER TRANSAPICAL NEOCHORDAE IMPLANTATION 
8.1 Introduction 
After the success of TAVR in treating severe AS, a great effort has been made in recent 
years on the development of minimally-invasive technologies for MV repair/replacement. 
In particular, transapical beating heart neochordae implantation has demonstrated potential 
effectiveness and safety in treating a subset of patients with primary MR (301). In the 
transapical chordae repair approach, ePTFE sutures are implanted on a beating-heart 
through a small incision under 2D/3D TEE guidance. Neochordae are anchored to the 
prolapsing leaflet segment on one end, and on the moving LV apex on the other end.  
Although transapical neochordae implantation has been demonstrated to be safe and 
effective in patients with primary MR (302), this is still a technically demanding 
technology in the early stage of use. A number of issues such as residual leaflet prolapse 
when treating multi-scallop disease, determination of the optimal LV access site, suture 
number, placement and length, as well as proper patient selection to ensure a safe and 
durable repair remain to be studied in detail (301, 303). Moreover, it is important to 
highlight that the growing experience with this technique has been mainly in patients with 
isolated central prolapse (302). Therefore, limited knowledge about the biomechanical and 
clinical outcomes in patients with multi-scallop or paracommissural prolapse exists. 
Clearly, long-term, large-volume clinical studies as well as highly controlled 
biomechanical studies are needed to assess the definitive value of this therapeutic approach. 
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Cardiac computational modeling is a powerful tool that can help us to better 
understand the functional and biomechanical environment of the heart under physiologic, 
pathological and repaired conditions. FE studies have been performed in the past to 
evaluate MV dynamics under different repair techniques (97, 98), including traditional 
surgical neochordae implantation, where the sutures are attached to the PM tips (99, 101-
103). Recently, a FE model was develop by Gaidulis and colleagues (304) to evaluate MV 
repair with transapical neochordae implantation. In particular, the effect of neochordae 
length on post-repair MV dynamics was investigated. However, for physiologically 
accurate simulations and rigorous evaluation of MV repair treatments, the intraventricular 
blood dynamics and the structural mechanics of the valves should be modeled together, an 
area where FSI is required (3, 76, 155).  
In Specific Aim 2a, we employed the LH model with primary MR due to chordae 
rupture developed in Specific Aim 1b – Part 1 to simulate transapical neochordae 
implantation and better understand the biomechanical interaction between the neochordae 
and the LH complex. Neochordae implantation using three and four sutures was modeled 
under three clinically relevant prolapse conditions: isolated P2, multi-scallop P2/P3 and 
multi-scallop P2/P1. We investigated the effect of selecting an antero-lateral vs. a postero-
lateral LV access site, and suboptimal neochordae length, compared to optimal suture 
length. An improved understanding of these aspects through a detailed and objective 
engineering approach is an important step towards the success of novel transcatheter MV 
interventions in the short- and long-term. 
8.2 Materials and Methods 
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8.2.1 LH model 
In this study, we employed the LH model with primary MR developed in Specific Aim 1b 
– Part 1. Three PML prolapse models that reproduce common clinical scenarios of acute 
chordae rupture were selected and analyzed: isolated P2, multi-scallop P2/P3 and multi-
scallop P2/P1. Briefly, the isolated P2 prolapse model was created by removing marginal 
and intermediate chordae elements from the central scallop, while the multi-scallop 
prolapse models were created by progressing towards rupture of the basal chordae 
elements. 
8.2.2 Transapical neochordae modelling 
Neochordae were modeled as CV-4 ePTFE sutures (W.L. Gore & Associates, Inc., 
Flagstaff, AZ, USA) (305) with a constant cross-sectional area of 0.074 mm2 (251), and 
using stress/displacement truss elements (T3D2) with an average element length of 1 mm. 
Mechanical properties derived from uniaxial tensile tests were obtained from literature 
(251, 306). In this study, virtual transapical neochordae procedures were modeled under 
optimal implantation conditions. That is, following the manufacture’s recommendations 
(307) (308, 309). and the clinical step-by-step guide (305, 310). 
Clinically, three or four neochordae are implanted on average in order to balance 
the tension per neochorda, provide structural support and avoid excessive mechanical stress 
on the leaflets (302). Thus, three (NC3) and four (NC4) neochordae were modeled in this 
study for each PML prolapse model, as seen in Figure 41 and Figure 42. Representative 
isolated P2 NC3 model showing the antero-lateral LV access site. Neochordae number and 
leaflet attachment location for the 6 post-repair models.. Each neochorda was modeled as 
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a simple suture loop, passing one end of the suture through the prolapsed scallop(s), while 
the two free ends were locked on the LV epicardium (305). Moreover, each neochorda was 
advanced and anchored to the leaflet as a single point attachment at individual nodes 
through the leaflet thickness. In real practice, the use of a girth hitch knot or a double-helix 
knot may reduce leaflet stress concentrations compared to our idealized knot modeling. As 
shown in Figure 41 and Figure 42, neochordae were uniformly distributed along the 
prolapsed scallop(s) and fixed 4 mm away from the leaflet free edge, as clinically 
recommended (305).  
Two LV access sites were modeled for the neochordae origin: a postero-lateral 
(Figure 41) and an antero-lateral (Figure 42) (305) (308). These sites were located 
approximately 3 cm from the true apex of the heart. Moreover, the location of the epicardial 
and endocardial walls of the LV entry site was tracked from the subject-specific MSCT 
images during the cardiac cycle, and their motion was imposed as a time-dependent nodal 
displacement boundary condition (Figure 43A). Optimal neochordae length was initially 
determined from the baseline LH model as the distance between the affected scallop(s) and 
the LV access site at peak systole, and later tuned to maximize leaflet coaptation and 
minimize MR in the post-repair LH models.  
Additionally to modeling ideal neochordae length, two suboptimal neochordae 
length configurations were simulated for the isolated P2 prolapse model when using NC4 
and an antero-lateral LV entry site. Optimal suture length was altered by ± 4 mm, 
simulating apparently correct transapical neochordae techiques with a slight under-tension 
(optimal + 4 mm) and over-tension (optimal - 4 mm). 
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Figure 41. Representative isolated P2 NC3 model showing the postero-lateral LV 




Figure 42. Representative isolated P2 NC3 model showing the antero-lateral LV 





8.2.3 Boundary conditions 
Time-dependent pressure boundary conditions were applied at the LA inlet and aortic 
outlet of the LH models. As seen in Figure 43B, for the baseline and post-repair models, a 
constant atrial pressure of 20 mmHg was prescribed at the inlet, while a physiological aortic 
pressure waveform was applied at the outlet. In acute MR, the regurgitant volume in a 
normal-sized LA results in a marked increase in the atrial pressure during systole (238) 
(elevated V-wave). Thus, the pre-repair models employed a pathological LA inlet pressure 
waveform, while the same aortic pressure waveform as in the baseline/post-repair models 
was applied at the outlet. 
 
Figure 43. A) Epicardial and endocardial wall motion between peak diastole (green) 
and peak systole (yellow). B) Aortic and LA pressure boundary conditions. 
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8.2.4 Data analysis 
A total of 18 LH FSI simulations were performed in this parametric study. One for the 
baseline model, three for the pre-repair models with chordae rupture, six for the post-repair 
models with optimal neochordae length (NC3 and NC4) and using a postero-lateral LV 
entry site, six for the post-repair models with optimal neochordae length (NC3 and NC4) 
and using an antero-lateral LV entry site, and two for the isolated P2 NC4 post-repair 
models with suboptimal neochordae length (optimal ± 4 mm) and using an antero-lateral 
LV entry site. In the text, “AL-NC” refers to the antero-lateral transapical neochordae 
configuration, while “PL-NC” refers to the postero-lateral configuration. 
Baseline, pre- and post-repair LH dynamics were analyzed in terms of the following 
hemodynamic and structural biomechanical parameters: 1) 𝑆𝑉𝐴𝑉, 𝑆𝑉𝑀𝑉, 𝑅𝑉𝐴𝑉, 𝑅𝑉𝑀𝑉, 
𝑅𝐹𝑀𝑉, and MR severity, 2) Native chordae tension (Fchordae), defined as the resultant force 
carried by the different chordae groups. The resultant force experienced by a particular 
chordae group was calculated as the sum of forces exerted by each native chorda attached 
to that chordae group, 3) PM force (FPM), defined as the resultant reaction force exerted on 
the APM and PPM to bear the tension of the native chordae, 4) Neochordae tension (FNC), 
defined as the resultant force exerted on the ePTFE sutures, 5) Percentage of the force 
carried by each neochorda (Fneochorda) relative to the total neochordae tension, 6) Peak value 
(Sɪ
MAX 
NC) of the maximum principal stress on the neochordae, 7) Average (Sɪ
AVRG
 MV) 
maximum principal stress in the MV leaflets. Leaflet free edge and annular regions were 
not included in the average stress calculation, 8) Peak value (Sɪ
MAX 
MV) of the maximum 
principal stress on the mitral leaflets with location. 
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8.3 Results 
8.3.1 LH hemodynamics 
Table 14 and Table 15 show the LH hemodynamic parameters for the baseline, pre- and 
post-repair models with PL-NC and AL-NC configurations, respectively. For each post-
repair model, the use of ePTFE sutures, regardless of the number used and location, 
resulted in the reposition of the prolapsed scallop(s) under the MA and acute reduction of 
MR. By using 𝑅𝐹𝑀𝑉 as a quantitative parameter to grade the MR severity, Table 14 and 
Table 15 show that all post-repair models can be classified as having trivial MR, like the 
baseline model. The mitral flow rate curves through the cardiac cycle for the LH models 
are shown in Figure 44, respectively. As expected, the 𝑆𝑉𝑀𝑉 was largely similar for all LH 
models, since the cardiac wall motion was assumed to remain unchanged. 
Table 14. Hemodynamic parameters for the baseline, pre- and post-repair (optimal 
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Table 15. Hemodynamic parameters for the baseline, pre- and post-repair (optimal 
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Figure 44. Flow rate curves (ml/s) across the MV throughout the cardiac cycle. A) 
PL-NC configuration, B) AL-NC configuration. The negative systolic mitral flow 
indicates the backflow into the LA due to MV closing and MR. 
 
8.3.2 Native chordae tension – PL-NC 
Forces on the different native chordae groups at peak systole are reported in Table 16 and 
Figure 45. When compared to the baseline model, AML marginal tension increased more 
than 30% for all post-repair models. On the other hand, AML strut tension was largely 
unchanged. As expected, PML chordae tension for the post-repair models was lower than 
for the baseline model, a direct result of the decreased number of native PML chordae 
available for coaptation.  
For the isolated P2 post-repair models, PML chordae tension decreased between 
30% - 50% in all chordae groups, when compared to the baseline model. For the P2/P3 
post-repair models, PML marginal/basal and intermediate chordae tension decreased more 
than 60% and 30%, respectively. Similarly for the P2/P1 post-repair models, PML 
intermediate/basal and marginal chordae tension decreased more than 60% and 30%, 
respectively. Overall, native mitral chordae did not see noticeable differences in their 





Table 16. Structural parameters for the baseline, pre- and post-repair (optimal 








































AML strut 3.49 
3.15 (-
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FNC (N) ̶ ̶ 1.83 2.11 ̶ 3.02 3.33 ̶ 3.02 3.10 
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Fneochorda values from left to right correspond to neochorda located from P1 to P3 scallops. 




Figure 45. Native mitral chordae tension (N) at peak systole. Asterisks highlight a 
marked reduction (>50%) in chordae tension with respect to the baseline model. 
 
8.3.3 Native chordae tension – AL-NC 
Native chordae tension at peak systole are reported in Table 17 and Figure 46. When 
compared to baseline conditions, except for the isolated P2 NC4 model, post-repair models 
demonstrated an important increase (>30%) in AML marginal tension. AML strut tension 
on the other hand, revealed minimum changes between baseline and post-repair states. For 
the isolated P2 post-repair models, PML marginal/basal and intermediate tensions 
decreased >30% and ~50%, respectively. For the P2/P3 and P2/P1 post-repair models, 
PML basal tension decreased at least 50%, while PML marginal/intermediate tension 
decreased at least 35%. Overall, the different chordae groups did not see a noticeable 
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change in their total tension when implanting NC3 or NC4 for each clinical scenario of 
MV prolapse. 
Table 17. Structural parameters for the baseline, pre- and post-repair (optimal 
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FNC (N) ̶ ̶ 2.06 2.68 ̶ 5.50 5.95 ̶ 2.97 3.29 
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1 – P2 1.41 – P2 
Fneochorda values from left to right correspond to neochorda located from P1 to P3 scallops. 




Figure 46. Native chordae tension (N) at peak systole. Asterisks highlight a marked 
reduction/increase (>50%) in chordae tension with respect to the baseline model 
(blue). 
 
8.3.4 Neochordae and PM tension – PL-NC 
Figure 47 shows the PM tension curves for the baseline model and the total neochordae 
tension curves for the post-repair models throughout the cardiac cycle. While the isolated 
P2 post-repair models had a total suture tension of ~2 N at peak systole, the P2/P3 and 
P2/P1 post-repair models reported a suture tension of ~3 N (Table 16). Moreover, the 
highest and lowest individual neochorda tensions between all post-repair models were 1.21 
N and 0.42 N, respectively. No marked differences in terms of total neochordae tension 
were found when implanting NC3 or NC4 for each clinical scenario of MV prolapse. 
8.3.5 Neochordae and PM tension – AL-NC 
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During peak systole, the isolated P2, P2/P3 and P2/P1 AL-NC post-repair models had a 
total suture tension between 2 N – 2.7 N, 5.5 N – 6 N, and 3 N – 3.3 N, respectively (Figure 
47 and Table 17). Moreover, the highest and lowest individual neochorda tension values 
between all models were 2.06 N and 0.39 N, respectively. When comparing the use of NC3 
and NC4, for the isolated P2 post-repair models, implanting NC4 showed a 30% increase 
in neochordae tension. For the P2/P3 and P2/P1 post-repair models, however, minor 
differences in total suture tension were reported. 
 
Figure 47. PM and total neochordae tension curves (N) for AL-NC and PL-NC 





8.3.6 Mitral leaflet stress – PL-NC 
Figure 48 and Table 16 show the average stress calculated for each of the four mitral leaflet 
segments at peak systole. It was found that the AML stress seemed to return to a baseline 
state in all post-repair models, after decreasing during PML prolapse. For the isolated P2 
models, the PML stress in the non-prolapsing scallops (i.e. P1 and P3) remained mostly 
unchanged between the baseline and post-repair states. The P2 stress, however, showed a 
marked variation, changing from a 50% reduction (compressive stress) in the pre-repair 
model, to a 50% increase (tensile stress) in the post-repair models, when compared to the 
baseline model. 
In the P2/P3 and P2/P1 post-repair models, the stress in the non-prolapsing scallop 
(i.e. P1 and P3, respectively) returned to a baseline value after neochordae implantation, 
while in the lateral prolapsing scallop (i.e. P3 and P1, respectively) the stress increased 
>120% compared to the baseline model. Similarly, the central P2 prolapsing scallop saw 
an increase in the stress of at least 40%. Importantly, no significant differences in the 
average mitral leaflet stress were observed when implanting NC3 or NC4. 
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Figure 48. Average stress (kPa) in the mitral leaflets at peak systole. Asterisks 
highlight a marked increase (>50%) in leaflet stress with respect to the baseline 
model. 
 
Additionally, Figure 49 shows the stress distribution across the mitral leaflets at 
peak systole. A similar pattern of stress distribution was observed in the AML for all 
models, displaying large stresses close to the fibrous trigones and at the insertion region of 
the strut chordae, regardless of the presence or repair of the prolapse. As seen in Table 16, 
for the baseline and isolated P2 pre-repair models, the peak stress was located in the AML, 
close to the right fibrous trigone, with values of 0.43 MPa and 0.52 MPa, respectively. For 
the P2/P3 and P2/P1 pre-repair models, the peak stress was located in the P2 scallop, near 
the scallop junction free edge region with values of 2.8 MPa and 2.25 MPa, respectively. 
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After neochordae repair, for the isolated P2 post-repair models, the peak stress 
increased ~100% in the P2 scallop when compared to the isolated P2 baseline model, and 
relocated close to the neochordae insertion zone, as seen in Figure 49. For the P2/P3 post-
repair models, the peak stress was now located in the P3 scallop at the level of neochordae 
insertion region, with an increase of >600% when compared to the P2/P3 baseline model. 
Nevertheless, these peak stress values of the post-repair models were markedly lower than 
the value reported for the P2/P3 pre-repair model. The peak stress in the P2 scallop also 
increased >150% when compared to the P2 baseline model.  
Likewise, for the P2/P1 post-repair models, the peak stress  remained located in the 
P2 scallop but relocated close to neochordae insertion region, with an increase of >200% 
when compared to the isolated P2 baseline model. Again, these values are markedly lower 
than the value reported for the P2/P1 pre-repair model. Peak stress values in the P1 scallop 
and AML also increased >150% and 30%, respectively. 
 
Figure 49. Stress distribution (MPa) in the mitral leaflets at peak systole. A stress 
value threshold of 0.5 MPa was applied such that relatively large stress values were 
displayed in grey, facilitating comparison between models. Red circles denote 
uneven coaptation regions. Native chordae and neochordae not shown for clarity. 
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8.3.7 Mitral leaflet stress – AL-NC 
The average stress values at peak systole calculated for each of the four leaflet segments 
are presented in Figure 50 and Table 17. After transapical neochordae implantation, the 
average AML stress returned to a baseline value in all post-repair models, after decreasing 
during PML prolapse. For the isolated P2 post-repair models, the non-prolapsing PML 
scallops (i.e. P1 and P3) maintained physiological values, while the average stress in the 
central scallop increased >50% and >30% for the NC3 and NC4 models, respectively, when 
compared to the baseline model. 
Similarly, for the P2/P3 and P2/P1 post-repair models, the non-prolapsing scallops 
(i.e. P1 and P3, respectively) maintained baseline values, while the average stress in the 
central scallop increased ~80%. There was also an important increase in the average stress 
of ~200% and >100% in the lateral prolapsing scallops (i.e. P3 and P1, respectively). 
Importantly, no significant differences in leaflet stress were observed when implanting 
NC3 or NC4. 
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Figure 50. Average stress (kPa) in the MV leaflets at peak systole. Asterisks 
highlight a marked increase (>50%) in leaflet stress with respect to the baseline 
model (blue). 
 
Figure 51 shows the stress distribution patterns across the mitral leaflets at peak 
systole. For the isolated P2 post-repair models, the peak stress in the central scallop 
increased ~100% when compared to the baseline model, and relocated close to neochordae 
insertion region, as seen in Figure 51. For the P2/P3 post-repair models, the peak stress 
was also located in the P2 scallop at the level of neochordae insertion, with an increase of 
>450% when compared to the baseline model. The peak stress in the P3 scallop also 
increased >350% from baseline to post-repair states. However, when compared to the 
P2/P3 pre-repair model, the peak P2 stress was markedly reduced from 2.8 MPa to 1.85 
MPa – 2 MPa.  
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For the P2/P1 post-repair models, the peak stress was again situated in the P2 
scallop at the level of neochordae implantation, and increased >200% when compared to 
the baseline model. The peak stress in the P1 scallop and AML also increased ~200% and 
>50% from baseline to post-repair states, respectively. However, when compared to the 
P2/P1 pre-repair model, the peak P2 stress actually decreased from 2.25 MPa to 1 MPa – 
1.4 MPa. 
 
Figure 51. Stress distribution (MPa) in the MV leaflets at peak systole. A stress 
value threshold of 0.5 MPa was applied such that relatively large stress values were 
displayed in grey, facilitating comparison between models. Native chordae and 
neochordae not shown for clarity. 
 
8.3.8 AL-NC vs PL-NC implantation 
Table 18 compares the AL-NC vs. PL-NC biomechanical outcomes by presenting the 
percentage variations of the main hemodynamic and structural parameters of the AL-NC 
post-repair models with respect to the PL-NC post-repair models. In regard to the 
hemodynamic outcomes, no significant differences in MR reduction were found between 
AL-NC and PL-NC configurations. When comparing neochordae tension measurements at 
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peak systole, however, Figure 47 and Table 18 show a significant increase in the total 
suture tension (~80%) for the P2/P3 AL-NC post-repair models. The other two clinical 
scenarios of MV prolapse (i.e. isolated P2 and P2/P1) did not show noticeable changes in 
neochordae tension between AL-NC and PL-NC configurations. 
Similarly, and from a leaflet stress perspective, the P2 scallop in the P2/P3 and 
P2/P1 AL-NC post-repair models showed a higher average leaflet stress than the PL-NC 
post-repair models, however, this increase was only important (>30%) for the P2/P3 AL-
NC3 model. In contrast, no marked differences in the average stress were found in the other 
leaflet segments (Table 18). Finally, when comparing peak stresses in the leaflets, although 
minor differences in the peak stress were reported for the isolated P2 post-repair models, 
for the P2/P3 post-repair models, the P2 peak stress increased >100% for the AL-NC 
configuration, while the P3 peak stress saw a decreased of ~30%. Additionally, for the 








Table 18. Percentage variations of the hemodynamic and structural parameters for 
the AL-NC post-repair LH models with respect to the PL-NC post-repair LH 
models. 









RVMV -2.39 8.57 -11.06 -6.72 -5.80 -7.59 
RFMV -1.79 10.10 -10.12 -5.85 -5.51 -8.35 
Fchordae       
AML marginal -2.82 -27.44 5.86 2.32 -0.90 7.13 
AML strut 1.46 -1.43 1.20 0.45 1.72 4.90 
PML marginal 1.04 -13.69 -4.35 24.57 8.96 -9.61 
PML intermediate -5.78 -0.56 -14.09 -14.07 1267.75 403.79 
PML basal 1.03 -0.85 -12.48 -15.12 5.89 8.79 
FPM       
APM -0.03 -6.29 -5.12 -5.80 2.88 5.94 
PPM -0.06 -9.47 4.25 2.54 3.63 7.11 
FNC 12.43 27.06 81.99 78.73 -1.70 5.91 
Sɪ
MAX 
NC 7.93 23.92 70.25 83.36 7.91 6.93 
Sɪ
AVRG
 MV       
AML -1.18 -6.68 -2.32 1.11 -0.90 4.07 
P1 -2.51 -0.61 -0.26 0.88 -3.40 -9.20 
P2 0.74 -16.51 31.74 25.05 9.11 11.12 
P3 -3.32 -10.00 -0.07 -0.30 -1.01 3.86 
Sɪ
MAX 
MV -7.69 -0.96 109.68 140.56 -3.47 9.18 
Percentage variations with respect to the isolated P2 NC4 model with optimal neochordae 
length are reported in parenthesis. 
 
8.3.9 Suboptimal neochordae length 
Table 19 and Figure 52 compare the main hemodynamic and structural parameters for the 
isolated P2 AL-NC4 post-repair LH models with optimal and suboptimal neochordae 
lengths. From Figure 52A it is evident that while the over-tension model presented a similar 
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RVMV as the optimal model, the under-tension model on the other hand, had a significant 
increase (>143%) in the RVMV, and can be determined to present moderate MR. 
Concerning neochordae tension measurements (Figure 52B), as expected, under-
tension of the neochordae resulted in a markedly lower total suture tension than in the 
optimal configuration, giving a value of 0.41 N at peak systole (Table 19). On the contrary, 
over-tension of the neochordae by 4 mm caused a significant increase in the total suture 
tension throughout the cardiac cycle, including the diastolic phase. At peak systole, 
shortened neochordae showed a tension of 12.22 N.  
Finally, while a systematic decrease in the leaflet stress was quantified for the under-
tension model, when compared to the optimal neochordae configuration, a systematic 
increase in AML and PML stress was quantified for the over-tension model (Figure 52D). 
Specifically, the central P2 scallop gave the highest stress variations between optimal and 







Table 19. Hemodynamic and structural parameters for the isolated P2 AL-NC4 
post-repair LH models with optimal and suboptimal neochordae lengths. 
 Optimal Under-tension Over-tension 
SVAV (ml) 57.26 41.06 55.55 
RVAV (ml) 4.62 4.54 5.28 
SVMV (ml) 62.99 63.76 62.36 
RVMV (ml) 11.02 26.71 (142.9) 12.33 (11.9) 
RFMV (%) 16.14 39.41 18.16 
MR severity (RFMV) Trivial Moderate Trivial 
Fchordae (N)    
AML marginal 1.71 1.60 (-6.4) 3.56 (108.8) 
AML strut 3.55 3.22 (-9.3) 4.27 (20.1) 
PML marginal 0.38 0.43 (12.1) 0.54 (39.4) 
PML intermediate 0.52 0.40 (-21.7) 0.39 (-24.8) 
PML basal 3.10 4.27 (37.6) 2.16 (-30.4) 
FPM (N)    
APM 4.84 5.27 (9.0) 5.47 (13.1) 
PPM 4.42 4.65 (5.1) 5.44 (23.0) 
FNC (N) 2.68 0.41 (-84.5) 12.22 (356) 
Fneochorda (%) 29.8, 14.5, 33.3, 22.5 29.0, 25.6, 17.9, 27.5 25.7, 9.0, 31.1, 34.2 
Sɪ
MAX 
NC (MPa) 12.07 1.63 (-86.5) 56.47 (368) 
Sɪ
AVRG
 MV (kPa)    
AML 132.7 109.7 (-17.3) 189.5 (42.8) 
P1 63.3 54.2 (-14.3) 105.9 (67.3) 
P2 160.1 65.7 (-58.9) 898.7 (461.2) 




Figure 52. Isolated P2 AL-NC4 post-repair LH models with optimal and suboptimal 
neochordae lengths. A) Flow rate curves (ml/s) across the MV throughout the 
cardiac cycle. The negative systolic mitral flow indicates the backflow into the LA 
due to MV closing and MR, B) Total neochordae tension curves (N) throughout the 
cardiac cycle, C) Native chordae tension (N) at peak systole, D) Average MV leaflet 
stress (kPa) at peak systole. Asterisks highlight a marked reduction/increase (>50%) 




In this study, we evaluated the biomechanical effects of ePTFE suture number and length, 
LV access site, and complexity of PML prolapse on restoring baseline LH dynamics after 
transapical neochordae procedures. The present parametric study, to our knowledge, is the 
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first to assess the magnitude and time course of the force transfer between the mitral 
apparatus, the transapical neochordae and the blood flow at baseline, pre- and post-repair 
states using a FSI modeling framework. FSI modeling tools, as used in this study, are 
required to quantify the regurgitant flow across the MV, accurately simulate full 
dynamic/transient valve dynamics (3, 155), and assess the time course of the force 
transmitted through the neochordae to the LH structures during MV repair. These data, 
formerly inaccessible, are thus innovative. Direct quantitative comparison of the LV-valve 
mechanical environment between baseline and post-repair states is vital to evaluate the role 
of transapical neochordae implantation techniques in restoring physiologic-like cardiac 
dynamics. The main findings of this study were the following: 
1) When using optimal neochordae length, PL-NC and AL-NC configurations 
resulted in successful MV repair from a hemodynamics perspective; regardless of the 
complexity of the prolapse lesion. From a tissue mechanics standpoint, however, the 
magnitude and distribution of the PML stress and native chordae tension had important 
changes between baseline and post-repair states. 
2) No marked differences in intraventricular hemodynamics, native chordae tension 
and MV average stress were found when implanting NC3 or NC4 for each clinical scenario 
of MV prolapse. Neochordae tension, however, increased 30% when using AL-NC4 
compared to AL-NC3 during isolated P2 prolapse repair. Moreover, for the P2/P1 AL-NC 
post-repair models, the peak P2 stress increased ~40% when using NC4. 
3) For this patient case, selecting an antero-lateral LV entry site for the treatment 
of multi-scallop P2/P3 prolapse generated a significant increase in the neochordae tension 
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(~80%), P2 average stress (~30%), and P2 peak stress (>100%) with respect to a postero-
lateral LV access site. No differences in MR reduction were found between AL-NC and 
PL-NC configurations. 
4) Neochordae length tuning is critical. During isolated P2 prolapse repair when 
using an AL-NC configuration, although over-tension of the neochordae led to minimal 
hemodynamic changes in the RVMV; compared to the optimal model, a significant increase 
in peak systolic neochordae tension (>300%), diastolic neochordae tension, and mitral 
leaflet average stress (40% - 460%) was quantified. Additionally, neochordae under-
tension led to MR severity worsening from trivial to moderate; giving a similar RVMV as 
the pre-repair model. 
8.4.1 Baseline vs PL-NC biomechanics 
Native chordae tension analysis showed that generally, PML chordae tension decreased at 
least 30% from baseline to post-repair states, while AML marginal tension increased 
>30%. Increased chordae tension can induce elongation of the chordae in the long term 
(219). When comparing pre- and post-repair states, Sturla and colleagues (102, 103) found 
that the tension in the PML marginal and basal chordae close to the prolapsing region 
decreased after the repair, partially transferring the load to the ePTFE sutures. We found a 
similar trend in this study. Nevertheless, we also showed that PML chordae tension was 
affected differently based on the number of prolapsed scallops. For the isolated P2 models, 
only basal chordae tension substantially decreased from pre- to post-repair states. For the 
P2/P3 and P2/P1 post-repair models, however, PML basal tension remained unchanged. 
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Interesting data were thus obtained, in particular concerning the force redistribution 
between marginal, intermediate and basal chordae. 
In biomechanics, the presence of physiologic tissue stresses has long been 
considered closely related to tissue homeostasis (226). Following transapical neochordae 
implantation, the average leaflet stress substantially increased in the repaired scallop(s) 
when compared to the baseline model. Moreover, this increase was more noticeable during 
multi-scallop prolapse than during isolated scallop prolapse. On the other hand, it was 
observed that AML stress was not directly affected by the implantation of the ePTFE 
sutures, showing similar values as the baseline model. In terms of stress distribution, the 
peak stress relocated from the AML region in the baseline model, to the neochordae 
insertion region in all post-repair models. In addition, peak leaflet stress values increased 
significantly (~100%) for the isolated P2 post-repair models, and between 200% - 600% 
for the P2/P1 and P2/P3 post-repair models, when compared to the baseline model.  
MV prolapse is commonly associated with alterations of the mitral apparatus tissue 
properties involving myxomatous degeneration (311). Although the detailed mechanisms 
for the development of MV prolapse in association with adverse tissue remodeling are still 
unclear, the underlying biomechanical goal of any optimal MV repair procedure is to 
restore normal valvular morphology, physiological loading and hemodynamic function. 
Our post-repair LH models demonstrated that both native chordae and mitral leaflets 
mechanical environments were affected by the implantation of the transapical sutures, with 
some chordae groups and leaflet segments not returning to physiologic-like biomechanical 
values. Although our data showed that, in some cases, post-repair native chordae tension 
and leaflet stress were markedly lower than in the pre-repair pathological state (Table 16), 
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changes in tissue deformation from those normally experienced under baseline conditions 
may lead to cellular responses and tissue remodeling that would ultimately dictate the 
extent of long-term durability of the MV repair procedures. 
8.4.2 Baseline vs AL-NC biomechanics 
When using optimal neochordae length, native chordae analysis showed that AML 
marginal tension increased >30%, while PML chordae tension decreased between 30% - 
90% from baseline to post-repair conditions, depending on the specific chordae group 
(Table 17 and Figure 46). More importantly, the average stress substantially increased in 
the prolapsing scallop(s) after MV repair. This increase was more noticeable during multi-
scallop prolapse than during isolated P2 prolapse, and in the lateral prolapsing scallop (i.e. 
P1 or P3) than in the central P2 scallop. Regarding the peak PML stress, stress magnitude 
in the P2 scallop increased ~100%, >200% and >450% for the isolated P2, P2/P1 and P2/P3 
post-repair models, respectively. Similar to the findings of Gaidulis et al. (304) and Sturla 
at al. (102, 103, 312), neochordae implantation did not have important effects on the stress 
distribution and peak values across the non-prolapsing PML scallops. 
Our results suggest that although transapical neochordae implantation may well 
regain normal MV coaptation and, at least in the short-term, treat MR, it may also deviate 
the MV leaflets from their normal physiological loading state. Valve leaflets have been 
shown to respond to increased stress by increasing collagen and proteoglycan synthesis, 
inducing a shift from predominantly type I to type III collagen. These changes can result 
in thicker but more compliant leaflets (313, 314), and may lead to cellular responses and 
tissue remodeling that would ultimately dictate the extent of the long-term durability of the 
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transapical neochordae procedure. It is important to remember that according to our data, 
although the peak PML stress from pre- to post-repair states markedly decreased, the 
average stress in the prolapsing scallop(s) actually increased (Table 17 and Figure 50). 
Clearly, further studies are necessary to determine the impact of transapical neochordae 
techniques on LV-MV biomechanics from pre- to post-repair states by means of reverse 
remodeling.  
8.4.3 AL-NC vs PL-NC biomechanics 
As shown in Table 18, a marked increase (>80%) in total suture tension and P2 peak stress 
was obtained for the P2/P3 AL-NC post-repair models, even though a similar RVMV was 
quantified for both AL-NC and PL-NC configurations. We hypothesized that this increase 
in neochordae tension and P2 stress during AL-NC repair can be related to a less 
physiological anterior trajectory of the implanted sutures, together with a longer suture 
length; compared to a more posterior insertion which provides a more natural orientation 
for the neochordae, with the LV anchoring point close to the base of the PPM (103, 315). 
Future studies with a larger sample size are needed to further investigate the particular 
transapical AL-NC biomechanics when treating P2/P3 prolapse and to confirm these 
preliminary findings. 
Despite apparent similarities between AL-NC and PL-NC procedures, some 
differences in the neochordae mechanics can be identified. It has been shown that 
neochordae insertion from the anterior aspect of the LV imparts both apical as well as 
anterior forces, the latter of which serves to decrease and stabilize the antero-posterior 
dimension of the mitral annulus, imparting a substantial annuloplasty effect (308). A 
 166 
slightly more anterior entry site also modifies the working angle of the PML, stretches it 
below the AML, and thereby increases the potential leaflet coaptation (316). On the other 
hand, some studies do not recommend an excessively anterior LV access site for 
neochordae implanted on the PML, due to the unphysiologic crossing of the left ventricle 
outflow tract and the significant risk of interference with the native chordae that may lead 
to AML rupture (317). In the TACT (Transapical Artificial Chordae Tendinae) trial, better 
procedural outcomes were obtained when the LV access site was moved toward the 
ventricular postero-lateral wall (317). 
It is important to highlight that current clinical experience is per protocol limited 
mainly to isolated P2 prolapse, not supporting therefore, the evidence that AL-NC or PL-
NC procedures will be effective/ineffective on the wide spectrum of primary MR, such as 
AML, multi-scallop, bileaflet or paracommissural diseases (302, 318). Procedure 
refinements, especially the revision of the LV entry site will be critical when attempting to 
restore baseline MV dynamics. An optimal LV access site should not interfere with the 
MV subvalvular apparatus, preserve LV-valve physiology, reduce risk of coronary injuries, 
and preserve the best symmetry and force distribution between the neochordae. 
8.4.4 Optimal neochordae mechanics 
To date, our knowledge of transapical neochordae mechanics has previously relied upon 
few in vivo animal and human models (303, 319), as well as on MV FE-only models that 
did not consider the blood-tissue interaction (304). Due to inherent procedural difficulties 
in the experimental setup while avoiding interference with normal valve dynamics, or due 
to limitations in the computational capabilities, these studies have been unable to assess 
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the mechanical interdependence between the neochordae and the LV-valve complex 
through the entire cardiac cycle. Moreover, up to now, it remained unclear how forces were 
distributed along the neochordae when tightened to the antero-lateral human LV apex, and 
how they compared to PL-NC tension curves and to native chordae tension curves. Our 
FSI computational framework allowed for a direct quantification of these forces in a 
simulated human beating heart for the first time (Figure 47).  
The PM tension curves obtained for the baseline model quantitatively agree with 
PM force measurements performed in an vivo animal setting (320, 321). In a recent in vivo 
human study (319), Grinberg and colleagues were able to measure real-time neochorda 
tension during PL-NC implantation. This in vivo model is the one that most approaches 
our MV repair computational modeling framework, with the measured suture tension 
curves quantitatively agreeing with our computed neochordae tension curves. Suture force 
increased rapidly during early systole until it reached a peak value. The initial shoulder of 
the force tracing was followed by a plateau between mid-systole, and then a rapid decline 
in force during end-systole. A recent large multicenter study that evaluated early and 1-
year results of transapical neochordae implantation reported a 10% technical failure despite 
initial good echocardiography results (302). This suggest the need to refine the procedure 
and include innovative tools that provide valuable data to better understand the 
biomechanical implications of MV repair techniques. Measurement of neochordae tension 
could be one of these mechanistic parameters, and could help to homogenize the tension 
on each of the neochordae (319). 
  In an animal study by Jensen et al. (303), force measurements on one neochorda 
attached to the APM tip and to the postero-lateral LV wall were compared in eight pigs 
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with AML (A2 scallop) prolapse. Although no significant differences in peak and mid-
systolic neochorda tension were found, the rate of change of neochorda force (dFchordae/dt 
max); which reflects the tension fluctuations in the sutures, was significantly higher in the 
transapical fixation group. It was suggested that such abnormal and faster suture tension 
fluctuations might be explained by the absence of the shock absorbing effect of the PM, or 
by the increased transapical neochorda length relative to the PM implantation length (306, 
322). Table 20 shows the computed maximum slope (dFchordae/dt max) of the AL-NC and 
PL-NC tension curves shown in Figure 47. A marked increase in the slope (>30%) from 
PL-NC to AL-NC configurations was found for the isolated P2 and P2/P3 post-repair 
models. This means that under these patient conditions, suture tension increased more 
rapidly in the AL-NC implantation group than in the PL-NC group, resulting in more 
abnormal neochordae tension fluctuations.  
Table 20. Maximum slope (dFchordae/dt max) of the neochordae tension curves for the 
post-repair LH models with optimal neochordae length. 


















The abnormal fluttering of the transapical neochordae might predispose to leaflet 
tears, neochordae rupture and repair failure (315). Durability of ePTFE sutures is well 
established, with only a few cases of neochordae rupture reported in conventional MV 
repair surgery in the past 25 years (323). However, recent cases of late suture rupture after 
transapical neochordae implantation have been reported (322, 324, 325). The length of 
neochordae implanted transapically is often twice the length of those implanted in the PM 
tips under conventional repair. Some studies have suggested that suture rupture could be 
caused due to tractional and frictional forces (326), especially when using a loop-in-loop 
technique, where the frictional component of the tear could occur due to the friction 
between the two loops. Caimmi and colleagues (306) also suggested that the extra length 
of neochordae used during transapical MV repair may result in decreased durability of the 
sutures and cause higher internal friction forces. Overall, these findings suggest that careful 
evaluation of neochordae failure and possible complications should be performed on a 
patient-specific basis. If the suture rupture occurs at the MV leaflets, the repair of the valve 
can be completed with new neochordae or converted to conventional MV surgery. In the 
case of rupture from the apex site, however, surgeons must concern themselves with 
myocardial fragility (325). 
8.4.5 Effect of neochordae number under optimal length 
In general, no marked differences in terms of MV stress, native chordae tension, and 
neochordae tension were found when implanting NC3 or NC4 for each clinical scenario of 
MV prolapse studied herein. We hypothesized that this is due to the fact that in our 
numerical simulations the transapical sutures had an ideal length and were uniformly 
distributed along the prolapsed scallop(s). Neochordae tension, however, increased 30% 
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when using AL-NC4 compared to AL-NC3 during isolated P2 prolapse repair. Moreover, 
for the P2/P1 AL-NC post-repair models, the peak P2 stress increased ~40% when using 
NC4. The main objective of this first-of-its-kind parametric FSI study was to evaluate 
baseline, pre- and post-repair LH dynamics assuming optimal transapical MV repair 
procedures, as this capability represents a critical advantage of novel transcatheter 
therapies over traditional surgical techniques. In conventional surgical neochordae repair, 
suture length adjustment on arrested hearts relies mainly on the surgeon experience and on 
saline/ink tests. With the introduction of minimally-invasive repair techniques performed 
on a beating heart under real-time TEE guidance, it is now possible to fix the length of the 
neochordae to the optimal position; neither too long nor too short. This feature was 
exploited in this work.  
Interestingly, even with an ideal neochordae configuration, a noticeably uneven 
alignment in MV coaptation in the posteromedial commissure was observed for the P2/P3 
PL-NC post-repair models, as shown by the red circles in Figure 49. This could be due to 
the lack of millimetric suture length tuning or an uneven load distribution between the P3 
scallop, the native chordae and the sutures. Indeed, it has been shown that suboptimal 
suture length tuning can affect the mitral apparatus biomechanics after traditional surgical 
neochordae repair (102). Our results are consistent with this finding, showing that the 
highest neochorda tension and peak leaflet stress between all post-repair models were 
obtained for the P2/P3 NC3 model, and were actually located in the P3 scallop (Table 16). 
Altogether, these results suggest that a precise and successful neochordae implantation 
treatment strongly depends on the patient-specific prolapse morphology and LV-valve 
anatomy.  
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8.4.6 Suboptimal neochordae length mechanics 
Previous studies have suggested that suboptimal neochordae tensioning during 
conventional MV surgery can lead to leaflet stress hot spots, excessive localized increase 
of neochordae tension, and an unbalanced leaflet configuration (102). During treatment of 
isolated P2 prolapse, our analysis showed that while transapical sutures with an optimal 
length carried a net peak systolic load of 2.7 N; with a peak stress value of 12.07 MPa, 
over-tensioned neochordae carried a higher load of 12.2 N; with a peak stress value of 56.5 
MPa (Table 19 and Figure 52). Thus, the net force exerted by the shortened sutures was 
370% higher than for sutures with an optimal length, even though hemodynamic outcomes 
were very similar. Our study also found that the highest tension experienced by a single 
neochorda was 4.18 N, which corresponded to the over-tension model. This peak 
neochorda tension is, however, lower than the failure load of ePTFE CV-4 sutures of 16.36 
N (327). These results suggest that under the specific anatomic, loading and neochordae 
conditions modeled in this patient case, early neochordae rupture is unlikely to occur due 
to excessively high tensile suture tension. 
However, as shown in Figure 52B, a key finding of this study is that during suture 
overtension there was not only a significant increase in neochordae tension during systole 
but also during diastole. During the cardiac cycle there is a synchronized reciprocal 
behavior between the mitral annulus and the PM, with their mutual distance undergoing 
only minimal changes (328). Under baseline conditions, this phenomenon probably 
induces small elongations/shortenings of the native mitral chordae. Under transapical 
neochordae implantation, however, much larger changes in neochordae length can occur, 
since the distance between the mitral annulus and the LV apex decreases in systole and 
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increases in diastole. Thus, this phenomenon probably induces important elongations of 
the neochordae; which can be exacerbated if initial suture overtension is performed. These 
variations can generate an unwanted high neochordae tension during diastole, as shown in 
Figure 52B, that can be transferred to the repaired scallop as an unphysiological load. 
Furthermore, a slight over-tension is usually applied during neochordae final fixation as a 
result of early LV remodeling and volume reduction after the procedure (329). Overall, 
careful estimation of initial neochordae length as well as suture tension evolution during 
mid- to long-term follow-up seem critical. 
8.5 Limitations 
This study has several limitations that need to be considered when interpreting the results. 
First, the 3 pre-repair models and 14 post-repair models were virtually created from one 
previously validated subject-specific LH model. Thus, no population-based statements can 
be made and no statistical conclusions can be drawn. We acknowledge that a larger cohort 
of patient-specific LH models is needed to further assess the biomechanics of the 
transapical neochordae procedure. Nevertheless, well-controlled side-by-side comparisons 
such as the ones obtained in this parametric study are difficult to obtain in a clinical setting. 
Second, although cardiac tissue properties were age- and gender-matched, we utilized 
healthy human valvular tissue material properties obtained from in-house multiprotocol 
biaxial tests due to the limited availability of patient-specific diseased human valvular 
tissue data. Third, this study aimed to evaluate the changes in LH biomechanics 
immediately after neochordae implantation. Thus, the same cardiac wall motion was 
maintained before and after the treatment procedures without considering any 
compensatory cardiac remodeling mechanisms. Finally, the use of SPH comes with its 
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disadvantages. The no-slip boundary condition is not fully constrained in the Abaqus SPH 
formulation. This limited imposition is likely to affect the flow solution in the boundary 
layer and limit the study of the small-scale flow features seen in the cardiac flow. However, 
in Specific Aim 1 we showed that the large-scale intraventricular hemodynamics as well 
as the heart valve tissue mechanics obtained using the proposed SPH-FE FSI method are 
in agreement with in vivo, in vitro and in silico measurements. 
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CHAPTER 9. SPECIFIC AIM 2B – LV-VALVE DYNAMICS 
UNDER TRANSCATHETER AORTIC VALVE REPLACEMENT 
AND CONCOMITANT MITRAL REGURGITATION 
9.1 Introduction 
The AV and MV are coupled via a common fibrous continuity known as the aortic-mitral 
curtain or intervalvular fibrosa (17). As a result, physiologic function of either of these two 
valves involves the complementary function of the other (330). A better understanding of 
the aortic-mitral structural coupling and the ability to accurately assess biomechanical 
changes in different treatment scenarios is important, especially in the context of heart 
valve intervention planning and post-procedural assessment, where these changes will not 
only have an impact on valve dynamics but also on LV function. A prime example of 
aortic-mitral functional complexity is during the treatment of severe AS in the presence of 
secondary significant MR.  
The prevalence of moderate-to-severe concomitant MR in patients undergoing 
TAVR ranges from 20% – 33% (331), with significant impact on prognosis (332, 333). 
Albeit, MR is inherently left untreated in this setting, and its severity may decrease, remain 
unchanged or even increase following the procedure (334, 335). The design of the two 
TAV devices currently used, balloon-expandable (BEV) and self-expandable (SEV) 
valves, might also contribute to the observed differences and add complexity to the 
interpretation of the results. The SEV consist of a nitinol stent with a more prominent 
protrusion into the LVOT, and self-expansion that has less radial force to surpass the 
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resistance of the calcified, oval-shaped aortic annulus, compared to the BEV stent (336). 
Some observational studies have pointed towards a higher degree of MR improvement in 
patients treated with a BEV as compared to a SEV (337-339), while others have found no 
differences (340). 
A thorough evaluation of aortic-mitral coupling and MR response after TAVR is of 
particular importance in the current era, where operable patients at low surgical risk are 
increasingly referred for TAVR. The presence of significant MR with low likelihood of 
MR improvement may influence the selection of combined surgical AV replacement with 
MV repair/replacement therapies in such patients. As existing clinical data on the direction 
and magnitude of MR severity following TAVR have demonstrated conflicting evidence 
and constitute a current clinical dilemma, a quantitative engineering analysis of the 
underlying synchronized reciprocal behavior and biomechanical AV-LV-MV coupling 
during and after TAVR can potentially provide the basis for an individualized treatment 
approach and better procedural planning. 
Patient-specific computer simulations for transcatheter interventions can be helpful 
in quantifying the interaction of a broad spectrum of devices with the human tissue/organs, 
based on the integration of detailed anatomic and biomechanical parameters in an objective 
and reproducible manner (341). In the TAVR population, however, no patient-specific 
computational models have been developed to analyze the effect of TAVR on aortic-mitral 
coupling and MR severity for patients with severe AS and concomitant MR. Thus, the main 
objectives of Specific Aim 2b are: 1) to model the TAVR procedure and analyze the 
influence of TAV type and stent implantation height on aortic-mitral structural coupling 
and function, and 2) simulate and validate the post-TAVR LH dynamics with the goal to 
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quantify the immediate changes in MR severity, identify the determinants of MR 
improvement, and compare SEV and BEV performance. 
9.2 Materials and Methods 
9.2.1 Patient-specific LH model 
In this study, we employed the patient-specific LH model with functional MR developed 
and validated in Specific Aim 1b – Part 2. Briefly, pre-TAVR examination revealed 
moderate-to-severe functional MR with restricted PML motion, resulting in a posteriorly 
directed regurgitant jet. The measured aortic annulus was 23 mm. During the TAVR 
procedure, a 26 mm first generation BEV Edwards SAPIEN device was successfully 
deployed. Post-operative echo examination showed a correct TAV deployment, absence of 
PVL, while moderate-to-severe MR remained. 
9.2.2 Balloon-expandable TAV model 
A generic BEV model, based on a 26 mm first-generation Edwards SAPIEN device was 
used in this study (112). As seen in Figure 53A, the TAV consists of three components: 
stainless steel stent, skirt and bovine pericardium leaflets. The stent, which was generated 
using depictions in the literature, had an external nominal diameter of 26 mm, a frame 
height of 16.1 mm, and a rectangular cross section of 0.4 x 0.55 mm for the frame struts. 
3D solid elements (eight-node hexahedral C3D8I elements) were used to model the stent, 
while 3D membrane elements (M3D4) were used to model the fully enclosed balloon, 
which resembled the Edwards RetroFlex 3 balloon geometry. Two layers of 3D solid 
elements (eight-node hexahedral C3D8R elements) were used to model the TAV leaflets, 
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with a uniform total thickness of 0.28 mm. The skirt was modeled by shell elements (three-
node triangular S3 elements). The attachment line of the TAV leaflets to the stent are 
curved from the commissures downwards to the leaflet cusps, having a scallop leaflet shape 
similar to that of the Edwards SAPIEN valve design. TAV leaflets bovine pericardium 
properties, as shown in Table 21, were obtained from our previous studies that 
characterized the mechanical properties of chemically-treated pericardial tissues (342, 
343), as presented in APPENDIX A. The stent was modeled as an elastic-plastic material 
with the properties of 316 stainless steel with a Young’s modulus of 193 GPa, a Poisson 
ratio of 0.3, and initial yield stress of 340 MPa (344). 
9.2.3 Self-expandable TAV model 
A generic SEV model, based on a 26 mm first-generation Medtronic CoreValve device 
was used in this study (130). As seen in Figure 53B, the SEV consists of a Nitinol stent, 
skirt and porcine pericardium leaflets. Two layers of 3D solid elements were used to model 
the TAV leaflets and the stent, while shell elements were used for the skirt. Abaqus (3DS, 
Dassault Systéms, Paris, France) built-in superelasticity material library was used to model 
the Nitinol stent, with austenite elasticity of 50 GPa, austenite Poisson's ratio of 0.3, 
martensite elasticity of 25 GPa, and martensite Poisson's ratio of 0.3 (344). TAV leaflets 
had a thickness of 0.28 mm and porcine pericardium properties obtained from our previous 
studies that characterized the mechanical properties of chemically-treated pericardial 
tissues (342, 343). TAV leaflets porcine pericardium properties, as shown in Table 21, 
were obtained from our previous studies that characterized the mechanical properties of 
chemically-treated pericardial tissues (342, 343). 
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Figure 53. A) Balloon-expandable valve (BEV) model, B) Self-expandable valve 
(SEV) model. 
 
Table 21. TAV leaflet material parameters. 
MHGO model 𝐶10 (kPa) 𝐶01 
𝑘1 
(kPa) 




6.358 16.734 13.415 96.850 0 0 5.0e-4 
Porcine 
pericardium 
1.2606 33.7972 386.842 276.732 0 0.1 5.0e-4 
 
9.2.4 FE modelling of TAVR procedure – BEV 
The TAVR procedure with a BEV was simulated in four major steps (111, 112). In order 
to accurately evaluate the impact of TAVR on MR severity, the patient-specific 
myocardium surrounding the aortic root, aortic-mitral curtain, MV and proximal LV/LA 
endocardial walls was also reconstructed from the MSCT images and integrated in the LH 
model, as seen in Figure 54B.  
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Step 1 - Stent crimping: Initially, the nominal stent was positioned coaxially within 
the aortic root and centered into the aortic annulus. The crimped stent and balloon 
geometries were obtained by applying a radial displacement on two cylindrical-surface 
sheaths. The stent was crimped to an exterior diameter of 8 mm (24 Fr catheter), as seen in 
Figure 54A, and positioned in a way that the TAV commissures had the same orientation 
as the native aortic sinuses. The AV leaflets were pre-opened with a cone-shaped catheter 
to simulate the effect of the insertion of the delivery system across the AV. 
To quantify the impact of BEV deployment height on LH dynamics and MR 
severity, the axial positioning of the stent with respect to the aortic annulus plane was 
parametrized to replicate three clinical deployment configurations: 1) Midway, denoted as 
post-TAVR 50%. The conventional manufacture’s recommendation for the Edwards 
SAPIEN system is to position the mid-point (i.e., 50:50) of the stent at the aortic annulus 
plane (345).  2) Post-TAVR 30%, defined as a slightly higher device implantation, with 
30% of the stent located below the aortic annulus. 3) Post-TAVR 10%, defined as a high 
device implantation, with only 10% of the stent located below the aortic annulus plane. 
The aortic annulus plane was defined as the virtual plane formed by joining the points of 
basal attachment of the BAV leaflets (345). 
Step 2 - Balloon inflation: The mechanical response of the fluid-filled balloon 
expansion was modeled by the surface-based fluid cavity method, capable of simulating 
the coupling between the deformation of the balloon and the fluid inside (112). The balloon 
was pressurized for 0.25 s until it was fully inflated. This method was initially calibrated 
to ensure a correct nominal stent size after balloon inflation. 
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Step 3 - Stent recoil: The internal pressure of the balloon was decreased over a time 
period of 0.25 s. Therefore, the stent recoiled and stabilized, and the native AV leaflets 
adopted a more natural open position. 
Step 4 - TAV leaflet and skirt positioning: The TAV leaflets and skirt were not 
included during the stent deployment procedure, but were added after stent recoil. Their 
effect on the biomechanical interaction between the stent and the native aortic tissue has 
been shown to be negligible (122) The TAV leaflets were mounted in the deformed stent 
using a virtual assembly method (346). Briefly, the nodes lying on the leaflet attachment 
and along the commissures were mapped onto the stent frame through a set of non-uniform 
imposed displacements, ensuring an appropriate final leaflet position.  
During TAVR modeling, the ascending aorta and myocardium were constrained at 
their distal ends allowing only rotational degrees of freedom. The balloon was constrained 
at its distal and proximal ends in order to mimic the bond to the catheter and avoid rigid 
body motion. The kinetic energy was monitored to ensure that the ratio of kinetic energy 
to internal energy remained under 10%. The resulting deformed LH models after BEV stent 
recoil were used to assess post-TAVR LH dynamics using FSI modeling. 
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Figure 54. A) Crimped BEV stent at the three deployment heights, B) LH models 
with myocardium after TAVR deployment and stent recoil. 
 
9.2.5 FE modelling of TAVR procedure – SEV 
The TAVR procedure with a SEV was simulated in three major steps: 
Step 1 - Stent crimping: The nominal SEV stent was positioned coaxially within 
the aortic root and centered into the aortic annulus. Next, the stent was crimped to an 
exterior diameter of 6 mm (18 Fr catheter), as seen in Figure 55A, by applying a radial 
displacement field to a cylindrical-surface sheath. Finally, the AV leaflets were pre-opened 
with a cone-shaped catheter to simulate the effect of the insertion of the delivery system 
across the valve. Pre-dilatation of the AV with a balloon was not simulated during the 
virtual procedure. 
To quantify the impact of SEV implantation depth on aortic-mitral coupling and 
MR severity, the axial positioning of the stent with respect to the aortic annulus was 
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parametrized to replicate three possible clinical scenarios: 1) Optimal, the conventional 
manufacture’s recommendation for the CoreValve system is to position the lowest point of 
the crimped stent ~5 mm below the aortic annulus (347), 2) High, defined as 3.6 mm higher 
than the optimal stent position, and 3) Low, defined as 3.6 mm lower than the optimal stent 
position. 
Step 2 – Stent release: The deployment of the crimped stent was simulated by 
axially displacing the cylindrical sheath away from the aortic root, followed by a stent-
tissue interaction phase to stabilize the dynamic component of the system and its contacts. 
The aorta and myocardium were constrained at their distal ends allowing only rotational 
degrees of freedom. The friction coefficient between the stent and cardiac tissues was 
assumed to be 0.1 (130), a frictionless contact was defined between the outer stent surface 
and the inner sheath surface, while a self-contact formulation was used for the stent. In 
order to reach a quasi-static state, viscous-elastic damping was added. This value was 
monitored to ensure that it did not exceed 0.8% of the total system energy. The kinetic 
energy was also monitored to ensure that the ratio of kinetic energy to internal energy 
remained under 10%.  
Step 3 - TAV leaflet and skirt positioning: The TAV leaflets and sealing skirt were 
added as previously explained. The pressure gradient was neglected during the TAVR 
procedure, since in the clinical setting rapid pacing is applied during device deployment. 
The deformed LH geometries, as shown in Figure 55B, were extracted from the FE 
simulations and used to assess the post-TAVR LH dynamics using FSI. 
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Figure 55. A) Crimped SEV stent at the three deployment heights, B) LH models 
with myocardium after TAVR deployment. 
 
9.2.6 Boundary conditions 
Time-dependent pressure boundary conditions were applied at the two atrial inlets 
(pulmonary veins) and at the aortic outlet of the pre- and post-TAVR LH models, as 
previously explained in Specific Aim 1b – Part 2. Pressure boundary conditions and cardiac 
wall motion were kept the same for the pre- and post-TAVR LH models, simulating 
immediate post-operative LH dynamics, without considering the cardiac remodeling 
mechanisms that occur over time after TAVR. 
9.2.7 Data analysis 
9.2.7.1 Aortic-mitral geometrical parameters 
Aortic-mitral structural coupling during TAVR was evaluated in terms of the geometrical 
parameters shown Figure 56. The following measurements were obtained during systole: 
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a) aortic annulus and MA areas, b) antero-posterior (AP) distance, defined as the distance 
between mid-anterior and mid-posterior MA points, c) anterolateral-posteromedial (AL-
PM) distance, d) inter-commissural (CC) distance, e) MA height, defined as the maximum 
vertical distance between the highest and lowest points of the saddle-shaped MV, f) aortic-
mitral angle, defined as the angle between the planes of the MA and the aortic annulus, g) 
aortic-mitral distance, defined as the centroid distance between the MA and the aortic 
annulus, h) aortic annulus motion, defined as the longitudinal excursion of the aortic 
annulus during TAVR, and i) anterior and posterior MA motion, defined as the posterior 
displacement of the MA during TAVR. 
 





9.2.7.2 Fluid parameters 
As introduced in Specific Aim 1b – Part 2, the following hemodynamic parameters were 
quantified: 𝑆𝑉𝐴𝑉, 𝑆𝑉𝑀𝑉, 𝑅𝑉𝐴𝑉, 𝑅𝑉𝑀𝑉, 𝑅𝐹𝑀𝑉, MR severity, LVEF, LV mean systolic 
pressure, AV mean and peak gradients, AV peak velocity, EOAAV, E wave, A wave, E/A 
ratio, MR peak and mean gradients, and MR peak velocity 
9.2.7.3 Structural parameters 
The three stent deployment heights for the BEV and SEV models were analyzed and 
compared during the TAVR procedure in terms of peak (Sɪ
MAX) and average (Sɪ
AVRG) 
maximum principal stress values in the BAV leaflets, sinus, calcification and MA, contact 
radial force between the stent and aortic root, and stent deformation. To facilitate 
comparison between different models and avoid the bias caused by local high stress 
concentration, only the 99-percentile values of the peak stress were evaluated (348). 
Moreover, leaflet annular regions were not included in the average stress calculation in 
order to avoid boundary effects. The contact radial force between the recoiled stent and 
surrounding cardiac tissues was calculated as 𝑅𝐹 = ∑ 𝑟𝑓𝑖,𝑝𝑜𝑠𝑡
𝑛𝑠
𝑖=1 , where ns is the total 
number of nodes in the stent, and 𝑟𝑓𝑖,𝑝𝑜𝑠𝑡 is the radial contact force at each stent node after 
recoil. Stent deformation was evaluated by quantifying stent eccentricity and recoil. Stent 
eccentricity, which assess the conformity of the stent deformation after recoil, was 
calculated as the ratio of the maximum stent diameter to minimum stent diameter. BEV 
stent recoil was determined as (𝐷𝑚𝑖𝑛 𝑒𝑥𝑝𝑎𝑛𝑑𝑒𝑑 − 𝐷𝑚𝑖𝑛 𝑟𝑒𝑐𝑜𝑖𝑙𝑒𝑑) 𝐷𝑚𝑖𝑛 𝑒𝑥𝑝𝑎𝑛𝑑𝑒𝑑⁄ , 
where 𝐷𝑚𝑖𝑛 is the minimum stent diameter during fully balloon expansion and stent recoil. 
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These two metrics were calculated at three different cross-sections of the stent (i.e. bottom, 
middle and top) with the mean value reported. 
Additionally, post-TAVR tissue mechanics were evaluated by the average maximum 
principal stress values calculated in the AV/TAV leaflets and MV leaflets during peak 
diastole and systole, respectively. Chordae forces (Fchordae) at peak systole were also 
reported. The force experienced by a particular chordae group was calculated as the sum 
of vectors representing the tension in each individual chorda attached to that chordae group. 
9.3 Results 
9.3.1 TAVR-in-BAV biomechanics – BEV 
Figure 54A shows the crimped BEV stent geometry at the three deployment heights, while 
Figure 54B shows the final deformed geometries after balloon deflation and stent recoil. 
No severe leaflet overhanging or potential risk for coronary obstruction were observed. 
The shortest distance between the coronaries and the native leaflets was found to be 7.5 
mm for the post-TAVR 10% case, which was between the left coronary ostia and the fused 
leaflet free edge. No evident gaps between the recoiled stent and the native annular tissue 
were observed in the post-TAVR LH models, which was later confirmed in the FSI blood 
flow simulations by absence of PVL. 
The stress distribution on the native AV leaflets after stent recoil is presented in 
Figure 57. Similar stress distribution patterns were observed for the three implantation 
configurations, where peak values were located in regions in contact with the higher 
portion of the stent for the post-TAVR 30% and 10% models, and in the leaflet-root 
 187 
attachment region close to the commissures for the post-TAVR 50% case, as shown by the 
red circles in Figure 57. Another leaflet region that experienced high stress values was the 
leaflet belly region in contact with the large calcification deposit due to the stiffer material 
properties. For the aortic root, high stress values were found at the leaflet-root attachment 
lines, especially in the fused leaflet commissures. 
As presented in Table 22, the highest deployment model (post-TAVR 10%) 
resulted in higher peak stress values in the leaflets, sinus and calcification regions. The 
highest peak stress in the anterior MA, however, was found for the midway implantation 
model (post-TAVR 50%), a direct result of a larger aortic-mitral curtain tissue in contact 
with the stent. The contact radial force between the recoiled stent and surrounding cardiac 
tissues is listed in Table 22. The post-TAVR 10% model gave the highest contact force, 
with a value of 108 N, while the post-TAVR 50% case gave the lowest contact force, with 
a value of 98 N. Stent eccentricity and recoil values are also presented in Table 22. All 
three stents showed a similar eccentricity, maintaining a nearly uniform circular pattern. 
Stent recoil, however, was lower for the midway implantation model (3.3%) than for the 






Table 22. TAVR-in-BAV biomechanical parameters after BEV stent recoil. 
 Post-TAVR 50% Post-TAVR 30% Post-TAVR 10% 
Sɪ
MAX (MPa)    
Native AV leaflets 2.75 2.93 3.15 
Sinus 2.11 2.16 2.34 
Calcification 1.88 1.95 2.02 
Anterior MA 0.151 0.064 0.036 
Posterior MA 0.012 0.024 0.014 
Sɪ
AVRG (MPa)    
Native AV leaflets 0.74 0.88 1.01 
Sinus 0.31 0.31 0.3 
Contact radial force (N) 98.13 104.09 107.79 
Stent eccentricity 1.05 1.08 1.07 
Stent recoil (%) 3.30 5.75 6.17 
 
 
Figure 57. Stress distribution (MPa) in the AV leaflets after BEV stent recoil. Red 
circles denote regions of peak stress values. A maximum stress value threshold of 4.5 
MPa was applied such that higher stress values were displayed in grey, facilitating 
comparison between models. 
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9.3.2 TAVR-in-BAV biomechanics – SEV 
Figure 55 shows the crimped and deployed SEV stent geometries at the three implantation 
depths. No potential risk for coronary obstruction was observed after TAVR. No evident 
gaps between the stent and aortic tissues were observed following TAVR, which was later 
confirmed in the FSI simulations by the absence of PVL. Figure 58 presents the stress 
distribution on the AV leaflets after stent deployment. Similar stress patterns were observed 
for the three implantation configurations, with high stress values found in the fused leaflet, 
especially in the upper half of the leaflet. For the high implantation model, the NCL also 
presented high stress values in the upper region of the leaflet. As shown by the red circles, 
peak stress values were located in the leaflet-root attachment line close to the commissures, 
in the leaflet free edge in contact with the stent, and in the fused leaflet belly region in 
contact with the large calcification deposit. 
Table 23 summarizes the peak (Sɪ
MAX) and average (Sɪ
AVRG) stress values in the 
aortic tissues, the stent-tissue contact force, and stent eccentricity. The high deployment 
model gave the highest peak and average stress values in the AV leaflets, the lowest peak 
stress values in the calcification and MA, and the lowest stent-tissue contact force. All three 





Table 23. TAVR-in-BAV biomechanical parameters after SEV stent deployment. 
 Low Optimal High 
Sɪ
MAX (MPa)    
Native AV leaflets 1.16 1.31 1.88 
Sinus 0.80 0.89 0.90 
Calcification 0.82 0.97 0.57 
Anterior MA 0.250 0.141 0.024 
Posterior MA 0.046 0.048 0.020 
Sɪ
AVRG (MPa)    
Native AV leaflets 0.22 0.27 0.40 
Sinus 0.10 0.12 0.09 
Contact radial force (N) 31.70 39.55 28.79 
Stent eccentricity 1.09 1.08 1.08 
 
 
Figure 58. Stress distribution (MPa) in the AV leaflets after SEV deployment. Red 
circles denote regions of peak stress values. A maximum stress value threshold of 3.5 
MPa was applied such that higher stress values were displayed in grey, facilitating 
comparison between models. 
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9.3.3 BEV impact on MR: structural changes 
Figure 59 and Table 24 present the aortic-mitral structural coupling before and after TAVR 
during peak systole. We found an important reduction in the MA height from pre- to the 
post-TAVR 50% model (15%), however, as the stent implantation height increased, the 
MA height increased instead; up to 8% for the post-TAVR 10% case. Additionally, the 
aortic-mitral angle decreased between 5% - 10% following TAVR, with a smaller systolic 
angle in the highest implantation model than in the midway implantation model. Although 
the MA area (~3.2%), AP distance (~4.3%) and aortic-mitral distance (~4.5%) decreased 
in all post-TAVR models, there were no evident changes when comparing these before and 
after TAVR. Similarly, both AL-PM distance (~3%) and aortic annulus area (~2%) had a 
slight tendency to increase after TAVR. In regards to the aortic annulus motion, it was 
found that this anatomic structure was displaced ~3.3 mm towards the LVOT during 
TAVR, and this motion seemed to decrease as the stent implantation height increased. 
Moreover, the anterior MA was also displaced ~2.5 mm posteriorly during TAVR, again, 
this motion decreased as the implantation height increased. Finally, Figure 59 shows the 
aortic-mitral complex before and after TAVR during peak systolic flow. Although it is 
evident that the regurgitant orifice area decreased in all post-TAVR models, MR was still 
present. Moreover, the post-TAVR 50% model exhibited the smallest regurgitant orifice 
area, which was later confirmed by quantification of the RVMV. 
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Aortic annulus area 
(cm2) 
4.93 5.13 5.00 4.94 
MA area (cm2) 11.40 10.97 11.04 11.10 
AP distance (mm) 35.53 33.29 34.30 34.41 
AL-PM distance (mm) 39.54 40.97 40.58 40.66 
CC distance (mm) 31.14 31.18 30.80 30.94 
MA height (mm) 6.00 5.10 (-15) 6.18 (3) 6.49 (8) 
Aortic-mitral angle (⁰) 123.05 116.88 (-5) 112.81 (-8) 111.23 (-10) 
Aortic-mitral distance 
(mm) 
28.46 27.48 27.06 26.97 
Aortic annulus motion 
(mm) 
̶ 3.87 3.15 2.82 
Anterior MA motion 
(mm) 
̶ 3.28 2.31 1.92 
Posterior MA motion 
(mm) 
̶ 1.00 0.76 0.48 




Figure 59. Aortic-mitral coupling at peak systole when using a BEV. 
 
9.3.4 SEV impact on MR: structural changes 
From Figure 60 it is evident that although the MV regurgitant orifice area appeared to 
decrease in most post-TAVR models, MR was still present. As presented in Table 25, we 
quantified a marked reduction (>20%) in the MA height from pre- to post-TAVR states, 
with the highest reduction found for the optimal implantation model (35%). Similarly, the 
aortic-mitral angle decreased (~10%) after low and optimal configurations. Although the 
aortic-mitral distance (~4.2%), MA area (~2.5%), AP distance (<1%), and CC distance 
(<1%) decreased in all post-TAVR models, there were no significant changes when 
comparing these before and after TAVR. Similarly, both AL-PM distance and aortic 
annulus area had a slight tendency to increase after TAVR. Regarding the displacement of 
the valve annuli, it was found that the anterior MA was displaced posteriorly ~1.6 mm 
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during the TAVR procedure, while the aortic annulus was displaced ~2.6 mm towards the 
LVOT. Importantly, this annuli motion seemed to increase as the stent implantation height 
increased. 
Table 25. Aortic-mitral geometrical parameters during systole – SEV. 
 Pre-TAVR Low Optimal High 
Aortic annulus area (cm2) 4.93 4.96 5.01 4.94 
MA area (cm2) 11.40 11.19 11.15 10.99 
AP distance (mm) 35.53 35.90 35.20 34.62 
AL-PM distance (mm) 39.54 39.58 40.21 39.78 
CC distance (mm) 31.14 30.82 31.02 30.74 
MA height (mm) 6.00 4.43 (-26) 3.93 (-35) 4.66 (-22) 
Aortic-mitral angle (⁰) 123.05 111.26 (-10) 110.10 (-11) 121.26 
Aortic-mitral distance (mm) 28.46 27.48 27.14 27.17 
Aortic annulus motion (mm) ̶ 1.61 2.93 3.14 
MA motion (mm) ̶ 1.17 1.67 1.88 




Figure 60. Aortic-mitral coupling at peak systole when using a SEV. 
 
9.3.5 BEV impact on MR: hemodynamic changes 
Figure 61 shows the flow rate waveforms across the AV an MV throughout the cardiac 
cycle for the pre- and post-TAVR LH models. The negative aortic flow at end-systole 
(Figure 61A) indicates the retrograde blood flow into the LV during AV closure, while the 
negative systolic mitral flow (Figure 61B) indicates the backflow of blood into the LA due 
to MV leaflet closing and MR. Diastolic inflow rates (positive) across the MV were 
approximately the same for all models, since LV size and motion remained unchanged 
immediately post-TAVR. As expected, the pre-TAVR LH model had the lowest peak aortic 
flow and 𝑆𝑉𝐴𝑉, as seen in Figure 61A. Following TAVR, correction of the AV obstruction 
led to an immediate reduction in the LV systolic pressure, which decreased the pressure 
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gradient across the AV and MV, and therefore led to a reduction in the 𝑅𝑉𝑀𝑉 and an 
increase in the 𝑆𝑉𝐴𝑉. 
As shown in Table 26, improved LV function and hemodynamic success of the 
procedure was found in all post-TAVR LH models, as confirmed by the reduction of MR 
and AV/MR peak velocities, and by the increase in the EOAAV. The greater degree of MR 
improvement (10%) was for the post-TAVR 50% model; which based on the 𝑅𝐹𝑀𝑉 
criterion can now be classified as moderate MR. When compared to the pre-TAVR model, 
the degree of MR severity remained unchanged for the post-TAVR 30% and 10% models. 
When comparing the pre- and post-TAVR aortic flow rate waveforms shown in 
Figure 61A, a noticeable change in the onset time of BAV/TAV closure was found. The 
TAV device had a distinct slower closure and higher closing volume compared to the native 
BAV leaflets, with the highest 𝑅𝑉𝐴𝑉 obtained for the post-TAVR 10% model. Pre-
procedural mild aortic regurgitation, found clinically in the patient’s echo examination, 
was also detected in the pre-TAVR computational model, as shown by the negative 
diastolic aortic flow (Figure 61A). Aortic regurgitation was resolved following TAVR, 
both in the real clinical case and in the FSI simulations. Moreover, the absence of PVL in 
all post-TAVR LH models matched the post-operative echo findings. 
Additionally, Figure 62 shows the intraventricular velocity streamlines colored by 
velocity magnitude during peak systole. Due to the restricted PML motion, the post-TAVR 
models displayed a posteriorly directed regurgitant jet. The regurgitant jet structures were 
similar between the post-TAVR models, with an eccentric “wall-hugging” jet that 
impinged the postero-lateral atrial wall, with a similar MR peak velocity (Table 26). 
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Overall, when compared to the patient-specific post-TAVR echo data, numerical 
results corresponded well to the echo measurements (Table 26), which demonstrate the 
accurate predictive capabilities of our patient-specific modeling methodology, that is, the 
simulated TAVR procedure using FE analysis, followed by the simulated post-TAVR LH 
dynamics using FSI analysis. Nevertheless, some differences between the echo and FSI 
data were found, especially regarding the AV pressure gradients. These differences, which 
will be later discussed, are in line with the inherent uncertainties in the echo flow recordings 
and the image-based computer simulations. 
 


















SVAV (ml) 46.28 52.24 49.11 51.94 48 
RVAV (ml) 9.34 11.43 7.21 15.39 ̶ 
SVMV (ml) 74.64 74.54 76.93 72.72 ̶ 
RVMV (ml) 37.59 33.84 34.8 35.89 32 
























2.82 1.74 1.73 1.70 2.0 
EOAAV 
(cm2) 
0.77 1.20 1.12 1.17 1.4 
E wave (m/s) 0.79 0.80 0.83 0.88 0.87 
A wave 
(m/s) 
0.54 0.54 0.57 0.58 0.54 








5.42 4.92 4.91 4.93 5.2 
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Figure 62. Post-TAVR velocity streamlines showing the regurgitant jet structures at 
peak systole. 
 
9.3.6 SEV impact on MR: hemodynamic changes 
Several findings can be described from Figure 63 and Table 27. First, improved systolic 
function and hemodynamic success of the procedure was found in the post-TAVR models, 
given by lower AV peak/mean pressure gradients, AV peak velocity, MR mean pressure 
gradient, and MR peak velocity, and higher EOAAV and 𝑆𝑉𝐴𝑉. Second, the greater degree 
of MR improvement (~10%) was for the high deployment model; which based on the 𝑅𝐹𝑀𝑉 
criterion can now be classified as moderate MR. The degree of MR severity remained 
unchanged for the low and optimal models. Third, the optimal model gave a higher 𝑅𝑉𝑀𝑉 
than the pre-TAVR model (40.49 vs 37.59 ml). Due to the coupled valve dynamics and 
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mass conservation, this model also gave a slightly lower 𝑆𝑉𝐴𝑉 than the pre-TAVR model 
(43.97 vs 46.28 ml). Fourth, central aortic regurgitation was resolved following TAVR for 
the low and optimal implantation models, while the SEV of the high deployment model 
did not fully close until mid-diastole (Figure 63A). No PVL was quantified in any of the 
post-TAVR models, as found clinically. Finally, Figure 64 shows the intraventricular 
velocity streamlines colored by velocity magnitude during peak systole.  
 









Table 27. Pre- and post-TAVR FSI hemodynamics – SEV. 
 Pre-TAVR Low Optimal High 
SVAV (ml) 46.28 47.89 43.97 51.01 
RVAV (ml) 9.34 7.91 6.87 15.19 
SVMV (ml) 74.64 76.12 77.60 69.54 
RVMV (ml) 37.59 35.96 40.49 33.65 
RFMV (%) 44.82 42.89 47.94 39.75 








LVEF (%) 28.55 28.54 28.75 28.82 
LV mean systolic 
pressure (mmHg) 
95.15 91.16 89.38 91.59 
AV peak gradient 
(mmHg) 
34.82 27.32 27.78 28.13 
AV mean gradient 
(mmHg) 
23.97 15.66 15.69 16.24 
AV peak velocity 
(m/s) 
2.82 1.76 1.66 1.70 
EOAAV (cm
2) 0.77 1.00 0.93 1.04 
E wave (m/s) 0.79 0.80 0.78 0.67 
A wave (m/s) 0.54 0.56 0.56 0.49 
E/A 1.47 1.44 1.40 1.36 
MR mean gradient 
(mmHg) 
57.25 51.83 52.85 50.90 
MR peak velocity 
(m/s) 




Figure 64. Post-TAVR velocity streamlines showing the regurgitant jet structures at 
peak systole. 
 
9.3.7 Post-TAVR biomechanics – BEV 
Table 28 presents the average stress values calculated for the AV/TAV leaflets and MV 
leaflets during peak diastole and systole, respectively. It was found that the average stress 
in the AML was at least 20% lower following TAVR, potentially due to morphological 
changes caused by the posterior displacement of the anterior MA during the procedure. 
Due to the restricted motion of the PML observed clinically, the average stress in the PML 
did not show significant changes between pre- and post-TAVR states. Although the 
average stress in the AML was generally higher than in the PML before and after TAVR, 
it was found that the peak mitral leaflet stresses were actually located at the tethered PML 
chordae insertion regions, near the leaflet free-edge and basal chordae locations. 
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Since this patient had a postero-lateral regurgitant gap with PML tethering near the 
APM, the LH models experienced high PML chordae forces when compared to AML 
chordae tensions. There was an imbalanced force distribution between the two PM, with 
anterior PM force being higher than posterior PM force. Due to anatomic changes in the 
MV and the mitral apparatus force redistribution following TAVR, AML strut tension 
increased at least 50%, while AML marginal and basal chordae tensions decreased between 
17% - 36%. Similarly, PML basal tension decreased at least 15%, while PML marginal 
chordae showed no evident changes in their tension. It is important to note, however, that 
the total AML and PML chordae tensions were largely unchanged during pre- and post-
TAVR states, and between the different three deployment models, which suggest that 
mitral leaflet tethering was not improved immediately after TAVR, but that there was a 
force redistribution between the different components of the mitral apparatus, in particular 
concerning changes in tension between marginal, basal and strut chordae. 











AVRG (MPa)     
AV/TAV 0.076 0.151 (99) 0.161 (112) 0.149 (96) 
AML 0.126 0.090 (-29) 0.101 (-20) 0.102 (-19) 
PML 0.082 0.082 (0) 0.079 (-4) 0.076 (-7) 





0.92 (-19) 0.86 (-24) 
AML strut 2.04 3.23 (59) 3.13 (54) 3.05 (50) 
AML basal 3.84 2.47 (-36) 2.90 (-25) 2.84 (-26) 
PML marginal 6.13 6.95 (13) 6.50 (6) 6.05 (-1) 
PML basal 7.33 5.58 (-24) 6.05 (-18) 6.24 (-15) 
Percentage variations with respect to the pre-TAVR model are reported in parenthesis. 
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9.3.8 Post-TAVR biomechanics – SEV 
Following TAVR, AML stress decreased between 5% - 21%, while PML stress decreased 
between 14% - 42%, potentially due to the reduction in the MR driving force. As shown in 
Table 29, the AML was subjected to a higher stress than the PML before and after TAVR. 
An imbalanced chordae force distribution was quantified for the pre- and post-TAVR 
models; a result of the restricted PML motion and postero-lateral chordae tethering. A 
higher tension was found for the PML chordae than for the AML chordae. Following 
TAVR, there was a force redistribution between the different chordae groups. AML and 
PML basal chordae tension decreased at least 36% and 22%, respectively, while AML 
marginal/strut and PML marginal chordae tension either increased or decreased depending 
on the stent implantation depth. More importantly, the total chordae tension decreased 
following TAVR (~20 N vs ~15 N) for the low and high implantation models, which 
suggests an improvement of mitral leaflet tethering. This phenomenon was not quantified 
for the optimal deployment model. 
Table 29. Pre- and post-TAVR tissue mechanics – SEV. 
 Pre-TAVR Low Optimal High 
Sɪ
AVRG (MPa)     
AV/TAV 0.076 0.113 0.106 0.108 
AML 0.126 0.120 (-5) 0.109 (-14) 0.099 (-21) 
PML 0.082 0.048 (-42) 0.071 (-14) 0.056 (-32) 
Fchordae (N)     
AML marginal 1.14 0.90 (-21) 1.14 1.28 (13) 
AML strut 2.04 2.67 (31) 3.07 (51) 1.82 (-11) 
AML basal 3.84 2.42 (-37) 2.48 (-36) 2.31 (-40) 
PML marginal 6.13 4.25 (-31) 6.91 (13) 5.41 (-12) 
PML basal 7.33 5.19 (-29) 5.72 (-22) 4.99 (-32) 
Percentage variations with respect to the pre-TAVR model are reported in parenthesis 
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9.4 Discussion 
The main contribution of the present study was a comprehensive analysis of TAVR impact 
on aortic-mitral coupling, MR severity and LH dynamics in a rigorously developed and 
validated patient-specific model. Specifically, this work presented an engineering 
mechanics study that: 
1) Investigated the impact of TAV type and stent deployment height on aortic-
mitral coupling and TAVR-host biomechanical interaction. 
2) Quantified that during TAVR, due to mechanical compression of the stent 
against the aortic-mitral curtain, the anterior MA was displaced posteriorly while the aortic 
annulus was displaced towards the LVOT. 
Moreover, the new knowledge learned from a clinical perspective include:  
1) Although improved systolic function was quantified for all post-TAVR models, 
no marked differences in early MR improvement/worsening (<10%) were noted at the three 
implantation depths, independent of TAV type. 
2) For this patient case, the BEV highest deployment model resulted in higher 
stresses in the native leaflets, contact radial force and stent recoil, while the BEV midway 
implantation model gave better hemodynamic performance and MR reduction. 
3) For this patient case, the SEV high implantation model gave the highest 
reduction in the 𝑅𝑉𝑀𝑉 and MR severity, and the lowest stent-tissue contact force. On the 
contrary, the SEV optimal implantation model gave a higher 𝑅𝑉𝑀𝑉 (~8%) than the pre-
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TAVR model, the highest stent-tissue contact force, and no mitral leaflet tethering 
improvement.  
4) Acute changes in MR severity following TAVR were predominantly related to: 
i) structural changes in the aortic-mitral complex caused by the grade of stent apposition 
and device anchoring, and ii) hemodynamic changes in global LV afterload/impedance 
caused by the relief of the AV obstruction. 
9.4.1 TAVR-in-BAV 
Patient-specific modeling of TAVR in a BAV patient under various procedural scenarios 
provided quantifiable information about device anchoring and the interaction between the 
stent, the aortic-mitral curtain and the native valve. The BEV highest deployment model 
(post-TAVR 10%) led to higher peak stresses in the AV leaflets, sinus and calcification, as 
well as higher contact radial force, stent recoil and average leaflet stress. These results are 
in agreement with a FE study by Bianchi et al. (127) that found that after stent recoil the 
high deployment model resulted in higher leaflet and sinus stresses, as well as higher 
contact forces than the midway deployment model. In our study, the peak stresses were 
generally found in the leaflet region in contact with the upper stent struts, in the leaflet-
root attachment lines, and in the transition region between calcification and leaflet tissue. 
Altogether, these results could indicate a higher risk for tissue damage and potential for 
aortic root injury or rupture for the highest stent positioning, as compared to a slightly 
lower or midway implantation configuration. This is especially important in the BAV 
space, as rates of annular rupture have been reported in some series to be as high as 5.3% 
using the balloon-expandable SAPIEN XT valve (349). Moreover, under BAV disease, the 
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TAV is usually implanted higher (+4 mm above the annulus) and anchored at the tightest 
part of the BAV commissures, with an often higher final implantation depth due to the 
anchoring effect of the calcification (350).  
Device apposition and, therefore, a correspondent measure of stent anchoring can 
be approximated by measuring the contact radial force, pressure or area between the stent 
and its surrounding tissue (111, 121). Previous in vitro and computational studies have 
aimed to improve the understanding of the relationship between radial force and TAVR 
performance (336, 351). Up to now, however, the value of this critical force for TAVR-in-
BAV was unknown. Our simulation results showed that the radial force for the three 
implantation models when using a BEV ranged between 205 – 230 N, and 98 – 108 N 
during fully stent expansion and after stent recoil, respectively. These forces, which 
increased as the implantation height increased, are markedly higher than the radial forces 
for a tricuspid AV reported by Egron et al. (336) and Wang et al. (111) between 100 – 150 
N during fully stent expansion. This difference in contact radial force between bicuspid 
and tricuspid AV anatomies may be important clinically, since TAV oversizing is common 
in TAVR-in-BAV in order to prevent significant PVL, especially with the older-generation 
TAV models.  
While radial dilatation is usually desired for proper device anchoring and to avoid 
dislocation of the implant, an excess in radial force may also lead to impairment of the 
conduction system, leading to left bundle branch or even complete atrioventricular 
conduction block. Indeed, PVL and high pacemaker implantation rates have been one of 
the main limitations of TAVR-in-BAV (352), with reported pacing rates of up to 25.5% 
for the balloon-expandable TAV (353). It has been postulated that the higher incidence of 
 208 
cardiac conduction disorders and permanent pacemaker implantation rates in TAVR-in-
BAV are related with difficulty in valve positioning and asymmetric expansion due to the 
irregular leaflet shape, heavy calcification and the inability to achieve a coaxial position 
during valve deployment (353). For the patient-specific case studied herein, a symmetrical 
expansion of the BEV stent was obtained, as supported by a stent eccentricity value close 
to one for the three deployment models (Table 22). This positive outcome can be explained 
by the less complex BAV type present in this patient, which was Sievers type 0 L/R without 
aortic root dilatation. The absence of a raphe and excessive bulky calcification, especially 
in the LVOT, allowed an apparently safe stent positioning with a circular uniform 
expansion, with no post-operative PVL found in this patient, agreeing with the clinical 
findings. 
9.4.2 Effect on TAVR on MR severity 
Following TAVR, several clinical studies have found the etiology and severity of MR to 
have varying effects on short- and long-term mortality (335, 337, 354). Less is known, 
however, on the changes in MR severity post-TAVR, with single-center and multicenter 
registry studies often giving conflicting results (334, 335, 337, 355). Given the paucity of 
high-quality data on this topic, the American Heart Association’s guidelines and the 
European Society of Cardiology have opted not to make recommendations on concomitant 
MR treatment in patients undergoing TAVR. Nevertheless, with the previous knowledge 
of physiologic aortic-mitral reciprocal behavior (356), some echo studies have aimed to 
identify the structural changes in the aortic-mitral complex that may influence MR degree 
following TAVR (355, 357, 358). Although these imaging studies have greatly enhanced 
our understating of the aortic-mitral coupling in this setting, the use of 2D/3D echo only 
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allows a semi-quantitative analysis of the AV-MV anatomy and coupled function. Taking 
into account the fast-paced developments in transcatheter valve therapies, there is a need 
for more robust quantitative methods for objective and accurate assessment of AV-MV 
coupled dynamics. The patient-specific computational model developed in this study 
provided a quantitative engineering analysis of the relationship between MR severity and 
the 3D structural changes of the aortic-mitral continuity throughout the cardiac cycle 
following TAVR in a virtual human beating heart. 
In agreement with previous clinical imaging studies (357, 358), our analysis 
showed that during TAVR procedure the MA height decreased in the post-TAVR models 
compared with the pre-TAVR model. Interestingly, with a higher BEV stent implantation 
configuration, we found that the MA height increased instead; up to 8% for the post-TAVR 
10% model. The aortic-mitral angle also decreased, with a narrower angle in the highest 
implantation model than in the midway implantation model. Narrower distances between 
the center of the aortic and mitral annuli matched changes in the aortic-mitral angle. The 
reports by Shibayama et al. (355) and Vergnat et al. (358) are also consistent with the 
present study, showing that the MA area, AP distance and AL-PM distance did not 
significantly changed after TAVR. A critical finding of this study was that during TAVR, 
the aortic annulus was displaced longitudinally towards the LVOT, while the anterior MA 
was displaced posteriorly. Particularly, the posterior displacement of the anterior MA 
suggests an actual mechanical effect of the TAV stent on the aortic-mitral curtain. We also 
found that the post-TAVR model that gave a worse MR than the pre-TAVR model (SEV 
optimal) presented the highest stent-tissue contact force, and no mitral leaflet tethering 
improvement (Table 23 and Table 29). 
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Overall, these results give a plausible mechanistic proposition for early MR 
improvement following TAVR. Geometric perturbation of the aortic-mitral fibrous 
continuity during TAVR can contribute to improved MV leaflet coaptation and decreased 
leaflet tethering, therefore reducing MR. These mechanistic parameters may suggest early 
avenues of MR improvement, such as contact force between the TAVR stent and the 
surrounding tissue, with potential compression of the aortic-mitral continuity. While 
existing medical imaging modalities to assess the impact of TAVR on MR severity are 
post-operative and lack high reproducibility, novel and more powerful tools, such as the 
patient-specific computer simulations presented in this work, can enhance our 
understanding of the biomechanical interaction between the device and the host, and may 
eventually help to improve TAVR procedure characteristics and optimal patient selection 
to ensure best patient care in AS with concomitant MR. 
From a hemodynamics perspective, after relief of AV obstruction by TAVR, acute 
reduction of the LV afterload accounted for an improvement in systolic function and better 
hemodynamic balance. In fact, LV pressure immediately decreased following TAVR, and 
consequently, the MR pressure gradient decreased, which contributed to a reduction in the 
pathological retrograde flow through the MV. Although AV peak and mean pressure 
gradients were similarly reduced among the three post-TAVR models, there was a trend 
towards a higher reduction of the MR pressure gradient among those models with improved 
MR. Assessment of MR severity by echocardiography under severe AS can be challenging 
and relies on several mathematical assumptions. For example, MR jet velocity may 
increase due to a high LV pressure. A large color Doppler jet with a high driving velocity 
but small effective regurgitant orifice area is probably not severe MR, and is likely to 
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appear less severe after TAVR (359). On the other hand, moderate-to-severe MR may lead 
to underestimation of the severity of the AS, since the decreased 𝑆𝑉𝐴𝑉 due to MR lowers 
the flow across the valve and, hence, the AV velocity and gradient (360). To the best of 
our knowledge, this is the first computational study to directly quantify the changes in the 
LV-valve hemodynamics pre- and post-TAVR under different TAV configurations, and to 
accurately measure the 𝑅𝑉𝑀𝑉 irrespective of MR jet geometry and geometric assumptions. 
9.4.3 SEV vs BEV performance 
Procedural characteristics, including the type of TAV, may also influence the post-
operative degree of MR. When comparing the BEV and SEV results, we found no 
significant changes in the 𝑅𝑉𝑀𝑉 (<10%) following TAVR, independent of the TAV type. 
It should be emphasized that in both studies, the same patient-specific computer model was 
used, and post-TAVR dynamics were simulated under the same loading and boundary 
conditions. Although no marked changes occurred in the degree of MR, some differences 
were identified when comparing SEV and BEV device performance. First, there was a 
trend towards a more consistent MR reduction with the BEV, whereas the likelihood of 
improvement was lower and less predictable when using a SEV; with mixed MR 
improvement/deterioration results depending on the deployment height. As shown in Table 
26 and Table 27, when comparing SEV vs. BEV performance at an optimal implantation 
depth, while the SEV model gave a higher 𝑅𝑉𝑀𝑉 than the pre-TAVR model (40.49 vs 37.59 
ml), the BEV model gave a lower 𝑅𝑉𝑀𝑉 (33.84 vs 37.59 ml). Moreover, while the optimal 
SEV model was the only post-TAVR model that resulted in worsening of MR, the optimal 
BEV model led to the highest decrease in the 𝑅𝑉𝑀𝑉 between the three BEV implantation 
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models (361). These results are in agreement with clinical studies that point toward a 
greater degree of MR reduction in patients treated with a BEV as compared to a SEV (337-
339, 362, 363).  
Several TAV-related factors have been postulated to help explain these differences 
in MR outcome: i) It has been suggested that the longer frame of the SEV may anatomically 
or functionally interfere with the AML, especially in the presence of a low implantation 
(364, 365). This was not confirmed in a large CoreValve series (366) or found in this 
computational study. In line with this hypothesis is the observation that a deep positioning 
of the SEV could be correlated with MR worsening (364), although this has not been 
observed in all studies (367). Our data also rule out this phenomenon for this patient 
computer model, since MR worsening only occurred in the post-TAVR model with an 
optimal implantation height. ii) The first generation CoreValve device has been associated 
with a higher degree of PVL, which may maintain volume overload and contribute to a less 
MR improvement (368, 369). PVL, however, was not quantified in any of our post-TAVR 
models. Moreover, the first-generation SEV has now been replaced by newer and enhanced 
versions with low PVL rates and are usually implanted at a shallower depth than the older 
generation CoreValve device.  
The second key finding was obtained when comparing the results of the SEV and 
BEV models that gave the greater degree of MR reduction. We identified four mechanistic 
parameters that appear to be associated with early MR improvement, independent of the 
TAV type: stent-tissue contact force, aortic-mitral angle, aortic annulus displacement and 
MA displacement. Specifically, the post-TAVR models with the lowest contact force, 
highest aortic-mitral angle, and highest valve annuli compression led to the greatest MR 
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reduction, when compared to the other two SEV/BEV implantation models. As such, it 
could be hypothesized that a TAVR deployment configuration that causes a large 
compression of the aortic-mitral continuity without an excessive stent-tissue contact force 
should be used. Clearly, the biomechanical mechanism of MR evolution after TAVR is 
multifactorial, and appears to be mediated by several structural and hemodynamic changes. 
Moreover, a large comparative study would be required to establish a more definitive 
framework to guide appropriate TAV selection.  
9.5 Limitations 
Several limitations should be taken into consideration when interpreting our findings. First, 
in this study only one patient-specific anatomy was examined, and as such the specific 
results regarding the TAVR biomechanics and its impact on MR severity cannot be 
assumed to represent the entire population. However, the validity of the results stands due 
to their comparative nature. Second, while, on one side, cardiac tissues were realistically 
described as nonlinear elastic, on the other side, patient-specific cardiac tissue material 
properties were not available. Thus, tissues mechanical response was defined from an 
extensive human tissue database obtained from in-house multiprotocol biaxial and uniaxial 
tests. Estimation of in vivo material parameters inversely from medical images would be 
ideal to produce more accurate predictive results (370). 
Third, since this study did not consider the zero stress–free configuration of the 
aortic wall, a rigid body constraint was assigned to the aortic root/ascending aorta wall 
elements during the pre- and post-TAVR FSI simulations; however, deformable tissue 
properties were attributed during the TAVR FE simulations. For the same reason, aortic 
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wall pre-stress state was neglected during the TAVR FE analysis. This assumption, which 
will be tacked in a future study, could lead to uncertainties on the computed stresses as well 
as in the tissue compliance (371-373). The pre-stress assumption of the native leaflets 
might have a small impact on the solution since the transvalvular pressure is very small 
during TAV deployment.  
Fourth, post-operative MSCT images were not available, thus it was not possible to 
compare the deformed TAV stent geometries from the simulations with post-TAVR 
clinical images. However, the current study still enabled us to compare different 
implantation configurations and evaluate the impact of stent depth on several clinically 
relevant parameters. Finally, the current SPH-FE FSI modeling framework involves a high 
computational cost. The FE TAVR simulations required approximately 3 days to run while 
the pre- and post-TAVR FSI simulations required approximately 5 days to run one cardiac 
cycle in an Intel Xeon E5-2670 cluster. As a result, the present modeling methodology 
cannot be used in a clinical setting and currently, is only suitable for a research 
environment. Nevertheless, among other advantages, SPH is easy to parallelize. The ability 
to run both FE and SPH codes on GPUs will significantly reduce the running time in the 
near future and avoid the need for a computer cluster (299, 300). Advances in machine 
learning techniques could also eventually render real-time biomechanical analysis for time-
sensitive clinical applications (374). 
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CHAPTER 10. SPECIFIC AIM 2C – LV-VALVE DYNAMICS 
UNDER MITRACLIP AND ANNULOPLASTY IMPLANTATION 
10.1 Introduction 
The percutaneous edge–to-edge MV repair technique using MitraClip (Abbott Vascular, 
Santa Clara, CA) is the most widely used minimally-invasive treatment option for patients 
with symptomatic MR and high surgical risk (375). Based on the surgical method by 
Alfieri, AML and PML are clipped, which results in a double-orifice valve. Although 
MitraClip was recently approved by the FDA for treatment of significant functional MR, 
two large randomized clinical trials showed apparently conflicting results. While the 
COAPT trial showed that MitraClip is associated with a lower rate of hospitalization for 
heart failure and lower all-cause mortality within 24 months of follow-up, compared with 
using medical therapy alone (376), the MITRA-FR trial did not show significant 
differences between the intervention and control groups (377).  
Differences in the two trials are likely to be related to level of functional MR, 
medical management, operator experience and most importantly, to patient selection (378); 
with markedly improved outcomes in the setting of a disproportionately larger severity of 
MR relative to LV volumes after optimizing medical therapy for heart failure (379). Indeed, 
several studies have shown that persistence of moderate-to-severe MR after MitraClip is 
associated with a considerably higher 1-year mortality (380-382), such that MR reduction 
to moderate or less is of paramount importance. Thus, it is clear that for a successful 
MitraClip procedure: i) a multidisciplinary team needs to be involved, ii) procedural 
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techniques need to be optimized, and iii) physicians should individualize treatments in 
accordance with patient characteristics and perform careful preoperative planning to select 
patients who would benefit the most from the procedure.  
In this context, there is a clear indication for a better mechanistic understanding and 
further improvement of the MitraClip technique under functional MR. Particularly, patient-
specific computer simulations could help to better understand the complex biomechanical 
interaction between the device and the human host, predict device performance (efficacy) 
and possible complications (safety). This may eventually allow physicians to personalize 
treatments strategies and select patients who would benefit the most from the MitraClip 
procedure with a higher level of accuracy, thereby improving clinical outcomes. 
Computational simulations using FE analysis have been useful in assessing MV 
biomechanics under healthy and diseased conditions, as well as in evaluating the functional 
and structural effects of different surgical and transcatheter MV repair techniques (293, 
383). While several FE studies have modeled the edge-to-edge and MitraClip procedures 
under degenerative MR (96, 384-388), to the best of our knowledge, no computational 
study has to date evaluated the impact of MitraClip on MV biomechanics under functional 
MR. Previously, Lau and colleagues (92) investigated the effect of the edge-to-edge 
surgical technique on an idealized MV model with a dilated but static MA and healthy 
chordae structure with no leaflet tethering.  
In Specific Aim 2c, we employed the previously validated patient-specific LH model 
with functional MR developed in Specific Aim 1b – Part 2 to simulate the MitraClip 
procedure and assess the biomechanical interaction between the device and the host. The 
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FSI framework implemented in this study allowed us to investigate the impact of central 
and lateral MitraClip placement, as well as combined MitraClip and annuloplasty therapies 
on biomechanical outcomes, and post-clip LH structural and fluid dynamics. 
10.2 Materials and Methods 
10.2.1 Patient-specific LH model 
In this study, we employed the patient-specific LH model with functional MR developed 
and validated in Specific Aim 1b – Part 2. Briefly, echo examination revealed moderate-
to-severe MR with a tethered PML with restricted motion and reduced leaflet coaptation. 
The LVEF was estimated to be 25%. The LV thickness was normal but the chamber was 
mildly dilated. The patient-specific LH model, shown in Figure 65A, was composed of the 
ascending aorta, aortic root, AV, calcification, MV, LV and LA endocardial walls, detailed 
chordae structure and distribution, accurate leaflet geometry and thickness, dynamic MA 
and chordae origins, anisotropic hyperelastic material models, and human age- and gender-
matched material properties. Additionally, chordae tethering forces due to PM 
displacement were accounted for accurate modeling of MV dynamics under FMR, as 
explained in Specific Aim 1b – Part 2. 
10.2.2 MitraClip model 
The clip model was simplified as two rectangular rigid plates with dimensions similar to 
the real MitraClip device. Figure 65B illustrates the clip model used in this study and the 
real MitraClip device. The length of each plate was 9 mm and the width was 5 mm. As 
shown in Figure 65B, a reference node was defined at the middle bottom edge of each 
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plate, allowing each arm to rotate with respect to its own reference node. A connector 
element connecting the two reference nodes was defined in order to impose mutual 
kinematic constraints. During the simulations, the relative motion of the two clip arms was 
constrained by the connector element to prevent relative displacement between them. 
Based on the location of the regurgitant gap, two MitraClip placement locations were 
simulated in this study: i) central positioning, between the AML and P2 scallop, and ii) 
lateral positioning, between the AML and P1 scallop. 
10.2.3 Annuloplasty ring model 
There are several models of ring available for use in MV repair in various shapes (partial 
vs complete, flat vs saddle-shape) and with different material properties (rigid vs semi-
rigid vs flexible). Under functional MR, the standard annuloplasty treatment involves the 
use of a ring that reduces the antero-posterior diameter of the MA. Thus, in this study we 
used a complete ring based on the Carpentier-Edwards Classic ring (Edwards Lifesciences, 
Irvine, California). Following the selection guidelines for the Classic ring (389), a 38 ring 
size was chosen based on the similarity between the surface area of the device and the 
surface area of the AML. The 3D ring shape and dimensions were obtained from literature. 
However, rather than implanting a virtual ring with its full cross-sectional geometry, ring 
implantation was simplified as prescribed boundary conditions on the MA. 
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Figure 65. A) Patient-specific LH model, B) Real and simplified MitraClip devices, 
C) Aortic and LA pressure waveforms, D) MV geometrical parameters. AV: aortic 
valve, LV: left ventricle, LA: left atrium, MV: mitral valve, AML: anterior mitral 
leaflet, PML: posterior mitral leaflet is divided into lateral P1 scallop, central P2 
scallop and medial P3 scallop. 
 
10.2.4 FE modelling of MitraClip and annuloplasty procedures 
10.2.4.1 Step 1 – MV closure 
Simulation of MV closure under systolic pressure and chordae tethering has been described 
in detail in our previous studies (287, 390). Briefly, since the patient had moderate-to-
severe MR with PML tethering and dilated LV, pre-existing forces within the posterior 
chordae at diastole were modeled in the first sub-step of the simulation. Thus, before 
running the FE simulations, a total of 8 posterior chordae were shortened by translating the 
chordae origins towards the MA plane along the original direction of the chordae. At the 
beginning of the simulations, those chordae origins were initially displaced to their original 
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locations to generate the tethering tension. After those chordae origins reached their 
original locations on the PM tips, a rough contact with no separation behavior was enforced 
to connect the chordae with the PM tips (287). The reaction force on each node of the MA 
was output at the end of this first sub-step. Next, the dynamic motion of the MA and 
chordae origins from diastole to systole obtained from the MSCT images was applied as a 
nodal displacement boundary condition(287). The clinically measured transmitral pressure 
gradient of 114 mmHg was then applied to the ventricular surface of the leaflets to simulate 
MV closure. At the end of this step, the two MitraClip arms rotated so that the clip opened 
at 120 degrees. 
10.2.4.2 Step 2 – Clip attachment 
Clip grasping to the mitral leaflets was modeled at diastole when the valve just started to 
open. Initially, displacement boundary conditions on the MA and chordae were applied so 
that the mitral apparatus restored to a diastolic position and the leaflets opened due to the 
release of the pressure on the ventricular surface. Next, the MA nodal displacement 
boundary condition was replaced by the MA reaction forces obtained in Step 1 from the 
pretension simulation at diastole to account for the tension within the MA during diastole. 
Meanwhile, to grasp the leaflets, the two clip arms rotated back to a closed position until a 
gap of 4 mm was left between the upper end of the two arms (391). At the end of the step, 
rough contact with no possible slippage and no separation behavior was initiated between 
the arms and the mitral leaflets. The clip arms remained mutually parallel but could 
rotate/tilt following the interaction with the leaflets. During all simulation steps, nodes on 
the septal wall of the myocardium were fixed to prevent excessive cardiac motion. 
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10.2.4.3 Step 3 – Annuloplasty ring 
To align the virtual ring with the MA plane, least-square planes were created for both the 
ring and the MA. The ring was rotated until its least square plane was parallel to that of the 
MA. Next, middle anterior and posterior portions of the ring were aligned with the middle 
anterior and posterior portions of the MA until the ring was positioned such that the anterior 
portion of the ring overlaped with the anterior MA as much as possible, avoiding excessive 
displacement of the LVOT. 
Following ring alignment, a total of 18 node clusters uniformly distributed along 
the MA were identified as boundary nodes; each cluster contained 3 adjacent nodes. On 
the virtual ring, 18 uniformly distributed nodes were also identified. Suturing of the 
annuloplasty ring to the MA was mimicked in the FE simulations by imposing kinematic 
displacements on the 18 node clusters on the MA from their original locations to the 
locations of the 18 corresponding nodes identified on the virtual ring. During this step, the 
boundary conditions on the chordae origins were unfixed to allow PM movement. 
Meanwhile, a point load equivalent to the reaction force obtained at each chordae origin 
from the pretension simulation was applied to the same chordae origin to account for the 
tension within the chordae due to leaflet tethering at diastole. No separation between the 
clip and the leaflets was maintained in this step. The deformed LH geometries were 
extracted from the FE simulations and used to assess the post-clip LH dynamics using FSI. 
10.2.5 Boundary conditions 
Time-dependent pressure boundary conditions were applied at the two LA inlets 
(pulmonary veins) and at the aortic outlet of the pre- and post-clip models, as previously 
 222 
explained in Specific Aim 1b – Part 2. Cardiac wall motion was kept the same for all pre- 
and post-clip models, simulating immediate post-operative LH dynamics, without 
considering any possible cardiac remodeling mechanisms that occur over time after 
MitraClip. In functional MR, the regurgitant volume in the LA cavity results in an elevated 
V-wave pressure during systole (238). Thus, the pre-clip model employed a pathological 
LA inlet pressure waveform, as seen in Figure 65C. After MitraClip implantation, the LA 
pressure was decreased by 33% (392) (393). 
10.2.6 Data analysis 
10.2.6.1 MV geometrical parameters 
Morphologic changes in the MV during MitraClip were evaluated in terms of the 
geometrical parameters shown Figure 65D. The following measurements were obtained 
during systole: a) antero-posterior (AP) distance, defined as the distance between mid-
anterior and mid-posterior MA points, b) anterolateral-posteromedial (AL-PM) distance, 
c) MA spherecity index (ASI), defined as the ratio between AP and AL-PM distances, d) 
inter-commissural (CC) distance, e) MA height to inter-commissural width ratio 
(AHCWR), defined as the ratio between MA height and the CC distance  f) MA area, and 
g) aortic-mitral distance, defined as the centroid distance between the MA and the aortic 
annulus. 
10.2.6.2 Fluid parameters 
As introduced in Specific Aim 1b – Part 2, the following LH hemodynamic parameters 
were quantified throughout the cardiac cycle: 𝑆𝑉𝐴𝑉, 𝑆𝑉𝑀𝑉, 𝑅𝑉𝐴𝑉, 𝑅𝑉𝑀𝑉, 𝑅𝐹𝑀𝑉, MR 
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severity, LVEF, LV mean systolic pressure (LV-MSP), LV end-diastolic pressure (LV-
EDP), peak systolic pressure gradient (PSPG), mean systolic pressure gradient (MSPG), 
AV peak velocity, EOAAV, peak diastolic pressure gradient (PDPG), mean diastolic 
pressure gradient (MDPG), E and A wave velocities, EOAMV, MR mean pressure gradient 




𝑀𝐷𝐹 is the root mean square diastolic flow rate (214). Similarly, EROA was defined as 
𝑀𝑅𝐹
31√MR−MPG
, where 𝑀𝑅𝐹 is the root mean square regurgitant flow rate. 
10.2.6.3 Structural parameters 
During the MitraClip procedure, the average maximum principal stress (Sɪ
AVRG) in the MV 
leaflets was quantified from the FE simulations. To avoid the bias caused by local high 
stress concentration, only the 99-percentile values of the peak stress values were evaluated 
(348). Moreover, leaflet annular regions were not included in the average stress calculation 
in order to avoid boundary effects. From the FSI simulations, pre- and post-clip MV 
biomechanics were evaluated by the Sɪ
AVRG in the MV leaflets during peak systole and 
diastole. AML and PML chordae forces (Fchordae) were also reported. The force experienced 
by a particular chordae group was calculated as the sum of vectors representing the tension 
in each individual chorda attached to a specific leaflet. Finally, the anatomic MV orifice 
area (AMVOA) was quantified throughout the cardiac cycle. The least square plane of the 
MA was calculated at each time point of the cardiac cycle. The AMVOA was then 
measured as the projected 2D area of the leaflets free edge on the MA least square plane. 
The regurgitant orifice area and opening orifice area values were obtained by selecting the 
minimum and maximum AMVOA values during systole and diastole, respectively. 
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10.3 Results 
10.3.1 MitraClip impact on LH dynamics: MV geometry 
Table 30 presents the changes in MV geometry during MitraClip implantation. The AP 
distance and ASI markedly decreased (>20%) after MitraClip for the central model, with 
or without ring. Similarly, the MA area and aortic-mitral distance had a tendency to 
decrease for all clip models, but these changes were not significant when compared to pre-
clip conditions. Furthermore, although the AL-PM distance and CC distance increased in 
all post-clip models, these changes were comparable before and after MitraClip. Generally, 
using a lateral clip led to the smallest changes in MV geometry, while using a central clip 
+ ring led to the biggest anatomical changes. Table 30 also presents the average stress 
(Sɪ
AVRG) in the MV leaflets during the clipping procedure. The PML was subjected to a 
higher stress than the AML for all clip models, with the central + ring model giving the 
highest leaflet stress values. 
Table 30. MV anatomical and biomechanical parameters pre- and post-clip.  
 Pre-Clip Lateral Central Central + Ring 
AP distance (mm) 34.37 31.90 27.37 (-20) 25.28 (-26) 
AL-PM distance (mm) 39.83 41.96 43.28 45.71 
ASI 0.86 0.76 0.63 (-27) 0.55 (-36) 
CC distance (mm) 33.87 35.22 34.90 37.42 
AHCWR 0.14 0.16 0.11 0.12 
MA area (cm2) 11.40 10.37 10.04 9.40 
Aortic-mitral distance (mm) 28.32 25.06 24.43 23.38 
Sɪ
AVRG AML (MPa) ̶ 0.101 0.084 0.113 
Sɪ
AVRG PML (MPa) ̶ 0.108 0.099 0.152 
Marked percentage variations with respect to the pre-clip model are reported in parenthesis. 
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10.3.2 MitraClip impact on LH dynamics: Intraventricular hemodynamics 
Figure 66 shows the flow rate waveforms across the valves throughout the cardiac cycle 
for the pre- and post-clip models. The positive flow indicates the forward flow towards the 
aorta (Figure 66A) and the LV (Figure 66B) during systole and diastole, respectively. In 
contrast, the negative flow indicates the backward blood flow due to valve closure and 
regurgitation. Table 31 summarizes the main hemodynamic parameters quantified for the 
pre- and post-clip models from the FSI simulations. 
 
Figure 66. Flow rate (ml/s) across the A) AV and B) MV throughout the cardiac 
cycle. 
 
Several important findings can be described during systole: First, successful 
MitraClip therapy led to an immediate hemodynamic improvement by decreasing the 
𝑅𝑉𝑀𝑉, and due to the coupled valve dynamics and mass conservation, a concomitant 
increase in the forward 𝑆𝑉𝐴𝑉. The greater degree of MR improvement, based on the RFMV 
criterion, was for the central + ring model (46%). Nevertheless, all post-clip models can 
now be classified as moderate MR. Second, MR reduction promoted LV unloading and a 
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decrease in preload, manifested by an increase in the LV-MSP and a decrease in the LV-
EDP, as seen in Figure 67C. The central + ring model presented the greatest decrease in 
LV preload. 
Third, the LVEF decreased post-Clip by less than 4%. Despite the slight reduction 
in the total LVEF, the effective LVEF markedly increased, as evidenced by an increase in 
the 𝑆𝑉𝐴𝑉 between 27 – 32%. Fourth, the MR-MPG increased after the procedure due to the 
decrease in the LA pressure and the increase in the LV-MSP. The peak MR velocity and 
EROA, on the other hand, decreased after MitraClip. Fifth, improvement in the systolic 
hemodynamic profile after clip implantation was also associated with a decrease in the 
PSPG and MSPG (Figure 67A), and an increase in the EOAAV. 
Similarly, important findings were identified during the diastolic phase: First, 
narrowing of the MV orifice after MitraClip caused higher PDPG and MDPG (Figure 67B), 
as well as higher MV inflow velocities. The MDPG increased from 1.35 mmHg pre-clip 
up to 7.47 mmHg when using a central clip + ring. Second, as seen in Figure 66B, the MV 
inflow curve profile changed pre- and post-clip. Due to the decrease in the EOAMV and the 
greater resistance to flow in the double-orifice valve post-clip, there was a decrease in the 
early E-wave dominant flow. The decrease in the E-wave flow curve was higher for the 




Table 31. Pre- and post-clip LH hemodynamics.  
 Pre-Clip Lateral Central 
Central + 
Ring 
SVAV (ml) 46.28 58.81 58.55 61.21 
RVAV (ml) 9.34 13.18 10.42 4.78 
SVMV (ml) 74.64 70.22 71.57 75.70 
RVMV (ml) 37.59 23.88 23.59 19.51 
RFMV (%) 44.82 28.88 28.72 24.17 
MR severity (RFMV) 
Moderate to 
severe 
Moderate Moderate Moderate 
LVEF (%) 28.55 28.15 27.96 27.47 
LV-MSP (mmHg) 97.64 102.89 105.83 105.83 
LV-EDP (mmHg) 15.96 9.67 8.39 0.92 
PSPG (mmHg) 34.82 30.74 30.58 33.90 
MSPG (mmHg) 23.97 20.97 20.7 21.34 
AV peak velocity (m/s) 2.82 2.72 2.8 2.8 
EOAAV (cm
2) 0.77 0.94 0.93 0.96 
PDPG (mmHg) 4.32 8.91 9.05 9.17 
MDPG (mmHg) 1.35 4.33 6.16 7.47 
E wave (m/s) 0.79 0.96, 1.46 1.43, 1.29 1.41, 1.36 
A wave (m/s) 0.54 0.71, 1.2 1.31, 1.15 1.32, 1.28 
EOAMV (cm
2) 4.1 2.19 1.76 1.53 
MR-MPG (mmHg) 57.25 75.24 76.65 76.66 
MR peak velocity 
(m/s) 
5.42 4.61 4.83 4.89 
EROA (cm2) 0.5 0.28 0.26 0.25 
E and A wave velocity values from left to right correspond to the double/triple orifices 
located from P1 to P3 scallops. 
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Figure 67. A) AV pressure gradient, B) MV pressure gradient, C) LV pressure, and 
D) AMVOA throughout the cardiac cycle. 
 
Figure 68 shows the intraventricular velocity streamlines colored by velocity 
magnitude during peak systole. Due to the restricted PML motion, the pre-clip model 
displayed a posteriorly directed regurgitant jet, which qualitatively and quantitatively 
matched the regurgitant jet measured clinically (361). The regurgitant jet structure was 
similar between pre- and post-clip configurations, with an eccentric “wall-hugging” jet that 
impinged the postero-lateral LA wall. The strength and velocity of the jet, however, 
decreased following MitraClip (Table 31). 
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Figure 68. Pre- and post-clip velocity streamlines showing the regurgitant jet 
structures during systole. 
 
Finally, Figure 69 shows the velocity streamlines during peak diastole. Marked 
differences in the inflow flow structure and magnitude were observed pre- and post-clip, 
as well as between the different clip models. MitraClip implantation significantly altered 
the LV hemodynamics by creating a double-jet configuration due to the double-orifice MV. 
Moreover, the post-clip jets were not oriented towards the apex, but towards the LV wall, 
where they impinge leading to higher near-wall velocities than the pre-clip model, 
especially for the central + ring model. The induced double‐jet configuration appears with 
a deeper jet penetration inside the LV. As shown in Table 31, due to the reduced orifice 
areas, the jets had much higher velocities than the central jet observed before clip 
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implantation. Additionally, the different orifice sizes caused differences in the peak jet 
velocities. 
 
Figure 69. Pre- and post-clip velocity streamlines showing the intraventricular blood 
flow during diastole. 
 
10.3.3 MitraClip impact on LH dynamics: MV tissue mechanics 
Table 32, Figure 70A and Figure 70C present the average (Sɪ
AVRG) stress in the MV 
leaflets and the chordae tension during peak systole pre- and post-clip. From Figure 70A it 
can be seen that both AML and PML were subjected to a higher systolic stress after the 
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procedure. This increase in the leaflet stress was significant (>50%) for the PML when 
using a lateral clip or a central clip + ring. Figure 71 shows the stress distribution patterns 
across the MV leaflets at peak systole. Before clip implantation, peak stress values in the 
AML were located at the right and left trigones, while peak values for the PML were 
distributed along the MA region and at the basal chordae insertion region. Following clip 
attachment, areas of high stress concentration were relocated near the clip arms for all 
configurations. As seen in Figure 70C, since this patient had a postero-lateral regurgitant 
gap with PML tethering, the pre- and post-clip models experienced a higher total PML 
chordae systolic tension when compared to AML chordae tension. After MitraClip, the 
chordae attached to the AML were subjected to a lower tension compared to the pre-clip 
model, while PML chordae were under a higher tension. These differences were only 
important (>30%) when a lateral clip was implanted. 
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Figure 70. A) Leaflet stress during systole, B) Leaflet stress during diastole, C) 
Chordae tension during systole, and D) Chordae tension during diastole. 
 
Table 32. Pre- and post-clip MV biomechanics during systole. 




AVRG (MPa)     
AML 0.126 0.159 (26) 0.131 (5) 0.145 (16) 
PML 0.071 0.125 (76) 0.091 (28) 0.129 (82) 
Fchordae (N)     
AML 7.04 4.07 (-42) 5.59 (-21) 5.88 (-16) 
PML 13.79 19.06 (38) 16.50 (20) 17.63 (28) 
AMOVA - regurgitant 
orifice area (cm2) 
0.51 0.38 (-26) 0.37 (-29) 0.35 (-33) 




Figure 71. Stress distribution on the MV leaflets during systole. 
 
Regarding the diastolic phase, Table 33, Figure 70B and Figure 70D show the 
average leaflet stress and the chordae tension. A significant increase (>50%) in AML and 
PML stress was quantified for all post-clip models. Moreover, the lateral model gave the 
highest increase in leaflet stress, while the central + ring model gave the lowest stress 
increase. As seen in Figure 72, similar stress distribution patterns were observed in the MV 
leaflets for all post-clip models during diastole. In the AML, peak stresses relocated near 
the clip arms and along strut and marginal chordae insertion regions. In the PML, peak 
stresses extended from the free edge at the level of the clip arms towards the P2 annular 
region, close to the insertion of the basal chordae. In regard to diastolic chordae forces, 
Figure 70D shows that although AML and PML chordae tension had a tendency to increase 
after the procedure, there were no significant changes when comparing these before and 
after MitraClip. Similarly, we observed higher chordae forces during diastole than systole 
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for all pre- and post-clip models, which could be attributed to the diastolic restriction of 
the MV leaflets  caused by PM relocation and LV dilatation. 
Table 33. Pre- and post-clip MV biomechanics during diastole.  




AVRG (MPa)     
AML 0.074 0.165 (122) 0.156 (110) 0.135 (82) 
PML 0.088 0.159 (80) 0.139 (57) 0.132 (49) 
Fchordae (N)     
AML 9.43 11.04 (17) 10.42 (11) 11.85 (26) 
PML 16.25 17.71 (9) 20.92 (29) 17.36 (7) 
AMVOA - opening 
orifice area (cm2) 
4.85 2.46 (-49) 2.14 (-56) 1.79 (-63) 
Percentage variations with respect to the pre-clip model are reported in parenthesis. 
 
Finally, Figure 67D shows the AMVOA throughout the cardiac cycle. During 
systole, the AMVOA markedly decreased (>20%) from 0.51 cm2 to ~0.36 cm2 after MV 
repair, with the highest reduction (33%) obtained for the central + ring model (Table 32). 
During diastole, the AMVOA decreased significantly (>50%) for all post-clip models, with 
the highest reduction (63%) quantified for the central + ring model (Table 33). 
Furthermore, the pre-clip double-peaked AMVOA curve during diastole changed to a flat 
curve post-clip, similarly as the MV inflow curve seen in Figure 66B. 
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Figure 72. Stress distribution on the MV leaflets during diastole. 
 
10.4 Discussion 
The results of this study can be summarized as follows: First, MitraClip induced acute 
morphologic changes in the MV geometry. Clip implantation resulted in a marked decrease 
of the AP distance by up to 26%, and a non-significant decrease and increase of the MA 
area and AL-PM distance, respectively. Consequently, there was a significant reduction of 
the ASI together with a non-significant decrease in the AHCWR, suggesting that MitraClip 
therapy leads to a more elliptical and planar MA. Second, MV leaflet stress increased 
throughout the cardiac cycle after clip placement, with a significant increase during diastole 
by up to 122% and 80% for the AML and PML, respectively. 
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Third, MitraClip was accompanied by the reduction of the AMVOA during diastole 
by up to 63% for the central + ring model, while the systolic AMVOA decreased by up to 
33% for the same model, resulting in improved but incomplete MV coaptation. 
Additionally, MitraClip altered the temporal course of the diastolic AMVOA and MV 
inflow profiles from double-peaked curves to more flattened curves. Fourth, the immediate 
reduction in the 𝑅𝑉𝑀𝑉 achieved by MitraClip resulted in an acute increase in the forward 
flow (>27%), in addition to favorable changes in LV loading conditions by reducing the 
LV-EDP and LA pressure, and increasing the LV-MSP. For this patient case, while 
implanting a central clip + ring resulted in the highest improvement in LV systolic function 
and magnitude of reduction in the regurgitant flow (46%), this clip configuration also led 
to the highest degree of MS by increasing the MDPG to 7.47 mmHg. 
10.4.1 Effects on MV geometry 
The acute effects of MitraClip on the MV geometry under functional MR have been 
investigated in a few clinical studies using echocardiography (394-396). Similar to these 
investigations, we found a marked reduction in the AP distance together with a non-
significant increase of the AL-PM distance, especially when a central clip + ring were 
implanted (Table 30). These changes were accompanied by comparable changes in the CC 
distance pre- and post-clip (397), and by a non-significant reduction in the MA area, as 
found in previous studies (394, 398). Some studies, however, have demonstrated a 
significant decrease of the MA area after MitraClip (395, 396). Nonetheless, this decrease 
is secondary to reduced AP distance after the procedure. Our results suggest that reshaping 
of the MA with a significant reduction of the AP distance contributes to a reduction of MR 
after MitraClip. Previous investigations have pointed that reduction in AP distance might 
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be an indicator of clinical benefit (396, 399, 400). This finding could be critical in a 
procedure in which patient selection is fundamental. Further studies in a larger population 
may be required to confirm such correlation. As a whole, it appears that the MitraClip 
device limits MV dilation by exerting traction on the MA (398); mainly in the antero-
posterior direction, analogous to a partial annuloplasty procedure. The small changes in the 
CC distance can be explained by the presence of the aortic-mitral continuity and the fibrous 
trigones, which is a region less prone to large deformations than the posterior MA, which 
is mainly muscular and more prone to dilatation (401).  
The decrease of the AP distance together with the increase in the AL-PM distance 
resulted in a significant reduction of the ASI in the central clip models, which confirms the 
reshaping of the MA from a rounder to a more oval shape. The reduction in the MA 
sphericity index has been quantified in patients with functional MR undergoing surgical 
MV repair with annuloplasty ring (402). AHCWR and aortic-mitral distance also decreased 
after MitraClip, but these changes were non-significant. The AHCWR is a measure of the 
MA non-planarity and describes its 3D shape. Our results suggest a flatter MA post-clip 
during systole, which can be related with the increased LV pressure and the more elliptical 
MA (403, 404). Overall, these findings, although not directly related to clinical outcomes, 
might be of interest for future studies determining independent anatomic implantation goals 
that predict sustained procedural success. Computational-based MV analysis, such as the 
one performed in this study, allows for a detailed quantitative understanding of the acute 
changes in MV geometry after MitraClip in an objective and reproducible manner. Further 
studies need to investigate the dynamic changes in the MV geometry at additional time 
points during the cardiac cycle and when using different clip numbers and positions. 
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10.4.2 Structural effects on the MV 
MV leaflet stress increased throughout the cardiac cycle after MitraClip procedure, in 
particular next to the site of clip insertion. This increase was significant (>50%) in all post-
clip models during peak diastole (Table 33). Moreover, during systole, AML stress was 
higher than PML stress for all pre- and post-clip models (Table 32), a direct result of the 
restricted PML motion caused by chordae tethering. During diastole, however, AML and 
PML had comparable stress values for each respective model. These results are congruent 
with the findings from Lau et al. (92) that showed that during diastole the MV leaflet stress 
can be up to 200% higher after MitraClip when treating MA dilatation, with respect to a 
physiological MV model. Morgan et al. (388) showed, on the other hand, that MitraClip 
resulted in similar or reduced MV leaflet stress values, relative to the MV model with no 
clip. However, the latter FE study was performed on a MV model with leaflet prolapse or 
primary MR, which is a different MV disease in its etiology and pathophysiology than 
functional MR.  
During diastole, the MV leaflets were subjected to abnormal stresses up to 27% 
(lateral model) and 52% (central model) higher than during systole. For the central + ring 
model, however, the leaflets were subjected to comparable stress values during systole and 
diastole. Thus, the use of an annuloplasty ring in combination with MitraClip appeared to 
i) give the lowest increase in leaflet stress during diastole with respect to the pre-clip model, 
and ii) induce a more homogeneous stress state in both leaflets when comparing systolic 
and diastolic states. These findings have a particular impact upon transcatheter MV repair 
techniques and their durability, whereby MitraClip is the only repair procedure 
implemented. 
 239 
Given that FDA approval for treatment of functional MR was recently granted, and 
that latest European guidelines implemented MitraClip as recommendation for the 
treatment of functional MR with a recommendation class IIb, level of evidence C (405), it 
is expected that MitraClip as non-surgical treatment option will revolutionize the treatment 
of functional MR. In vitro studies have shown that increased leaflet stress can alter 
proteoglycan and collagen synthesis, resulting in leaflet thickening with an increased 
compliance (104, 313). Moreover, under in vivo conditions the MitraClip device has been 
reported to gradually be encapsulated by connective tissue, have thicker fibrous capsules, 
and incite a fibrous reaction that results in the formation of a tissue bridge within the clip 
arms (406). Taken together, careful planning seems necessary to select respondent patients 
and to determine optimal clip placement. The biomechanical insight provided by FSI 
computational analyses such as the one developed in this study may aid in the better 
understanding of the biomechanical impact that MitraClip has on the load distribution and 
deformation of the LV-valve complex in the short- and long-term. 
10.4.3 Effects on anatomic MV orifice area 
We report, to our knowledge, the first set of time-dependent in-silico continuous AMVOA 
measurements pre- and post-clip, and under different clipping configurations (Figure 67D). 
We quantified a reduction in the diastolic and systolic AMVOA by up to 63% and 33%, 
respectively (Table 32 and Table 33). The computational-based approach implemented 
herein allowed us to directly quantify the true AMVOA at the level of the leaflet free edge 
throughout the cardiac cycle with high reproducibility. Clinically, this parameter could be 
assumed to represent an invasive measurement using catheterization or the “ground truth”. 
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Nevertheless, for better comparability of clinical results and simulation results, we 
also quantified the EOAMV and EROA by using the mathematical formulation that relates 
the pressure drop across the valve and the flow rate, and by combining the continuity and 
orifice equations (213, 214). Similarly, we measured a reduction in the EOAMV and EROA 
after MitraClip by up to 63% and 50%, respectively (Table 31). Congruent with our results, 
a recent 3D TEE study by Noack et al. (394) found that the EOAMV and EROA decreased 
by up to 65% and 67%, respectively. Previous works have also shown a decrease in the 
EOAMV of ~53% after the procedure (407, 408). In the latter studies, the EOAMV was 
calculated with 3D planimetry in the proximity of the commissures, which can lead to an 
overestimation of the post-clip EOAMV. This could help to explain the larger decrease in 
EOAMV quantified in our study. 
The clinical assessment of the continuous MV orifice area during MitraClip pre-
procedural planning and evaluation is technical challenging due to the 3D dynamic MV 
orifice, the limited capacity for echocardiographic measurement of areas below 0.5 cm2, 
and different TEE and Doppler-derived measurement techniques (408). When comparing 
our diastolic and systolic AMVOA values (Table 32 and Table 33) with our EOAMV and 
EROA values (Table 31), we observed the same trend towards a decrease of the MV 
opening and regurgitant orifice areas pre- vs post-clip, and when using a lateral clip vs. 
central clip + ring. However, we also quantified that overall, the echocardiographic method 
(EOAMV and EROA) underestimates the true MV orifice (AMVOA) (408),  especially the 
regurgitant orifice area after MitraClip, with an error up to 30%. 
Currently, there is no gold-standard method to measure the MV orifice area during 
MitraClip procedure. Moreover, in the absence of a reference method for its assessment 
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pre- and post-clip, it is challenging to determine the best echocardiography method to use. 
Our findings demonstrated for the first time the dynamic changes in the true MV orifice 
area before and after MitraClip in a patient with functional MR, and as such, it allows a 
fundamental improvement of the understanding of MV leaflet kinematics in patients with 
MR. This could provide useful information toward patient selection and procedural 
optimization for treatment with transcatheter edge-to-edge MV repair devices. 
Interestingly, this study also showed that MitraClip therapy altered the temporal 
MV leaflet kinematics, especially during diastole. Before MitraClip, a twin-peaked 
AMVOA curve was quantified, which can be explained by early MV inflow (E wave) 
followed by atrial contraction (A wave). After clip implantation, the double-peaked 
AMVOA curve changed to a mostly flat curve (Figure 67D). Although some clinical 
studies have detected this diastolic flattening of the AMVOA curve (409), it was suggested 
this was caused by the prevalence of atrial fibrillation in the patients studied. But unlike 
previous reports, we prescribed the same LA wall motion pre- and post-clip in our virtual 
patient-specific model. Thus, we hypothesize the diastolic changes in the profile of the 
AMVOA and MV inflow curves post-clip are related to the MS caused by the narrower 
and double-orifice MV. 
10.4.4 Effects on LH fluid dynamics 
10.4.4.1 Impact on residual MR 
Up to now, the most important hemodynamic parameters that determine procedural success 
after MitraClip are residual MR and increased transmitral pressure gradient (MDPG). Even 
moderate MR after the procedure has been associated with increased mortality (410), 
 242 
particularly in patients with impaired LV function (411). Indeed, residual MR is discussed 
as one of the main drivers for worse patient outcome undergoing MitraClip implantation 
in the MITRA‐FR trial, compared with the COAPT trial, with 50% residual MR ≥ 2 in 
MITRA‐FR, and 31% residual MR ≥ 2 in COAPT after 1 year (376, 377). In our study, the 
post-clip model that gave the highest residual MR was the lateral clip model, followed 
closely by the central clip model (Table 31). Importantly, all post-clip models presented 
moderate MR.  The post-repair finding of moderate MR is considered a suboptimal 
outcome for the MitraClip procedure (412). Such a determination would often contribute 
to the consideration to deploy additional clips.  
As a general guideline, additional clips should not be placed if the patient has a 
mean MDPG ≥ 4 mmHg (413), which was the case for all our post-clip models. Thus, 
implantation of a second clip was not modeled in this study. The decision to proceed with 
a second clip is complex and based on the degree of reduction of MR with the first clip, 
residual MR, MDPG, EOAMV, improvement in hemodynamics, and the technical 
feasibility of placing a second clip. Regardless of whether 1 or more clips are deployed, 
the currently recommended approach relies on an overall echocardiographic assessment of 
MR severity integrating multiple parameters (414, 415), some of which are not validated 
in the specific MitraClip clinical scenario, are limited by operator dependence, or are 
difficult to obtain with TEE imaging (298, 416-418). 
10.4.4.2 Impact on MV diastolic pressure gradient 
The benefit from MR reduction can be counterbalanced by the formation of MS. In cohorts 
of patients undergoing surgical annuloplasty for functional MR, development of MS was 
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associated with reduced patient functional capacity as assessed by the 6‐minute walk test 
(419). Similarly, an increased MDPG after surgical MV repair was associated with reduced 
functional capacity (420) Bertrand et al. (421) stressed the relevance of the EOAMV after 
annuloplasty to treat functional MR for the long-term outcome. After MitraClip, the 
creation of a double-orifice MV is often associated with an increase in the MDPG (422, 
423). The abrupt change of the LV hemodynamic status from elevated preload caused by 
MR, to elevated afterload caused by MS and decrease of the low-impedance regurgitant 
flow into the LA can have a major impact on procedural outcomes. A recent study by Neuss 
and colleagues (424) found that MS after MitraClip has a negative impact on long-term 
clinical outcomes. A cutoff value was found at 5 mmHg for invasively and 4.4 mmHg for 
echocardiographically measured MDPG. Based on this threshold value, implantation of a 
central clip, with or without ring, caused MS in our patient model. In clinical studies, the 
frequency of MS at discharge has been reported to occur in approximately 25 - 35% of 
patients (424, 425). Overall, accurate quantification of the MDPG seems critical to 
optimize MitraClip procedural outcomes, as the goal is to find an acceptable compromise 
between residual MR and transmitral gradient. 
As previously explained, TEE echocardiography and color Doppler are the tools 
available to assess both residual MR and MDPG. In clinical practice, the pressure drop 
across the MV during MitraClip is usually calculated using the simplified Bernoulli 
equation and the maximum velocity measured by TEE or Doppler-derived 
echocardiography (426, 427). An in vitro study (428) that investigated the effect of 
MitraClip on the MDPG found a good agreement between the MDPG measured with 
Doppler echocardiography and invasively (peak: 9 vs. 7 mmHg, mean: 4 vs 3 mmHg). This 
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study, however, also found that alignment of the Doppler probe is essential to limit 
measurement errors. At the peak of the E-wave, the jet velocity was approximately three 
times higher than the central line velocity, while at the peak of the A-wave, the jet velocity 
was about six times higher. Maisano et al. (429) also showed that an error up to 35% could 
be obtained in the estimation of the MDPG depending on the location of the velocity 
measurement. Thus, Doppler measurements are operator dependent and strongly 
influenced by LV function, LA compliance, and loading conditions (430). In addition, 
some Doppler echocardiographic methods have not been adequately validated in a double-
orifice MV (431). Under these limitations, evaluation of directly measured hemodynamic 
parameters pre- and post-clip should be included to support decision making. In our study, 
all hemodynamic LH variables, including the MDPG and residual MR were accurately 
calculated using the velocity and pressure fields obtained by the simulation algorithms. 
10.4.4.3 Impact on intraventricular hemodynamics 
A few research attempts have been conducted to study the impact of MitraClip on LV fluid 
dynamics (432, 433). Using an in vitro model, Jeyhani et al. (428) showed that vortex 
development in the LV during diastole was significantly different after MV repair. 
MitraClip significantly increased the amplitude of the Reynolds and viscous shear stresses, 
as well as the number of high shear regions in the LV. By means of CFD simulations of 
different suture lengths and positions, Hu and colleagues (434, 435) demonstrated that 
while clipping at a commissural location maintained the single vortex structure observed 
in a normal LV, central and lateral clipping created two jets and vortex rings entering the 
ventricular cavity in the diastolic phase. Each jet was deflected laterally and impinged on 
the septal and lateral LV walls. Highest energy loss was found in the impingement regions, 
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whereas energy losses in the vortices were generally low. Another important takeaway was 
that decreasing the total orifice area enhanced this energy loss. 
The results of our study detected potentially harmful changes in LV flow dynamics. 
Two jets downstream of the MV were formed when the clip was implanted at the central 
and lateral positions. The inflow velocity, PDPG, MDPG, and jet deflection angle all 
increased in the central + ring model, compared to the central model. Lateral clipping 
demonstrated a LV flow field closest to that of the pre-clip MV. The peak velocities across 
the MV were strongly affected by the total cross-sectional area of the orifices. From Figure 
69 it is clear that the jets impinged the LV wall as they were deviated laterally due to the 
reduction in the MV orifice area. This deflection can compromise the fluid mechanics such 
as rapid dissipation of the large LV anterior vortex (434). Subsequently, the blood ejection 
from the LVOT may be affected by increasing the LV inflow energy dissipation in diastole 
and recycling in systole. Although previous computational and in vitro studies provided 
initial insights on the LV flow after MitraClip, the LV-MV complex used was a simplified 
model without the inclusion of realistic LV geometry and leaflet configurations. It is 
uncertain how these assumptions would influence the vortex dynamics and jet deflection. 
An improved understanding of the LH-device hemodynamics using FSI models that are 
more accurate may help to optimize MitraClip placement. We are currently working on 
performing a quantitative analysis of the pre- and post-clip intraventricular blood flow 
dynamics and energetic parameters that have been associated with maladaptive changes 
and LV reshaping (436, 437). 
10.4.5 From color to quantitative hemodynamic assessment  
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In daily MitraClip routine, the interventional team has to face several difficult situations or 
“gray zones” from a decisional standpoint. Many questions commonly present. What 
should be done in the case of a residual MR? In case of a second or third clip implantation, 
would the adjunctive benefit of more MR reduction be nullified by the incremental increase 
of the MDPG? What should be done in the case of MR reduction, but a significant increase 
in transmitral gradient? The answers to these questions are not always clear, suggesting 
that procedural assessment should be performed in a more integrated way, taking into 
account both conventional methods (color jet and echocardiographic gradient) and 
continuous real-time hemodynamic measurements. 
Indeed, intraprocedural assessment of LA pressure has been described as a helpful 
tool during MitraClip (438, 439). Ikenaga et al. (440) showed that changes in pulmonary 
vein flow following MitraClip can predict recurrent MR, and have an important and 
independent association with long-term outcomes. Kuwata et al. (392) also demonstrated 
the value of real-time monitoring of LA pressure during MitraClip to predict clinical 
outcomes. An increase in LA mean pressure was predictive of worse clinical outcomes at 
short-term follow-up, independent from echocardiographic findings. As intraprocedural 
decisions have a strong impact on procedural outcomes, long-term results and prognosis, 
the clinical message from these studies is extremely relevant for the interventional 
community: evaluation of MitraClip should shift from a solely echocardiography-based 
color Doppler assessment to a more integrated hemodynamic-based approach. 
To the best of our knowledge, this is the first patient-specific FSI study to directly 
quantify the changes in LH hemodynamics and tissue mechanics pre- and post-clip under 
different MitraClip configurations throughout the cardiac cycle in a virtual human beating-
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heart. FSI modeling tools, as used in this study, are required to quantify the regurgitant 
flow across the MV, accurately simulate full dynamic/transient valve dynamics (3, 155), 
and shift the conventional MitraClip paradigm from a solely anatomic approach, towards 
a more functional and physiological approach based on objective hemodynamic data. Much 
needed clinically relevant flow indicators may be obtained by applying the modeling 
approach herein proposed to the analysis of MitraClip procedure, as well as to gain insight 
into the different clinical scenarios that are currently critical for this minimally-invasive 
procedure. The same concept should could applied to other structural MV interventions, 
including MV replacement.  
10.5 Limitations 
The present study has several limitations. The main one is its small sample size. This study 
only used one previously validated patient-specific functional MR model. A large cohort 
of patient-specific models would be necessary to draw conclusions with confidence. 
Second, simulations results were not validated against post-procedural clinical data, since 
the patient studied herein did not undergo MitraClip therapy. Nevertheless, this study 
allowed for a systematic investigation of various biomechanical scenarios resulting from 
the MitraClip procedure. Such well-controlled side-by-side comparisons under the same 
patient and loading conditions are challenging to obtain in a clinical setting. Third, although 
cardiac tissue properties were age- and gender-matched, they were not patient-specific. 
Estimation of in vivo material parameters inversely from medical images would be ideal 
to produce more accurate predictive results. Fourth, only one clip placement was simulated 
in order to avoid significant MS. Implantation of additional clips is clinically common, as 
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residual MR after MitraClip is associated with higher mortality than that for patients 




CHAPTER 11. SUMMARY 
Specific Aim 1a – Part 1 investigated the capability of SPH, a fully Lagrangian mesh-free 
method, to simulate the bulk blood flow dynamics in two realistic LV models. 3D 
geometries and wall motion of the LV, proximal LA and aortic root were extracted from 
Cine-MR and MSCT imaging data. SPH simulation results were analyzed and compared 
with those obtained using a traditional CFD numerical method, and to in vivo 4D PCMR 
and echocardiography data, in terms of the large-scale blood flow phenomena usually 
clinically measured. A quantitative comparison of the velocity field and global flow 
parameters between the in silico models and the in vivo data showed a reasonable 
agreement, given the inherent uncertainties and limitations in the modeling and imaging 
techniques. The results of this study indicated the capability of SPH as a promising 
computational tool for predicting clinically relevant large-scale LV flow information, and 
serve as the cornerstone for the development of the SPH-FE FSI modeling framework. 
Specific Aim 1a – Part 2 presented a fully-coupled FSI framework that combined 
SPH and nonlinear FE method to investigate the coupled AV and MV structural response 
and the bulk LV hemodynamics in a subject-specific LH model during the entire cardiac 
cycle. The FSI model incorporated valve structures that considered native asymmetric 
leaflet geometries, nonlinear elastic material models, and human material properties. 
Comparison of FSI results with subject-specific echocardiography data demonstrated that 
the SPH-FE approach was able to quantitatively predict the opening and closing times of 
the valves, the MV leaflet opening and closing angles, and the large-scale intraventricular 
flow phenomena with reasonable agreement. Moreover, comparison of FSI results with a 
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LV model without valves revealed substantial differences in the flow field. Peak systolic 
velocities obtained from the LV-valve model and the LV model without valves were 2.56 
m/s and 1.16 m/s, respectively, compared to the Doppler echo data of 2.17 m/s. The 
developed SPH-FE FSI framework represents a further step towards modeling patient-
specific coupled LH dynamics, and has the potential to improve our understanding of 
cardiovascular physiology. Moreover, successful completion of Specific Aim 1a serves as 
a basis for the investigation of pathological and post-procedural LH dynamics in Specific 
Aim 1b and Specific Aim 2, respectively. 
MV dynamics depends on a force balance across the mitral leaflets, the chordae 
tendineae, the mitral annulus, the papillary muscles and the adjacent LV wall. Chordae 
rupture disrupts the link between the MV and the LV, causing primary MR. In Specific 
Aim 1b – Part 1, a FSI modeling framework was implemented to investigate the impact of 
chordae rupture on the LH dynamics and severity of MR. A control and seven chordae 
rupture LH models were developed to simulate a pathological process in which minimal 
chordae rupture precedes more extensive chordae rupture. Different non-eccentric and 
eccentric regurgitant jets were identified during systole. Cardiac efficiency was evaluated 
by the ratio of external stroke work. MV structural results showed that basal/strut chordae 
were the major load-bearing chordae. An increased number of ruptured chordae resulted in 
reduced basal/strut tension, but increased marginal/intermediate load. Chordae rupture in 
a specific scallop did not necessarily involve an increase in the stress of the entire prolapsed 
leaflet.  
Functional MR is a significant complication of LV dysfunction and strongly 
associated with a poor prognosis. In Specific Aim 1b – Part 2, a patient-specific LH FSI 
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model with functional MR was developed. The model included detailed chordae tendineae 
structure and distribution, accurate leaflet geometry and thickness, dynamic MA and 
chordae origins, tethering pre-tension forces, nonlinear elastic material models, and human 
age- and gender-matched material properties. The MV structural model was validated by 
comparing the simulation results from valve closure simulation with the in vivo geometry 
at systole. It was found that the MV model could not replicate the in vivo geometry without 
the application of tethering pre-tension force in the chordae at diastole. Upon applying the 
pre-tension force and performing model optimization by adjusting the chordae length, 
position, and leaflet length, a good agreement between the computational model and the in 
vivo model was established. Additionally, the accuracy and predictability of the FSI 
framework were validated with echocardiography hemodynamic data. This work 
represents a further step towards patient-specific modeling of pathological LH dynamics, 
and has the potential to improve our understanding of the biomechanical mechanisms and 
treatment of primary and functional MR. 
Transapical beating heart neochordae implantation is an innovative MV repair 
technique that has demonstrated promising clinical results in patients with primary MR. 
However, as clinical experience continues to increase, neochordae implantation criteria 
have not been fully standardized. Quantifying the complex biomechanical interaction and 
interdependence between the LH structures and the neochordae during this procedure is 
needed. Specific Aim 2a investigated the effect of i) selecting an antero-lateral ventricular 
access site; compared to a postero-lateral one, and ii) suboptimal neochordae length; 
compared to optimal suture length, on restoring baseline LH dynamics. Neochordae 
implantation using three and four sutures was simulated under three clinically relevant 
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PML prolapse conditions: isolated P2, multi-scallop P2/P3 and multi-scallop P2/P1. 
Baseline, pre- and post-repair LH dynamics were evaluated using a FSI modeling 
framework. Despite the absence of residual MR in all post-repair models with optimal 
neochordae length, the average and peak stresses in the repaired scallop(s) increased >40% 
and >100%, respectively, compared with the baseline state. Additionally, PML native 
chordae tension decreased at least 30%, while AML marginal chordae tension increased 
>30%.  
Selecting an antero-lateral ventricular entry site for the treatment of P2/P3 prolapse 
generated a significant increase (>80%) in neochordae tension and central scallop peak 
stress, with respect to a postero-lateral access site. Neochordae length tuning is critical. 
During isolated P2 prolapse repair, although over-tension of the neochordae led to minimal 
hemodynamic changes in the regurgitant volume; compared to using an optimal suture 
length, a significant increase in peak systolic neochordae tension (>300%), diastolic 
neochordae tension, and mitral leaflet average stress (40% - 460%) was quantified. 
Additionally, neochordae under-tension led to regurgitation severity worsening; giving a 
similar regurgitant volume as the pre-repair model. We report, to our knowledge, the first 
set of time-dependent in silico human neochordae tension measurements during transpical 
neochordae repair. This parametric FSI study represents a further step towards an improved 
understanding of the biomechanical outcomes of transapical neochordae techniques. 
The AV and MV function in a reciprocal interdependent fashion. However, the 
impact of TAVR on the aortic-mitral continuity and early post-procedural MR severity are 
poorly understood. Using a comprehensive computational engineering FSI framework, 
Specific Aim 2b evaluated the structural and hemodynamic impact of TAVR on aortic-
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mitral continuity and MR severity in a rigorously developed and validated patient-specific 
LH model with AS and concomitant functional MR. The TAVR procedure was virtually 
simulated using BEV and SEV devices at three implantation heights. Pre- and post-TAVR 
LH dynamics as well as intra-operative biomechanics were analyzed. The accuracy and 
predictability of the modeling framework were validated with pre- and post-operative echo 
data.  
No significant differences in early MR improvement/worsening (<10%) were noted 
at the three implantation depths when compared to the pre-TAVR state. The highest 
deployment BEV model resulted in higher stresses in the native leaflets, contact radial 
force and stent recoil, while the midway implantation BEV model gave better 
hemodynamic performance and MR reduction in this patient case. The high deployment 
SEV model resulted in a higher stress in the native aortic leaflets, lower stent-tissue contact 
force, and higher MR reduction for this patient case. When comparing SEV vs. BEV 
performance at an optimal implantation height, the SEV model gave a higher regurgitant 
volume  than the pre-TAVR model (40.49 vs 37.59 ml), while the BEV model gave the 
lowest regurgitant volume (33.84 vs 37.59 ml). Acute improvement in MR was i) due to 
the mechanical compression of the stent against the aortic-mitral curtain, ii) due to an 
immediate drop in the LV pressure and transmitral pressure gradient. Contact force, aortic-
mitral angle, and valve annuli compression were identified as possible mechanistic 
parameters that may suggest avenues for early MR improvement. Albeit a single real 
clinical case, it is our hope that such detailed engineering computational analysis could 
shed light into the underlying biomechanical mechanisms of TAVR impact on MR. 
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Percutaneous edge-to-edge repair of MR sing the MitraClip has been established as 
an option for high-risk and inoperable patients with degenerative MR, as well as for 
patients with functional MR who failed medical therapy. MitraClip was recently approved 
in the US for treatment of functional MR, which significantly expands the number of 
patients that can be treated with this device. Specific Aim 2c quantified the morphologic 
changes and evaluated the biomechanical interaction between the MitraClip device and the 
LH complex of a real patient case with functional MR using FSI modeling. MitraClip 
implantation using a central and a lateral clip, as well as combined annuloplasty procedure 
were simulated in a patient-specific model that integrated detailed geometries of the LH 
structures, incorporated age- and gender-matched nonlinear elastic human material 
properties, and accounted for chordae tethering forces. AP distance, ASI, anatomic 
regurgitant orifice area, and anatomic opening orifice area decreased by up to 26%, 36%, 
33% and 63% when compared to the pre-clip model, respectively. MitraClip implantation 
immediately improved the hemodynamic profile and promoted LV unloading, but imposed 
a non-physiologic configuration and loading on the mitral apparatus, with anterior and 
posterior leaflet stress significantly increasing up to 122% and 80% during diastole, 
respectively. For this patient case, while implanting a central clip + ring resulted in the 
highest improvement in LV systolic function and magnitude of reduction in the regurgitant 
flow (46%), this clip configuration also led to the highest degree of mitral stenosis. FSI 
modeling as used here can be a powerful tool to examine the complex MitraClip-host 




CHAPTER 12. CONCLUSIONS AND FUTURE WORK 
12.1 Specific Aim 1 
12.1.1 Conclusions 
12.1.1.1 Specific Aim 1a 
In Specific Aim 1a, the first subject-specific LH FSI model that includes detailed valve 
structures, cardiac wall deformation, nonlinear elastic material models, human cardiac 
tissue material properties, and pulsatile hemodynamic loads throughout the cardiac cycle 
was developed. A detailed quantitative comparison of FSI results with those of subject-
specific in vivo measurements, clinical observations and in vivo and in vitro studies has 
been presented. Despite some modeling simplifications and limitations, FSI results were in 
reasonable quantitative agreement. This study demonstrated the ability of the SPH-FE FSI 
framework to model the physiologic valves structural response and the bulk 
intraventricular hemodynamics in a subject-specific LH model during the entire cardiac 
cycle. The development of a FSI framework which is capable of reproducing the coupled 
LH dynamics in an accurate and practical way not only enhances our basic understanding 
of the functional morphology of these structures, but is also needed to obtain clinically 
relevant results, and to better understand the implications of a broad spectrum of valve 
repair and intervention replacement procedures. 
12.1.1.2 Specific Aim 1b 
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Specific Aim 1b – Part 1 investigated the impact of PML chordae rupture on LH dynamics 
and severity of primary MR. We performed a parametric computational study that 
simultaneously quantified and analyzed chordae forces, PM forces, leaflet stresses, 
intraventricular hemodynamics and cardiac efficiency in the sequential transition from a 
physiological state to severe acute MR through multiple levels of chordae rupture. A 
detailed mechanistic understanding of the mitral apparatus force redistribution and coupled 
fluid and structural LH dynamics can give deeper insight into the pathophysiologic 
developmental mechanisms of MV prolapse due to chordae rupture, allow for evaluation 
and prediction of interventional treatments, and ultimately support improved clinical 
outcomes. 
Specific Aim 1b – Part 2 evaluated the LH dynamics in a rigorously developed and 
validated patient-specific model with BAV, low-flow low-gradient AS, and functional MR. 
This study showed that the incorporation of pre-tension tethering forces improved the 
modeling accuracy of MV dynamic function. A computational method was carried out to 
optimize the chordae length in combination of adjusting the leaflet height to model the 
effect of pre-tension. The results showed that the MV model can closely replicate the in 
vivo valve geometry at systole from MSCT images. Moreover, FSI results showed good 
quantitative agreement when compared to the patient’s available echo data, which 
demonstrates that the SPH-FE FSI modeling framework can accurately simulate the 
patient-specific LH pathological dynamics under severe AS and concomitant functional 
MR. Overall, Specific Aim 1b provided a comprehensive investigation of the LH dynamics 
under various MR conditions, BAV, and AS, which enabled by the FSI framewrokd is not 
only expected to unfold new perspectives for the understanding of cardiac physiology in 
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the setting of heart valve pathology, but can offer potential for patient-specific clinical 
diagnostic and prognostic information. 
12.1.2 Future work 
Though the subject- and patient-specific LH models developed in Specific Aim 1 are the 
first of their kind, there is still room for improvement. For example, cardiac wall motion 
was prescribed based on in vivo medical imaging data. The use of this one-way FSI 
coupling method is based on the assumption that the flow-induced load on the cardiac wall 
is minor in comparison to the structural-induced load on the fluid flow (231). The biggest 
advancement to our SPH-FE FSI modeling framework would be the inclusion of the 
mechanical deformation of the myocardium. Cardiac function involves a considerable 
range of spatial scales and different tightly coupled multi‐physics problems. In the muscle, 
the electrical stimuli propagates through the myocytes causing the cardiac muscle 
contraction, which in turn exerts work upon the blood inside the atria and ventricles. 
Therefore, from the computational mechanics standpoint, the heartbeat is a tightly coupled 
fluid‐electro‐mechanical problem. The final objective is to model the pumping action of a 
heart. Nevertheless, despite the extensive work done in experimental and computational 
research of multi‐physics heart modeling (441), up to now, there is no reference of a 
coupled scheme that includes electrophysiology, solid, and fluid mechanics of the whole 
human heart. 
The use of human age- and gender-matched cardiac tissue properties is a substantial 
improvement over animal tissue properties. Nevertheless, there are limitations of using 
tissue properties from human cadaveric hearts. First of all, ex vivo tissue properties are not 
 258 
patient-specific. Rather, tissue properties are selected from a cadaveric heart with similar 
characteristics to the patient of interest. This requires a thorough testing database of human 
tissue properties from an array of patients with differing ages, genders, and degrees of 
disease because all these factors can significantly impact the tissue response. The ultimate 
goal would be to obtain patient-specific tissue properties inversely from medical images 
using the inverse FE method (442, 443), a multi-resolution direct search approach (444), 
or machine learning algorithms (445). However, such approaches have not been applied to 
heart valve tissues. Accurate identification of in vivo nonlinear, anisotropic mechanical 
properties of cardiac tissues of individual patients has long been regarded as one of the 
critical challenges in the field of cardiovascular biomechanics. Along the same lines, 
mechanical properties of heart valve tissues are known to be dependent on a variety of 
factors such as degree of calcification, aging, and disease conditions. Thus, future studies 
could investigate how different pathophysiological conditions affect the opening/closing 
speed and shape of the valves, and how the dynamics of the valve in turn affects the LV 
hemodynamics. 
Although in this study we focused on the left side of the heart, the developed FSI 
computational modeling framework can be easily adapted for simulation of right heart 
dynamics, including the tricuspid and pulmonary valves, and for the modeling of different 
valve repair/replacement procedures. The capability of SPH for cardiac modeling where 
complex geometries and large deformations are present should be taken advantage of. This 
research is advancing the capability for large-scale computational modeling of cardiac 
dynamics. In the long term, patient-specific cardiac computational models may be 
developed based on this research, and could be used as a valuable pre- and intra-operative 
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planning tool.  Furthermore, the data from this research may be used to develop low-order 
flow models that can serve as a complementary tool for multiple purposes such as BHV 
design and optimization, and multiscale modeling of the cardiovascular system.  
12.2 Specific Aim 2 
12.2.1 Conclusions 
12.2.1.1 Specific Aim 2a 
In Specific Aim 2a, we quantified the complex biomechanical interaction between the 
neochordae and the LH structures under various PML prolapse scenarios, neochordae 
number, LV access sites and neochordae lengths using an integrative FSI computational 
framework. Despite MR reduction and restoration of leaflet coaptation in all post-repair 
LH models, transapical neochordae implantation altered the mitral apparatus 
biomechanical environment compared with a baseline state. We report original quantitative 
biomechanical data regarding leaflet stress magnitude and distribution, cardiac 
hemodynamics, and native and neochordae forces throughout the cardiac cycle during 
baseline, pre- and post-repair states under a broad spectrum of prolapse scenarios and 
neochordae implantation configurations. Direct comparison of the LV-valve 
biomechanical environment between baseline and post-repair states is imperative to 
evaluate the role of transapical neochordae technologies in restoring physiologic-like 
cardiac dynamics and demonstrate non-inferiority to conventional surgical MV repair 
procedures. While we are approaching the limits of existing in vitro, animal and clinical 
models to quantify the time-dependent force exchange between the LV-valve structures 
and minimally-invasive repair devices, the development of innovative and more powerful 
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tools, such as the FSI computer simulations presented in this work, may eventually help to 
determine the mid- to long-term biomechanical outcomes of transapical neochordae 
procedures.  
12.2.1.2 Specific Aim 2b 
MR is commonly found in conjunction with severe AS, but concomitant significant MR in 
the setting of TAVR is typically left untreated. In this era of transcatheter interventions 
advances, prediction of MR magnitude and direction following TAVR is critical but 
remains difficult in individual patients. With these challenges in mind, in Specific Aim 2b, 
we performed a comprehensive computational engineering analysis to investigate the 
impact of TAVR on MR severity, aortic-mitral coupling, TAVR-in-BAV device 
performance, and pre- and post-TAVR LH dynamics in a retrospective real clinical case.  
No significant changes in MR severity were identified following TAVR with 
different TAV types and implantation heights. Our results demonstrated that the 
biomechanical mechanism of MR evolution after TAVR is clearly multifactorial. The 
structural coupling of the AV-MV is a relationship that undergoes measurable changes 
following TAVR as the stent compresses the aortic-mitral continuity. Moreover, we 
showed that correcting the AS abruptly reduces LV systolic pressure, which results in a 
lower transmitral systolic pressure gradient, which in turn reduces the pathological 
retrograde flow through the MV. Mechanistic intra-procedural predictors that may suggest 
early avenues of MR improvement were identified.   
Although this work is limited by its small sample size and is not designed to 
specifically answer questions about the late post-procedural period, it does report a novel 
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and promising approach for elucidating the biomechanical mechanisms through which 
TAVR can influence early MR severity. Further development and validation of the 
computational modeling techniques in a large cohort of patients could eventually enable 
the use of such techniques for an individualized treatment approach and ultimately support 
improved clinical outcomes. 
12.2.1.3 Specific Aim 2c 
Feasibility and safety of MitraClip has been largely described in a variety of studies and 
case-reports. Results concerning efficacy and durability, however, are not entirely 
satisfactory. Additionally, results tend to be less impressive immediately after the 
procedure compared to surgical MV repair. In this era of booming technology, the 
collaboration between industry and academia is of utmost importance in order to bring 
further advancements in the field of percutaneous treatment of MV disease. In Specific 
Aim 2c, the acute LH hemodynamic and structural changes during and after MitraClip 
therapy were evaluated. Although this patient-specific FSI study provided further evidence 
to support that MitraClip is a viable approach to treat functional MR by improving LV 
systolic function and promoting LV unloading, clip implantation also imposed a non-
physiologic configuration and loading on the LV-valve complex, especially during 
diastole. FSI modeling as used here can be a powerful and versatile tool that can pinpoint 
specific biomechanical implications and potentially play an important role in elucidating 
the optimal setting and efficacy of percutaneous MV repair procedures. 
12.2.2 Future work 
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The insights derived from the data presented in Specific Aim 2 have important clinical 
implications; however, those insights should be supported by a few other studies. Firstly, 
in this study, the deformed LH geometries after neochordae, MitraClip, annuloplasty and 
TAVR procedures obtained using FE analysis were used as the initial stress-free 
geometries for the post-procedural FSI simulations, thus the induced stress state from the 
repair/replacement procedures was neglected. Additional studies should investigate if this 
assumption is valid in such complex simulations, or integrate the FE and FSI models in a 
single simulation file. However, as all of the measurements and analyses in this work are 
the first of their kind, such exploration is beyond the scope of this thesis. 
Secondly, the cardiac geometries obtained from the in vivo MSCT images for the 
development of the subject- and patient-specific LH models were assumed to be in their 
stress-free state. However, cardiac structures are continuously under a loaded and 
pressurized state. Several computational methods have been proposed to compute the load-
free configuration and the pre-stress of different structures of the cardiovascular system, 
especially large arteries. These include manual trial-and-error techniques, as well as 
automatic inverse techniques such as solving the inverse elastostatics problem, and shape 
matching techniques. In order to obtain realistic patient-specific tissue compliance and 
hemodynamics, the LH pre-stress needs to be accounted for in the computational 
formulation using the load-free state of the cardiac structures. Our lab recently 
demonstrated the feasibility and potential of using machine learning techniques as a fast 
surrogate of FE‐based inverse methods to recover the zero‐pressure geometry of the human 
thoracic aorta (373). Future studies should investigate the capabilities of this method to 
compute the stress-free geometry of the remaining LH structures. These two additions 
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would not only make the FSI modeling framework more physiologically accurate but 
would also open up the possibility of tackling more clinical issues in cardiac physiology. 
In recent years, there has been immense interest in the evaluation of blood flow 
dynamics in cardiac function analysis for their ability to provide independent and 
prognostic information over conventional measures (446-448). The LH hemodynamics 
computed in the current study were from clinically relevant large‐scale intraventricular 
flow features present in the heart. As recent studies have shown that some parameters 
derived from this intraventricular flow field can be associated with changes in LV 
dimensions and function in different clinical conditions (436, 437, 449), futures studies 
should aim to quantify these intraventricular vortex and flow energetic indices from our 
FSI models. The occurrence of maladaptive changes after transcatheter valve 
repair/replacement procedures may stimulate further research in the field with the aim to 
identify intraventricular flow patterns associated with LV reshaping and positive/negative 
clinical outcomes. 
Finally, Specific Aim 2 outlined a number of biomechanical implications resulting 
from repairing the MV under degenerative and functional MR, and from replacing the AV 
under low-flow low-gradient stenosis, and BAV. Numerous additional future studies 
should follow to enhance, further, and/or complement the present work. For example, a 
larger parameter sweep could be performed which also includes other valvular diseases, 
stages of the disease (e.g. LV remodeling), hemodynamic conditions (e.g. heart rate, blood 
pressure), tissue properties, cardiac anatomy variability, next-generation catheter-based 
devices, etc. This study represents an effort to bring personalized medicine closer to reality. 
The tools developed in this study may one day be used for the prediction of device 
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performance and complications through patient screening, optimal device placement, 
rational device selection, and improved device design. This advance would help medical 
device companies by providing better devices that can be developed more quickly and with 
fewer physical design cycles. Most importantly though, personalized medicine will benefit 
the patients, providing reduced complication rates through better patient screening, patient-
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APPENDIX A. BIOMECHANICAL CHARACTERIZATION OF 
CHEMICALLY-TREATED FETAL, CALF AND ADULT BOVINE 
PERICARDIUM 
A.1  Introduction 
Biosprosthetic heart valves (BHV) designed to be implanted surgically or percutaneously 
are commonly made from bovine pericardium (BP), porcine pericardium or porcine aortic 
valve tissue (450). Due to adequate biological and mechanical properties, wide availability, 
and rigorous quality control related to intensive battery farming, adult BP (ABP) or calf 
BP (CPB) are considered as biomaterials of choice to manufacture BHV (451). The 
pericardial sac is a fibrous meshwork with varying degrees of collagen orientation and 
constituent components throughout the sac (452), and thus is considered to be mechanically 
anisotropic (453). Several studies have analyzed and compared the fiber architecture, 
mechanical properties and morphology of fresh and chemically treated BP, with and 
without the application of stress or strain constraints during tissue fixation (454-457). A 
function-structure relationship between collagen alignment and the mechanical behavior 
of the BP has been identified, where collagen fiber orientation and fiber diameter play a 
paramount role in the overall tissue behavior (454, 458).  
It is also known that the mechanical properties of collagenous tissues change with 
growth, maturation and aging (459). For example, it has been shown that tendon elastic 
modulus and ultimate stress increase with maturity (460) (461-463). Nonetheless, 
knowledge regarding the age-related changes in the mechanical properties of BP xenografts 
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is highly limited. A recent study by Sizeland et al. (2014) (464) found significant 
differences in the tissue tensile response between glutaraldehyde-treated (GL-treated) ABP 
and neonatal BP. The markedly thinner neonatal tissue showed a higher elastic modulus 
and a higher ultimate tensile strength (UTS) than ABP. While yielding important 
quantitative information, uniaxial mechanical testing is non-physiologic for soft tissues as 
the coupling of the tissue’s directional response is ignored. Additionally, it is still not clear 
whether the effect of maturation and aging on the mechanical behavior of the BP is 
orientation-dependent. Clearly, multi-protocol biaxial mechanical data are necessary for 
the complete mechanical characterization of the BP. 
The strength and thickness of leaflet tissues are of crucial importance for the 
required lifetime of the biomaterial, but also for valve delivery in applications such as 
percutaneous BHV replacement. The first generation of transcatheter aortic valves required 
the use of 18-Fr, 22-Fr, and 24-Fr delivery sheaths. This translates into minimal vessel 
diameters of 6 mm, 7 mm, and 8 mm in noncalcified arteries (465). The new generation of 
transcatheter aortic valves further reduces the device profile, allowing for delivery sheaths 
as small as 14 Fr (466). In the rapidly growing field of minimally-invasive heart valve 
replacement, it is clear that the industry is trending towards lower-profile devices that 
minimize incisions and simplify advancement of the catheter through small and/or tortuous 
arteries. However, the size of the delivery catheter system is limited by the minimum 
crimped diameter of the valve, which is in turn determined by the crimping profile of the 
stent, but mainly by the thickness of the BP tissue. 
Younger BP has been shown to be thinner than CBP and ABP (464), giving it a 
potential physical advantage for percutaneous BHV production. However, a detailed 
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understanding of the age-dependent anisotropic mechanical properties of the BP remains 
unknown. Therefore, the objective of the present study was to investigate and compare the 
mechanical response of chemically treated ABP, CBP and fetal BP (FBP) through 
comprehensive mechanical testing and structural analysis. An improved understanding and 
utilization of the BP mechanical properties may ultimately result in BHV designs with 
more predictable performance and improved durability, as well as enable percutaneous 
valve technologies to develop the minimal profile size required to improve the 
advancement of the catheter through small and/or tortuous arteries and reduce adverse 
events. 
A.2 Materials and Methods 
A.2.1 Tissue preparation 
Fresh pericardial sacs were obtained from 10 adult (12-24 months old), 11 calf (6-12 
months old) and 11 fetal (third trimester of gestation) cattle from Animal Technologies, 
Inc. (Tyler, TX). The fresh pericardia were stored in cryopreservant solution (10% 
dimethyl sulfoxide and 90% culture medium RPMI 1640) at −80 °C until fixation could be 
performed. Cryopreservation has been shown to retain the native tissue`s structural 
integrity and mechanical properties (467) (468). Prior to testing, the pericardia were thawed 
via the published protocol (467) and cut into flat sheets. Regions of the pericardial sacs 
with defects such as cuts or tears and those in which the pericardial ligaments could not be 
clearly distinguished were excluded.  
The tissue was pinned slightly around the edges to hold flat, and any adherent 
adipose tissue and loose surface fibers were carefully removed prior to treatment. Care was 
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taken with the handling of the pericardium to not stretch the material to avoid changes in 
fibril alignment (453). Tissue treatment and fixation were performed in two steps at room 
temperature. First, the flat pericardium was immersed in a container of 0.625% 
glutaraldehyde and placed on an orbital shaker at 100 rpm for 2 hours. In the second step, 
the tissue was treated with a crosslinking anti-calcification solution composed of 
formaldehyde, ethanol, and Tween 80 (Sigma Aldrich, St. Louis, MO), and placed on an 
orbital shaker at 100 rpm for 18 hours. Treated pericardium was then stored at 4°C in 0.25% 
glutaraldehyde for a minimum of 48 hours prior to testing.  
Selection of testing samples was based on the orientation of macroscopically visible 
collagen fibers, uniform thickness and local homogeneity. First, visual inspection of the 
pericardium sheets under a light source was used to identify a potential local preferred fiber 
direction. Biaxial testing samples were cut into a 20 mm x 20 mm square such that the 
preferred fiber direction and the cross-preferred fiber direction aligned with the X1 and X2 
directions of the device’s loading axes, respectively (Figure 73A). Second, if after biaxial 
testing an isotropic response was obtained from the sample, mechanical alignment 
consisting of sample rotation was performed until an anisotropic response was acquired.  
Uniaxial testing samples adjacent to the biaxial samples were carefully cut into a 
“dog-bone” shape using a stencil with a central zone 30 mm long x 3 mm wide to ensure 
failure in the center region and to minimize grip effects. Each sample was cut in such a 
way as to insure that the preferred fiber direction was parallel with the loading axis of the 
tensile device. Sample thickness was measured and averaged in five different places with 
a Mitutoyo 7301 rotating thickness gage (Aurora, IL) with an accuracy of ± 0.01 mm. 
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A.2.2 Planar biaxial mechanical testing 
Planar biaxial testing was conducted following the methods detailed in Sacks and Sun 
(2003) (469). Briefly, four graphite markers delimiting a square approximately 2 mm x 2 
mm in size were glued to the central region of the tissue surface for optical strain 
measurements. Specimens were immersed in saline solution for at least 30 minutes prior 
to testing to allow for tissue hydration. Samples were then mounted in a trampoline fashion 
and tested in aqueous 0.9% NaCl solution at 37 °C. A stress-controlled test protocol was 
utilized (469), wherein the ratio of the normal Lagrangian stress components T11:T22 was 
kept constant with T12 = T21 = 0. Preconditioning of up to 40 cycles, with a rest period of 
25 s between each set of 10 consecutive cycles was performed to reduce tissue hysteresis 
and achieve a stable tissue response. Seven successive protocols were performed using the 
ratios T11:T12 = 1:0.75, 1:0.5, 1:0.3, 1:1, 0.75:1, 0.5:1, 0.3:1 with 10 cycles per run. Tissue 
samples were assumed to be incompressible and planar, and the unloaded reference 
markers were obtained using the post-preconditioning state. 
Stiffness and extensibility in both the preferred fiber direction (X1) and cross-
preferred fiber direction (X2) were computed from the equibiaxial stress-strain curves as 
material metrics. Tissue stiffness was quantified by means of the secant modulus at three 
equibiaxial stress values: 1) 60 kPa for tissue response under small load, 2) 250 kPa to 
examine tissue response at a physiological level (455), and 3) 500 kPa for a high stress 
state, representing areas of the valve that may experience greater stress (i.e. attachment to 
stent, commissure regions). Linear regression was used to calculate the extensibility in the 
high-modulus linear region (Figure 73B). In addition, the degree of anisotropy (DA) was 
analyzed using the ratio of Green strains, E11 / E22 , at maximum equibiaxial loading. 
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Figure 73. A) Orientation of BP biaxial samples, B) Representative equibiaxial 
stress-strain curve and calculated parameters. EXT: Extensibility, SC60: Secant 
modulus at 60 kPa, SC250: Secant modulus at 250 kPa, and SC500: Secant modulus 
at 500 kPa, for both X1 and X2 directions. 
 
A.2.3 Uniaxial mechanical testing 
Testing was conducted using a TestResources 100Q Universal Testing Machine 
(Shakopee, MN). Four graphite optical markers were placed on the narrow portion of the 
samples for optical strain measurements. The axial force was measured by means of a 500 
lbf load cell (TestResources SM-500-294). The specimens were mechanically fixed to 
specially-designed anti-slip clamps, and special care was taken to avoid damage during 
clamping while avoiding slippage from the grips. The specimens were immersed in saline 
solution for at least 1 hour before testing and continuously hydrated after mounting to allow 
for optimal tissue hydration during testing. 
All specimens were mechanically preconditioned by means of a series of 10 
loading–unloading cycles estimated to 30% of the maximum load prior to testing (data not 
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shown) (470). The samples were then loaded at a rate of 50 mm/min until failure. A CCD 
camera was used to capture optical marker motion, while an in-house LabVIEW (National 
Instruments, Austin, TX, USA) program was used to simultaneously correlate the markers’ 
location and load information with each video frame. Stress–strain curves were obtained 
and analyzed using an in-house Matlab code. The UTS and ultimate tensile strain (UTE) 
were determined from the uniaxial data, defined by the peak stress and maximum 
deformation withstood by the samples prior to failure, respectively. Tissue stiffness was 
also quantified by means of the tangent modulus defined as the slope of the stress-strain 
curve in the high-modulus linear region. 
A.2.4 Multiphoton microscopy 
To corroborate the visual findings of the local preferred fiber direction and quantify the 
orientation of the collagen fibers, tested biaxial samples were imaged using second 
harmonic generation (SHG). Tissues were imaged on a Zeiss 710 NLO inverted confocal 
microscope (Carl Zeiss Microscopy, LLC, Thornwood, NY, USA) equipped with a mode-
locked Ti:Sapphire Chameleon Ultra laser (Coherent Inc., Santa Clara, CA) in combination 
with non-descanned detection (NDD). The laser was set to 800 nm and emission was 
filtered from 380–430 nm (471). Samples were kept hydrated with saline solution during 
imaging to prevent drying artifacts and covered with #1.5 coverslips. SHG was collected 
using a Plan-Apochromat 40x oil immersion objective. Zeiss ZEN software was used to 
visualize and export image stacks for analysis. Image resolution was set to 1024 x 1024 
pixels at 12-bit pixel depth. 
A.2.5 Local collagen fiber orientation and distribution 
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Estimation of a local preferred fiber direction for each z-stack was done using a 
semiautomatic ImageJ-Matlab in-house code (The Mathworks, Inc., Natick, MA). First, 
OrientationJ (472), an ImageJ (473) plug-in developed for directional analysis, was used 
to generate a weighted histogram of local angles between ±90° for each optical slice, where 
0° aligned to the X1 biaxial axis and ±90° to the X2 axis (Figure 73A). The local collagen 
fiber orientation was evaluated pixel-by-pixel based on the structure tensor, commonly 
used in image processing (474). Next, the individual histograms at each slice were 
combined and normalized using Matlab to calculate a mean local angular histogram for 
each BP sample. 
A.2.6 Histology 
Ten samples for each age group were selected for quantitative histological analysis after 
biaxial testing. Samples were cut into strips parallel to the X1 direction of the biaxial test 
fixture, fixed in 10% neutral buffered formalin and embedded in paraffin. Sections cut at 
5-µm thickness were stained in picrosirius red solution for one hour (reagents from Sigma 
Aldrich, St. Louis, MO). The slides were then washed in acidified water, three changes of 
100% ethanol, and xylene before being mounted in a resinous medium and coverslipped. 
Picrosirius red staining was used in conjunction with circularly polarized light microscopy 
to assess collagen fiber thickness and organization. Fiber thickness determines the color, 
changing from green to yellow to orange to red with increasing thickness (475). This 
principle can be used to quantify the relative proportion of collagen fiber maturity in the 
tissue. For example, yellow-orange strong birefringence would be assigned to mature thick 
collagen fibers, whereas newly-synthesized thin collagen fibers would display a weak 
birefringence associated with a greenish color (476). 
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The proportion of different colored fibers was assessed using published methods 
(477). Briefly, images from four different locations in each sample were viewed with the 
use of a N-Achroplan 10x objective on an Axio Scope.A1 microscope (Carl Zeiss 
Microscopy, LLC, Thornwood, NY) equipped with filters to provide circularly polarized 
illumination, recorded by a AxioCam MRc Rev.3 digital camera (Carl Zeiss Microscopy, 
LLC, Thornwood, NY) and analyzed using an in-house Matlab code. Images were resolved 
into their hue, saturation and value components. A histogram of hue frequency was 
obtained from the resolved 8-bit hue images, which contained 256 colors, defined as 
follows: red 2 to 9 and 230 to 256, orange 10 to 38, yellow 39 to 51, and green 52 to 128 
(477). The number of pixels within each hue range was determined and expressed as a 
percentage of the total number of collagen pixels, which in turn was expressed as a 
percentage of the total number of pixels in the image analyzed to give collagen content.  
A.2.7 Constitutive modelling 
For this study, two different constitutive models were used to fit the experimental data. BP 
was assumed to be an incompressible, anisotropic, nonlinear, hyperelastic material (478). 
Exponential descriptions in terms of the Green strain have the benefits of being invertible 
and fairly simple to interpret. Thus, the first model utilized was a Fung-type model (479) 




(𝑒𝑄 − 1) 
𝑄 = 𝐴1𝐸11
2 + 𝐴2𝐸22
2 + 2𝐴3𝐸11𝐸22 + 𝐴4𝐸12




where 𝑐 and 𝐴𝑖 are material parameters. Formulations based on polynomials and 
exponentials of strain invariants are also common in the literature and have been 
implemented into many standard FE packages. The second model used was a fiber-
reinforced material model based on the work of Holzapfel et al. (2000) (480)  and Gasser 
et al. (2006) (481), as presented in Specific Aim 1a – Part 2.  
Each constitutive model was fit simultaneously to the mean response of the seven 
stress-controlled protocols for each age group to provide material parameters for the 
computational modeling simulations. The goodness-of-fit was determined by the 
correlation coefficient based on a nonlinear regression model in Matlab. The average 
material parameters obtained from the individual responses of the specimens are not given 
since the parameters (and their averages) are not individually meaningful; only as a set do 
the parameters completely describe the biaxial data. 
A.2.8 Statistical analysis 
All measurements are presented as a mean ± standard deviation. The One Way Analysis of 
Variance (ANOVA) test was implemented in SigmaPlot (V11.0, Systat Software Inc., San 
Jose, CA). If statistical differences were found (P<0.05), pairwise multiple comparisons 
were performed using the Holm–Sidak or the Dunn`s methods. Student’s t-tests were used 
when two groups were compared. Probability values P< 0.001 were considered to indicate 
a high statistically significant difference. 
A.3 Results 
A.3.1 Tissue thickness 
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The mean thickness was 0.451 ± 0.0278 mm for ABP, 0.321 ± 0.0294 mm for CBP, and 
0.231 ± 0.0167 mm for FBP. There was a high statistically significant difference between 
the three age groups (P<0.001), with FBP having approximately half the thickness of ABP 
(Table 34).  
Table 34. Mean and standard deviation values for material metrics calculated from 
the equibiaxial and uniaxial tests.  
 ABP (n=10) CBP (n=11) FBP (n=11) 
Tissue thickness (mm) 0.451 ± 0.0278 0.321 ± 0.0294 
0.231 ± 
0.0167 
Secant modulus X1 – 60 kPa 
(MPa) 
1.903 ± 0.831 1.651 ± 0.790 0.896 ± 0.185 
Secant modulus X1 – 250 kPa 
(MPa) 
3.816 ± 1.199 4.030 ± 1.922 2.650 ± 0.570 
Secant modulus X1 – 500 kPa 
(MPa) 
6.041 ± 1.832 6.824 ± 3.164 4.625 ± 0.872 
Secant modulus X2 – 60 kPa 
(MPa) 
0.817 ± 0.242 0.733 ± 0.167 0.485 ±0.128 
Secant modulus X2 – 250 kPa 
(MPa) 
1.814 ± 0.371 1.763 ± 0.312 1.358 ±0.249 
Secant modulus X2 – 500 kPa 
(MPa) 
2.989 ± 0.538 2.946 ± 0.460 2.357 ± 0.348 








Extensibility X2 0.153 ± 0.0256 0.157 ± 0.0164 
0.189 ± 
0.0291 
UTS (MPa) 21.087 ± 4.144 22.438 ± 5.619 
12.324 ± 
4.352 















A.3.2 Biaxial mechanical response 
The mean equibiaxial stress–strain curves in the preferred and cross-fiber directions for the 
three age groups are shown in Figure 74. In general, the mean curves exhibited the well-
known nonlinear stress-strain response of soft tissues. The initial portion of the curves, 
known as the toe region, had a high deformation/low stress characteristic due to the un-
crimping of collagen fibers and elasticity of elastin. Collagen fibers were then 
progressively recruited and dominated the stiff mechanical response at higher stress levels. 
A more gradual transition from low to high stiffness regions was observed in FBP, while 
ABP and CBP had a more pronounced rapid stiffening effect at the transitional region in 
both directions. From Figure 74 it can also be seen that all of the tested tissues exhibited 
anisotropic behavior, being much less extensible in the preferred fiber direction. 
From Figure 75 and Table 34 it can be seen that a significant difference in tissue 
stiffness was observed in the preferred fiber direction at 60 kPa, where ABP and CBP were 
significantly stiffer than FBP (P<0.001 and P=0.016, respectively). Similarly, at 250 kPa 
ABP was significantly stiffer than FBP (P=0.029), and although CBP had a higher stiffness 
than FBP at this stress value, this difference cannot be considered statistically significant. 
A similar trend was observed at 500 kPa in the preferred fiber direction, but this also cannot 
be considered statistically significant. In the cross-preferred fiber direction, however, ABP 
and CBP were significantly stiffer than FBP at all stress values (P<0.001 and P=0.007 at 
60 kPa respectively, P=0.007 and P=0.010 at 250 kPa respectively, and P=0.010 at 500 
kPa), see Figure 75 and Table 34. There was no statistically significant difference in tissue 
stiffness between the ABP and CBP groups at all stress values. 
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Figure 74. Equibiaxial response data for ABP, CBP and FBP, presented as mean 
curves with standard deviation bars. 
 
To further illustrate the differences in mechanical properties between the three age 
groups, linear regression was used to calculate the extensibility at the high-modulus linear 
region of the stress-strain curves (see Figure 76, Table 34). As expected, FBP showed a 
higher extensibility than ABP and CBP, with a statistically significant difference in the 
cross-preferred fiber direction (P=0.007 and P=0.011, respectively). CBP samples 
exhibited a similar strain range to ABP samples. The mean DA values for the three age 
groups indicated that the BP specimens exhibited anisotropic behavior, where the cross-
fiber direction doubled the strain value found in the preferred fiber direction at all ages 
(Table 34). The DA was not significantly different between the three age groups. Overall, 
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ABP and CBP demonstrated a markedly higher stiffness than FBP, while FBP was 
significantly thinner and more compliant than the ABP and CBP groups. 
 
Figure 75. Mean and standard deviation of stiffness measurements calculated as 
secant modulus at three stress levels for ABP, CBP and FBP. (*) indicates a 




Figure 76. Mean and standard deviation of extensibility measurements for ABP, 
CBP and FBP. (*) indicates a statistically significant difference. 
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A.3.3 Uniaxial failure 
The UTS of ABP and CBP is found to be much greater than for FBP, with a high statistically 
significant difference (P<0.001) (Figure 77A). On the other hand, the UTE was 
significantly greater for FBP than for ABP and CBP samples (P<0.001) (Figure 77B). 
These tensile properties reflect the significantly higher tangent modulus of the ABP and 
CBP tissue compared with the FBP  (P=0.003 and P=0.007, respectively) (Table 34), and 
is in agreement with the biaxial data presented. There was no statistically significant 
difference in tensile properties between the ABP and CBP groups. 
 
Figure 77. Mean and standard deviation of A) UTS measurements and B) UTE 
measurements for ABP, CBP and FBP. (*) indicates a statistically significant 
difference while (**) indicates a high statistically significant difference. 
 
A.3.4 SHG imaging and local angle analysis 
SHG microscopy is a nondestructive imaging tool that allows for clear visualization of 
collagen fibers throughout connective tissue without staining or pretreatment (482). 
Regarding the estimation of local collagen fiber orientation, Figure 78D, E, F shows an 
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example of the local angle distributions for BP samples of different ages. The measured 
preferred fiber orientation of these samples agrees with the fiber architecture visually 
identified under the light source, with peak angles around 10°, 8° and 4° for ABP, CBP 
and FBP samples, respectively. As can be seen in the mean local angular histograms, the 
angular values obtained with the ImageJ-Matlab in-house code are in line with the way the 
samples were positioned in the biaxial device. By identifying the preferred and cross-
preferred fiber directions, errors caused by intra- and inter-specimen structural variations 
can be reduced, providing a means for the improved characterization and modeling of the 
mechanical properties of the BP. 
 
Figure 78. Representative SHG images for ABP, CBP and FBP (A-C) and 
estimation of local collagen fiber orientation (D-F). 
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Examination of collagen fibril architecture clearly indicates a different structural 
arrangement between the FPB tissue and the ABP/CBP groups (Figure 78A, B, C). At the 
fetal stage, small collagen fibers were primarily arranged parallel with the X1 loading axis. 
However, some regions showed fibers traversing and interweaving with other fibrils, which 
were not aligned with the principal axis (Figure 79C). In general, SHG images of FBP 
showed loosely packed small collagen fibers that lacked the typical mature closely packed 
collagen morphology. On the other hand, the collagen architecture of the adult and calf 
samples indicated a more organized collagenous matrix. Thick collagen bundles were still 
predominantly parallel to the X1 direction in a dense wavy pattern, although with an 
apparent increased crimp period (Figure 79A,B). Collagenous tissues typically fall into two 
categories: one composed of typically large, closely packed fibers, and the other composed 
of more uniform fibers of smaller average diameter with larger inter-fiber spaces (483). 
A.3.5 Histological analysis 
The picrosirius polarization method is simple, sensitive and specific for collagen staining. 
In conjunction with circularly polarized light, it is particularly useful to quantify the 
collagen content and study the organization and thickness of collagen fibers (475). 
Histological images revealed that the FBP samples contained more immature collagen 
fibers than those of the ABP and CBP samples (Figure 79). Collagen color (hue) 
quantitative examination of the images substantiated this finding, with a statistically 
significant difference in the percentage of green thin fibers between ABP and FBP (1.969% 
versus 5.548%, P<0.001), and between CBP and FBP (2.629% versus 5.548%, P<0.001), 
where the proportion of thin newly synthesized fibers decreased with increasing age. 
Although the differences between the three age groups for the yellow-orange (thick) 
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collagen fibers did not achieve statistical significance, our SHG results indicate changes in 
collagen fiber structure during BP tissue maturation. 
 
Figure 79. Representative picrosirius red-stained cross-sections for A) ABP, B) 
CBP, and C) FBP. 
 
A.3.6 Constitutive modelling fit 
The two constitutive models successfully fit the experimental data quantitatively in both 
the preferred and cross-preferred fiber directions. The material parameters and r2 values 
for each age group obtained from the two models fit are summarized in Table 35. The mean 
seven-protocol stress–strain curves with the corresponding fit are shown in Figure 80. The 
individual parameters for each sample and r2 values are listed in Table 36,  
Table 37 and  
 




Table 35. Material parameters for the Fung and Modified-Holzapfel models. 
Fung model 
 𝑐 (𝑘𝑃𝑎) 𝐴1 𝐴2 𝐴3 𝐴4 𝐴5 𝐴6 𝑟
2 
ABP 21.88 58.25 27.87 4.49 5.54 -1.43 0.62 0.98 
CBP 10.71 104.62 39.89 -4.60 9.89 1.80 -0.15 0.98 
FBP 4.54 76.36 33.85 0.61 7.23 1.17 -0.008 0.98 
Modified-Holzapfel model 
 𝑐1 (𝑘𝑃𝑎) 𝑐2 𝑘1 (𝑘𝑃𝑎) 𝑘2 𝐷 𝛩 (𝑑𝑒𝑔) 𝑟
2 
ABP 11.58 41.37 34.61 7.13 0.0005 0 0.97 
CBP 14.16 30.57 55.21 3.84 0.0005 8.6 0.96 




Figure 80. Mean responses of the seven experimental protocols (open circles) for 
ABP, CBP and FBP with A) fit to Fung model (solid diamonds), and B) fit to 
modified-Holzapfel model (solid diamonds). 
 
Table 36. Individual APB material parameters for the Modified-Holzapfel model. 
𝒄𝟐 𝒌𝟏 (𝒌𝑷𝒂) 𝒌𝟐 𝒄𝟏 (𝒌𝑷𝒂) kappa 𝜣 (𝒅𝒆𝒈) 𝒓
𝟐 
7.476 57.491 14.651 14.706 0.000 0.000 0.971 
12.599 44.854 46.487 4.477 0.000 0.000 0.955 
10.864 198.394 16.649 8.334 0.000 0.000 0.966 
13.326 24.103 58.410 9.317 0.000 0.000 0.973 
10.257 56.497 26.584 5.190 0.000 0.000 0.969 
11.151 5.802 60.969 12.584 0.000 18.677 0.960 
9.646 29.807 13.855 4.880 0.000 0.000 0.961 
10.924 17.544 34.441 6.412 0.000 0.000 0.970 
12.852 22.735 49.923 5.116 0.000 0.000 0.943 
14.599 39.965 159.399 11.735 0.000 14.407 0.922 
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Table 37. Individual CPB material parameters for the Modified-Holzapfel model. 
𝒄𝟐 𝒌𝟏 (𝒌𝑷𝒂) 𝒌𝟐 𝒄𝟏 (𝒌𝑷𝒂) kappa 𝜣 (𝒅𝒆𝒈) 𝒓
𝟐 
12.228 22.596 59.077 5.570 0.000 0.000 0.955 
15.088 338.596 438.799 5.181 0.172 0.000 0.947 
16.302 170.374 321.873 3.336 0.113 9.373 0.962 
13.899 0.244 31.591 1.560 0.000 90.000 0.954 
13.232 4.065 61.644 5.084 0.000 0.000 0.954 
13.948 522.786 84.803 1.687 0.130 0.000 0.987 
16.735 13.416 96.851 6.358 0.000 0.000 0.948 
13.604 5.450 68.675 5.747 0.000 0.000 0.937 
11.201 34.070 27.854 5.066 0.000 0.000 0.950 
11.847 46.574 157.574 3.669 0.204 0.000 0.957 
10.974 3.710 87.112 9.489 0.010 0.000 0.966 
 
 
Table 38. Individual FPB material parameters for the Modified-Holzapfel model. 
𝒄𝟐 𝒌𝟏 (𝒌𝑷𝒂) 𝒌𝟐 𝒄𝟏 (𝒌𝑷𝒂) kappa 𝜣 (𝒅𝒆𝒈) 𝒓
𝟐 
12.618 1.646 28.692 1.546 0.000 0.000 0.913 
10.172 64.281 64.510 2.327 0.119 8.895 0.982 
12.860 2.732 20.421 3.421 0.000 0.000 0.927 
15.654 48.178 98.776 0.519 0.167 0.002 0.961 
12.805 46.280 194.971 4.714 0.187 0.001 0.964 
11.214 15.470 44.285 1.879 0.056 5.275 0.954 
7.788 2.075 25.084 3.865 0.040 19.568 0.948 
11.509 17.494 61.585 3.576 0.070 0.000 0.952 
14.314 2.927 76.390 1.431 0.000 0.000 0.973 
11.319 8.674 101.780 1.202 0.082 0.000 0.927 





A.4.1 Tissue properties related to collagen maturation and aging 
The age-related changes that manifest in the increased stiffness and mechanical strength of 
the CBP and ABP tissues can be attributed primarily due to the intermolecular cross-linking 
of the collagen. The molecular mechanisms involved during growth, maturation and aging 
of collagenous tissues are well known and comprise two different mechanisms, a precise 
enzymatic process during development and maturation, and a subsequent non-enzymatic 
adventitious reaction with glucose and its oxidation products during aging, a process 
referred to as glycation (459). Although both of these processes affect the mechanical 
properties of collagenous tissues, the most dramatic changes in stiffness and mechanical 
strength occur between embryonic growth and maturity (484), as observed between the 
FBP group and the ABP/CBP groups in this study. This age-related stiffening of the BP is 
consistent with findings previously reported in other connective tissues such as cartilage 
(485) and tendons (463), as well as with human and porcine valves (486) (487).  
The histological analysis revealed a statistically significant difference in the 
percentage of green collagen fibers between the three tissue groups, where the proportion 
of thin fibers decreased with increasing age. The results of the histological analysis are in 
line with the findings of the SHG microscopy, showing that the FBP samples are mainly 
composed of small collagen fibers.. Collagen’s ultimate tensile strength, in the range of 1 
MPa, is directly proportional to the diameter of the fibrils (458). Thus, thicker fibers in the 
mature collagen will be stronger than the thinner fibers observed in the younger collagen 
(488) (489) (490). However, with increasing diameter, the flexibility of the tissue also 
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decreases and a reduction in the ability to resist crack propagation can be observed. 
Conversely, the plastic deformation, or creep, is directly related to the proportion of small 
diameter fibrils (491).  
Regarding tissue elongatiom, there was a significant difference in the extensibility 
between the fetal and mature tissues, where FBP showed a higher extensibility than ABP 
and CBP. When viewed under SHG microscopy, the FBP tissue appeared to exhibit a 
higher waviness than the CPB and ABP samples. This crimp is believed to act as a shock 
absorber system and is responsible for the initial low-slope “toe region” of the biological 
stress–strain curve. The higher extensibility found in the FBP tissue can be ascribed to the 
lower level of crimp period of the fiber network, resulting in a higher elongation at 
alignment and a higher elongation at break. With increasing age, the crimp amplitude 
decreases and crimp wavelength increases thus decreasing the shock absorbing effect 
(492). The finding that extensibility decreases with collagen maturation and aging is 
consistent with previous age-related studies in tendon collagen (493), human aortic valves 
(494) and in porcine mitral and aortic valves (487). 
A.4.2 Comparison with BP tissue properties reported in the literature 
To the author's knowledge, the only published study that has mechanically assessed and 
compared the age-related differences in BP was developed by Sizeland et al. (2014) (464). 
GL-treated neonatal (4-7 days old) and adult (18-24 months) BP samples were subjected 
to uniaxial testing. Beyond the limited uniaxial tensile methodology reported, the authors 
found that neonatal pericardium had a significantly higher elastic modulus and UTS than 
ABP. On the other hand, the UTE was significantly higher for ABP than for neonatal BP. 
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An opposite trend was observed in the uniaxial testing results of this study. It is important 
to note that the fetal tissue used in our study was obtained during the third trimester of 
cattle gestation, while the neonatal tissue used by Sizeland and colleagues was obtained 
from cattle between 4-7 days old. Additionally, it was not clear from the study what type 
of tissue presorting and preconditioning, if any, were carried out. Although this age 
difference and testing criteria could help to explain the discrepancies in the mechanical 
properties, current literature generally agrees that in collagenous tissues the stiffness and 
UTS increase with maturity (460) (484) (487), as found in this study.  
The results of this study are also consistent with previous reports regarding the 
mechanical properties of chemically treated CBP (495). Recently, uniaxial tensile tests 
performed by Gauvin et al. (2012) (496) showed an UTS for GL-treated CBP of 
approximately 25 MPa, while Bai et al. (2013) (497) reported an UTS of 29 MPa and 25 
MPa for GL-treated and decellularized CBP, respectively. Further uniaxial loading tests 
were performed on native and GL-treated BP by Hulsmann et al. (2013) (498). The UTE 
value of 50% obtained for the fixed tissue is comparable to the value found in this study 
for CBP. The results of this study are also consistent with previous reports regarding the 
UTE (499) (500) and UTS (501) (502) of BP. 
Concerning stiffness, it is accepted to define the elastic modulus as the slope of the 
stress-strain curve in the linear portion of it. However, there is a plurality of biomechanical 
parameters used in the literature, because of the pseudoelastic nature of soft tissues. 
Reported values for the elastic modulus of GL-treated BP under uniaxial loading range 
from 10 MPa up to 190 MPa (496, 498). A study done on decellularized BP samples 
showed similar values of elastic modulus as presented in this study (92.9 ± 21.6 MPa) 
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(502). Similarly, Sanchez et al. (2010) (503) reported an elastic modulus for GL-treated 
ABP with three different fiber orientations (0°, 45° and 90°). For the ABP samples at 0° 
fiber orientation, as defined in this study, Sanchez and colleagues found a stiffness value 
of 105 MPa, a finding consistent with this study.  
Even though uniaxial tensile testing is advantageous for the determination of failure 
properties, biaxial testing can provide more complex insight into the coupling of the tissue 
directional response. Until now, only limited studies on the mechanical properties of 
chemically treated or fresh BP using biaxial testing were available (453, 456, 457, 495), 
which did not quantify the age-dependent mechanical differences. The Sacks group 
investigated the relationship between BP mechanical properties and tissue structure, 
suggesting that the local collagen fiber architecture plays a major role in determining the 
degree of mechanical anisotropy (454, 504, 505). The results of this study are in line with 
the above findings, showing that the BP stress–strain response is highly anisotropic.  
A.4.3 Implications for BHV manufacturing 
In this study, three main findings can be highlighted in relation to the identification of an 
optimal BP candidate biomaterial for manufacturing BHV. First, there were no statistically 
significant differences in the mechanical properties between the ABP and CBP tissues. 
Therefore, CBP is as strong but significantly thinner than ABP. These findings suggest 
(and support the current tissue selection process (457)) that CBP may be a better tissue 
source for the design of BHV, especially in the manufacturing of percutaneous heart valve 
technologies. Second, although FBP was significantly thinner than CBP and ABP, the fetal 
tissue was also significantly more extensible and more compliant than the adult and calf 
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tissues. It has been shown that heterogeneity in the structure and properties of the BP, with 
particularly high extensibility in a particular site, can cause stretching of the leaflet and 
result in prolapse (506). One could argue that the decreased thickness of the FBP would 
enable percutaneous BHV to develop smaller profile configurations. However, FBP— 
having the mechanical properties and characteristics described herein—  should be used 
with caution and additional tissue characterization is needed before it can be considered as 
a suitable biomaterial for BHV design.   
Third, biaxial mechanical testing revealed that the mechanical behavior of the BP 
was quantitatively consistent with the specimen local fiber architecture. The high 
compliance of the aortic valve leaflet along its radial direction allows the leaflet to be 
stretched in the diastolic cycle, while the circumferential stiffness is important for 
supporting the high transvalvular pressure (507). Such anisotropic properties of the valve 
leaflets are important for proper valve function (508); however, there is no evidence that 
the current process on fabrication of BP BHV considers the direction of the tissue fibers 
with respect to the flow. Based on the findings of this study, it is  suggested that in order 
to mimic the native response of native valve leaflets, BP specimens with good structural 
uniformity should be oriented in a way such that the preferred fiber direction aligns with 
the circumferential direction of the leaflet, thus increasing stiffness in that direction; while 
the cross-preferred fiber direction should be aligned along the radial direction, enhancing 
leaflet apposition. 
A.4.4 Modelling of BP leaflets 
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This study provides the first complete set of multi-protocol biaxial mechanical data for BP 
tissues of varying age. Biaxial testing provided independent control of stresses along 
perpendicular axes and information regarding the changes in coupling between the primary 
fiber and cross-fiber directions in BP tissue. BP demonstrated complex, highly anisotropic 
mechanical behavior, including pronounced mechanical coupling between the preferred 
and cross-preferred fiber directions. In fact, mechanical coupling between the axes 
produced negative strains along the preferred fiber direction in some samples subjected to 
non-equibiaxial loading. Additionally, our biaxial data clearly demonstrated the impact of 
maturation and age on the mechanical behavior of the BP, both in terms of stiffening and 
extensibility. Taken together, these results demonstrate the importance of utilizing 
multiaxial constitutive relationships within finite element models to accurately predict the 
mechanical response of BP. The constitutive models developed throughout this study, 
which describe the mechanical behavior of adult, calf and fetal BP tissues to a high degree 
of accuracy, may now be implemented in finite element models to study the biomechanics 
of a widely used BHV biomaterial. 
A.5 Limitations 
There are some limitations in this study. First, BP sacs were cryopreserved prior to fixation 
and testing. However, cryopreservation has been shown to ensure the structural integrity 
of collagenous tissues (509, 510) (511) (512) (513, 514). Vinci et al. (2013) (515) 
investigated the mechanical properties of decellularized cryopreserved human 
pericardium. Uniaxial tensile loading tests revealed equivalent elastic modulus, UTS and 
UTE of the decellularized tissue, before and after the cryopreservation, in comparison with 
the fresh tissue. Second, the sample size for the three age groups was relatively small; a 
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larger sample size would provide more statistical power in analyzing the data. Considering 
the effects of age on the mechanical properties of biomaterials, another limitation was the 
relatively narrow age range between the CBP and the ABP tissues compared to the broader 
age range between the FBP and the CBP tissues. A larger sample size including BP tissue 
between birth and 6 months of age would facilitate a deeper understanding and comparison 
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